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BACKGROUND Poultry production is facing a challenging future as there is a growing global demand for human-edible protein sources (Wu et al., 2014). Poultry meat could play a role in fulfilling this demand due to its favourable hedonic value, its nutritive value, the absence of cultural or religious restrictions concerning its consumption and the efficiency of its production (Magdelaine et al., 2008). As a consequence, intensive poultry production is regarded as one of the main provider of additional animal protein to meet the growing global demand (Mottet and Tempio, 2017). Policy makers are, however, concerned that a further increase in worldwide livestock production could lead to a competition for the use of human-edible ingredients between feed, fuel and food production activities (Banerjee, 2011). Such concerns can be mitigated by substituting cereals by local oilseeds by-products in livestock diets (Manceron et al., 2014) and by achieving modest gains in feed efficiency (Mottet et al., 2017). Both strategies are sometimes difficult to conciliate in the European context. For instance, complete substitution of overseas imported soybean meal by locally produced rapeseed meal can hamper growth performance of broilers (Qaisrani et al., 2014). Thus, there is a need to find strategies that allow an extensive use of locally available by-products while maintaining or even improving growth performance of birds. Additionally, welfare of broilers and the use of antibiotics as growth promoters are developing concerns in Western societies (Smith, 2011). Taken together, these facts indicate that the poultry production sector is prompted to find strategies that can ensure improved growth performance, health and welfare while using new feed ingredients that decrease cereal use and soybean meal dependence as well as the use of antibiotics (Jez 
et al., 2011).   A better understanding of digestive dynamics of macronutrients in the avian GIT (Liu and Selle, 2015) and their associated effects on growth performance and nutrient utilization (Liu et al., 2016) may help address this challenging future. Gaining a fundamental understanding of unique features of the avian GIT such as digesta reflux may be of relevance in this context (Sacranie et al., 2005). In addition, several technological advances maybe equally relevant: e.g. next-generation sequencing to further improve the health and growth potential of birds (Diaz-Sanchez et al., 2013), enzymatic and processing technologies to upgrade the nutritional value of by-products (de Vries et al., 2012) or feed additives modulating gut functions and immunity (Klasing, 2006). Among feed additives, butyrate has received much attention and has been proposed as a potential solution to help the poultry sector to address the aforesaid challenges (Ahsan et al., 2016). This nutritional strategy is governed by the putative capacity of butyrate to trigger different mechanisms in the avian gastrointestinal tract (GIT) as presented in Figure 1.  
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Dietary butyrate supplementation has however an inconsistent effect on the growth performance of broilers, with factors such as inclusion level, health status, age of the bird or diet composition being influential for the observed effects on growth performance (Cerisuelo et al., 2014; Polycarpo et al., 2017). Several mechanisms underlying the observed effects of butyrate on growth of livestock have been hypothesised (For review, see Guilloteau et al., 2010). At present, a limited number of studies have investigated the existence of such mechanisms in poultry (Zhang et al., 2011; Liu et al., 2017). In addition, most of the poultry studies resorted to only one butyrate additive and did not report butyrate concentrations along the GIT (e.g. Czerwinski et al., 2012; Cerisuelo et al., 2014). Hence, it remains uncertain whether the effects elicited by butyrate are conditioned by the GIT segment wherein the molecule is present. This dearth of knowledge could limit the full use of butyrate supplements as a nutritional strategy to meet the challenges of the poultry industry.   
Bacteriostatic and 
bactericidal effects 
Butyrate presence in the gastrointestinal tract 
Intracellular effects Sensing by enteroendocrine cells 
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Figure 1. Putative modes of action of butyrate resulting in changes in the growth performance of 
broiler chickens 
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RESEARCH QUESTIONS AND HYPOTHESIS The present thesis aims to address the following research questions: 
• What are the effects of supplementing broiler diets with butyrate on digestive function, microbiota composition and immune responses? 
• Are such effects conditioned by the GIT segment wherein the molecule is present?  It is hypothesised that the presence of butyrate in the GIT may influence gut hormone levels and digestive functions (e.g. passage rate or enzymatic activities) in a manner that could influence nutrient digestibility. In addition, it is hypothesised that butyrate presence would also modify immune response (e.g. pro-inflammatory cytokines levels or specific antibody responses). Putative effects on digestive function and immune response may also add up to direct effects of butyrate on prokaryotic cells, resulting in changes in cecal microbiota composition. Finally, given the diversity of cell type and physico-chemical conditions encountered throughout the avian GIT, it was hypothesised that the effects elicited by butyrate would vary according to the GIT segment considered. Hence, the overall aim of this study was to gain insights in the mechanisms underlying the effects of dietary butyrate supplementation on growth performance of broiler chickens. 
OUTLINE OF THE THESIS This thesis describes the results of an in vitro experiment and two in vivo trials. Chapter 2 consists of a review of the literature concerning potential modes of action of butyrate in the avian GIT, highlighting a potential role of butyrate presence in the digesta of distinct GIT segments in triggering specific effects. In Chapter 3, an in vitro model was used to compare the release profiles of experimental and commercially available butyrate additives along a simulated poultry GIT. Based on the outcome of this 
in vitro screening, several additives were included in the trial described in Chapter 4, in order to investigate the effects of butyrate presence in the digesta of distinct GIT segments on digestive processes and amino acid digestibility. In Chapter 5, a gene expression approach was applied in an effort to associate observed changes in digestive processes to changes in the secretory activities of different enteroendocrine cells subsets. In addition, the relationship between mucosal butyrate concentration and the expression of genes related to butyrate metabolism was investigated. In Chapter 6, the intricate relationship between cecal microbiota composition, pre-cecal digestive processes, butyrate presence along the GIT and expression of immune effectors was explored. We investigated in Chapter 7 the effect of butyrate presence in the digesta of distinct GIT segments on immune responses after in vivo stimulations. Finally, Chapter 8 summarizes and discusses the results of the previous chapters.   
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ABSTRACT In the field of animal nutrition, butyrate is used as a feed additive and can be fed as an unprotected salt or in the form of protected additives such as butyrate glycerides or butyrate-loaded matrices. Dietary butyrate supplementation has been shown to improve growth performance and resilience of broiler chickens through distinct mechanisms operating on both eukaryotic and prokaryotic cells. Firstly, butyrate influences endogenous avian cells in multiple ways: it is an agonist of free-fatty acid receptors, an inhibitor of pro-inflammatory pathways, an epigenetic modulating agent and finally an energy source. Secondly, butyrate influences the microbiota residing in the avian gastrointestinal tract (GIT) as a result of its bacteriostatic properties. The responses, e.g. changes in growth performance, gut morphology, carcass traits or nutrient digestibility of chickens, to dietary butyrate supplementation are inconsistent with factors such as additive inclusion level, diet composition, age and health status of the bird modulating the effects of butyrate and its additives. For many additives, the precise GIT segment wherein butyrate is released is unclear. Release location may also affect the observed effects of butyrate given the diversity of cell types and pH conditions encountered throughout the gastrointestinal tract of poultry, and the differences in microbiota composition in the different gut segments. As a consequence, our understanding of the mode of action of butyrate is hampered. Characterization of existing additives and development of targeted-release formulations are, therefore, important to gain insight in the different physiological effects butyrate can elicit in broiler chickens.  
Keywords: Butyrate, broiler, release location, mode of action    
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INTRODUCTION Butyrate is used as a feed additive for broiler chickens and reported responses are mostly favourable in terms of maintaining optimal gut health and stimulating growth performance. Butyrate effects on growth performance, however, are sometimes inconsistent and its mode of action is not yet fully understood (Cerisuelo et al., 2014). In human medicine, butyrate has been advocated as a promising molecule for the prevention or amelioration of a number of human diseases such as inflammatory bowel disease and colon cancer (Segain et al., 2000; Sengupta et al., 2006). However, butyrate has not always achieved all the expected multifarious, positive effects in a consistent manner. As a result, reviews related to this molecule often contain interrogative titles, e.g. “The butyrate story: old wine in new bottles?” (Scheppach and Weiler, 2004) and “Butyrate: what is the future for this old substance?” (Sossai, 2012). Regarding its use as a feed additive for broilers, factors such as inclusion level, diet composition, age and health status of the birds should be taken into account when assessing the effects of butyrate additives (Cerisuelo et al., 2014). Several reviews have been published on this subject, describing endogenous production and effects on gastrointestinal epithelial cell function in mammals (Guilloteau et al., 2010a), butyrate metabolism (Astbury and Corfe, 2012) and its modulating effects on immunity in humans (Meijer et al., 2010).   The present review aims to describe the response of broiler chickens to dietary butyrate supplementation, with an emphasis on the importance of release location in relation to the various effects of this molecule. The first section of this review briefly describes the different butyrate additives currently used in the animal feed industry. Next, discrepancy in the literature regarding avian responses to dietary butyrate supplementation is discussed. Finally, proven modes of action in poultry of butyrate are discussed and putative modes of actions derived from research on mammals are presented. In this review, information from other species is used where there data on avian species is lacking. No distinction between endogenous synthesised or exogenous dietary butyrate are made in the present review, as the microbial or dietary origin of the molecule does not change its effect at the gut level. Butyrate can be present as an anion, as a salt or as an acid (Kato et al., 2011). It is widely accepted that the anion form (CH3-CH2-CH2-COO-) is mediating the effects reported in literature (Guilloteau et al., 2010a). The term “butyrate” used here encompasses the acid, salts and anion forms. Concerning the description of dietary inclusion rates in the present contribution, g/kg refers to g of butyrate, corrected for coating material, per kg of diet. 
BUTYRATE ADDITIVES USED IN ANIMAL NUTRITION 
Unprotected butyrate Unprotected butyrate will be mainly present in a protonated form due to the low pH in the stomach of monogastric animals due to its pKa of 4.82. Butyrate is taken-up by non-ionic, passive absorption in the stomach (Ichikawa et al., 2002). As such, supplementation of unprotected forms leads to a significant increase in butyrate concentration in the gastric region but not in the jejunal chyme of broilers (Hu and Guo, 2007) nor in the cecum, colon and rectum of pigs (Manzanilla et al., 2006). As a consequence, unprotected butyrate is supposed to exert mainly effects on epithelial 
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cells and microbiota of the crop, proventriculus and gizzard of broiler chickens. It is unclear whether delivery at these segments of the gastrointestinal tract (GIT) is effective in eliciting effects on growth performance, gut morphology and immune system regulation. Much research has been conducted to ‘protect’ the butyrate to achieve release in the more distal GIT, where it is also produced by microbiota. 
Mono-, di- and tributyrins Butyrins include mono-, di- and tri-glycerides of butyrate. As chickens have very limited pre-duodenal lipolytic activity (Moreau et al., 1988), it is assumed that butyrate will mostly be released in the small intestine under the action of pancreatic lipase. Pancreatic lipase can also be present in the gizzard of poultry due to reflux (Sklan et al., 1978). It is, however, known that pancreatic lipase activity on tributyrin is compromised at low pH (Borgström, 1975). Endogenous lipases are solely able to cleave ester bonds of triacylglycerol at the sn-1 and sn-3 position (Doreau and Chilliard, 1997). As a consequence, part of the butyrate is inevitably absorbed as sn-2 monobutyrin in the duodenum and jejunum.  
Butyrate-loaded matrices Butyrate can be embedded in a continuous matrix. Such matrices can be characterized by the type of embedding material used and by the average bead diameter. Although commonly referred to as fat coated or microencapsulated butyrate in the literature, these description are inaccurate as in microencapsulated or coated products, an outer shell can be distinguished from an inner core. Vegetable fat seems to be the most common embedding material for use in animal nutrition (Smulikowska et 
al., 2009; Zhang et al., 2011a; Czerwinski et al., 2012; Jerzsele et al., 2012). The used fat source and mean bead diameters of products are often not reported in the published research papers. In addition, the butyrate inclusion percentages in the matrix are variable. Most trials have been conducted with matrices loaded at a concentration of 30% w/w (e.g. Smulikowska et al., 2009). The use of matrices loaded at 70% w/w has also been reported (Jerzsele et al., 2012). Release kinetics can be affected by general parameters such as the type of embedding material used or inclusion level (De Brabander et al., 2000; Vervaeck et al., 2013). The aforementioned characteristics may vary from one feed additive supplier to the other. As a consequence, the GIT segment wherein butyrate is released is difficult to predict with currently used butyrate-loaded matrices. It is generally accepted that fat matrices provide a partial protection from gastric absorption, thus increasing the delivery of butyrate to the small intestine. Concerning the availability at colonic and caecal level, information is scarce. However, it has been shown that feeding vegetable-fat based matrices containing butyrate does increase the butyrate concentration in the colon of pigs (Mallo et al., 2012). Similar results are observed in the caeca of broilers (Onrust, unpublished data).    
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EFFECTS OF BUTYRATE ON GROWTH PERFORMANCE, GUT MORPHOLOGY, CARCASS 
TRAITS AND NUTRIENT DIGESTIBILITY IN BROILERS CHICKENS 
Effect on growth performance As indicated in Table 1, butyrate can improve body weight gain, voluntary feed intake and feed efficiency of broiler chickens. Literature data, however, show large discrepancies in the effect of butyrate on growth performance, both among and within additives. It has been reported that health status of the animal, diet composition and environmental conditions influence the response of the broilers to butyrate supplementation, thereby explaining part of the inconsistencies (Cerisuelo et al., 2014). In the case of unprotected butyrate supplementation, dose effects might also play a role. Indeed, Hu and Guo (2007) and Panda et al. (2009) used larger doses than Zhang et al. (2011b) and the latter authors could not find any effect of butyrate on growth performance of broilers. Concerning fat coated butyrate, discrepancies might also be due to differences in matrix characteristics. Fat coated butyrate used in published studies originated from various suppliers.  
Effect on gut morphology Long villi and short crypts are generally regarded as indicators of a healthy and functional small intestine. However, these parameters only provide partial information on the intestinal surface and function. Additional read-out parameters such as mucosal enzyme activity, mucus layer thickness and composition, or number and quality of goblet cells should be included to elaborate on gut health and digestive capacities (Van Dijk et al., 2002). In this section, only villus height (VH) and crypt depth (CD) are used as indicators of intestinal health.  As shown in Table 2, effects of butyrate additives on gut morphology are inconsistent. Unprotected butyrate seems to improve duodenal as well as jejunal morphology when fed at levels equal to, or higher than, 2 g/kg during the 0-35 d period (Hu and Guo, 2007). Concerning fat coated butyrate, information originating from the literature is inconsistent. Jerzsele et al. (2012) as well as Czerwinski et al. (2012) found positive effects of supplementation on jejunal VH using 1.05 and 0.3 g/kg inclusion levels, respectively. Conversely, Smulikowska et al. (2009) did not find any significant effect of 0.3 g/kg supplementation on jejunal morphology. Butyrate glycerides also seem to show conflicting effects on gut morphology. Leeson et al. (2005) did not find any effect of butyrate glycerides on VH or CD. Antongiovanni et al. (2009) found that butyrate glycerides can significantly reduce ileal and jejunal VH while increasing ileal CD. Sayrafi et al. (2011) reported a significant increase in duodenal CD when butyrate glycerides were fed to broilers. Antongiovanni et al. (2009), also showed that high levels of butyrate glycerides supplementation significantly increased the number of villi per length unit and the number of jejunal microvilli.    
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tal per
iod. 
Blend o
f mono
-, 
di- and
 tri-
butyrin
s 
 
Leeson
 e
t a
l. 
(2005)
 
Exp.1: 
C: Cont
rol, T1
: 11 pm
 virgini
amycin
 in SGF
, T2: 2 
g/kg 
BB in S
GF, T3:
 4 g/kg
 BB in S
GF. 
Exp. 2:
 C: Con
trol, T1
: 50 pm
 bacitra
cin in S
GF, T2:
 1 g/kg
 BB 
in SGF,
 T3: 2 g
/kg BB
 in SGF
. 
Experi
ment 1
: No eff
ect of d
ietary t
reatme
nts on 
BWG. T
3 birds
 showe
d a red
uced 
VFI (-7
.7%) co
mpare
d to co
ntrol b
irds. 
Experi
ment 2
: No eff
ect of d
ietary t
reatme
nts on 
perform
ance pa
ramete
rs. 
Antong
iovann
i 
et
 a
l.  (2009
) 
C: Cont
rol; T1
: 2 g/kg
 BB in S
GF; T2:
 3.5 g/k
g BB in
 SGF; T
3: 
5 g/kg 
BB in b
oth SGF
 and T4
: 10 g/
kg BB i
n only 
S. 
Birds f
rom T1
 (+3.1%
), T3 (+
1.7%) 
and T4
 (+1.7%
) show
ed a sig
nifican
tly high
er 
slaugh
ter wei
ght tha
n C bir
ds. 
Mahda
vi and 
Torki (
2009) 
C: Cont
rol, T1
: 2 g/kg
 BB in S
, T2: 2 
g/kg B
B in SG
, T3: 2 
g/kg 
BB in S
GF, T4:
 3 g/kg
 BB in S
, T5: 3 
g/kg B
B in SG
, T6: 3 
g/kg 
BB in S
GF. 
No sign
ificant 
effect o
f dietar
y treat
ments 
on perf
orman
ce para
meters
. 
Aghaza
deh an
d 
Taha Y
azdi 
(2012)
 
2 x 4 fa
ctorial 
arrang
ement 
with tw
o form
s of wh
eat (wh
ole 
vs. gro
und): C
: Contr
ol; T1: 
2.5 g/k
g BB SG
F; T2: 2
.5 g/kg
 BB 
in S an
d 1 g/k
g BB in
 GF; T3
: 2.5 g/
kg BB i
n S. 
No sign
ificant 
effect o
f suppl
ementa
tion du
ring sta
rter, gr
ower/f
inisher
 or who
le 
period
 on BW
G and F
CR. T2 
resulte
d in a s
ignifica
ntly hig
her VF
I (+1.5
%). 
1 B: But
yrate; B
B: Buty
rins Bl
end; BW
G: Bod
y Weig
ht Gain
; Exp.: 
Experi
ment; F
: Finish
er feed
; FCR: F
eed Co
nversio
n Ratio
; G: Gro
wer fee
d; LPS:
 Lipopo
lysacch
aride; S
: Starte
r feed; 
SCFA: 
Short C
hain Fa
tty Acid
; T: Tre
atment
; VFI: V
oluntar
y Feed
 Intake
. 
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  Table 2
. Effect
 of diffe
rent bu
tyrate a
dditive
s on gu
t morp
hology
 of broi
ler chic
kens1  
Supple
mentat
ion for
m R
eferenc
es 
Experi
mental
 set-up
 
Effects
 on per
forman
ce para
meters
 expres
sed as 
a perce
ntage o
f respe
ctive co
ntrols 
Unprot
ected b
utyrate
 
 
Hu an
d Guo
 
(2007)
 
C: Cont
rol, T1
: 0.5 g/
kg B in
 SGF, T
2: 1 g/
kg B in
 SGF, 
T3: 2 g
/kg B i
n SGF 
Jejunal
 VH:CD
 ratio w
as sign
ificantl
y incre
ased fo
r T3 (+
32.3%)
 
Panda 
et
 
al
. 
(2009)
 
C: Cont
rol, T1
: 0.5 g/
kg fura
zolidon
e, T2: 2
 g/kg B
 in 
SGF, T3
: 4 g/kg
 B in SG
F, T4: 6
 g/kg B
 in SGF
 
Duode
nal VH
 (T2: +
7.25%;
 T3: +8
.9%; T4
: +8.1%
) and C
D (T2: 
+10.3%
; T3: +1
8.1%; 
T4: +15
.5%) w
ere sig
nifican
tly incr
eased b
y B sup
plemen
tation 
Fat coa
ted but
yrate 
 
Smulik
owska 
et
 a
l. (2009
) 
2 x 3 fa
ctorial 
arrang
ement:
 Enzym
e (Non
e or 1 g
/kg 
in SGF)
 and SC
FA (No
ne, 0.3 
g/kg B
 in SGF
, 1 g/kg
 of a 
SCFA b
lend in
 SGF) s
upplem
entatio
n. 
No sign
ificant 
effect o
f B on V
H, villu
s width
, CD an
d tunic
a musc
ularis w
idth in
 the 
jejunum
 or the 
ileum. 
Jerzsel
e et a
l. 
(2012)
 
C: Cont
rol, T1
: 1.05 g
/kg B i
n SGF, 
T2: 1 g
/kg of 
an 
essenti
al oils (
EO) ble
nd in S
GF, T3:
 T1+T2
 in SGF
, T4: 
109  CF
U of a p
robioti
c. 
B signi
ficantly
 increa
sed jeju
nal VH
 (+15.8
%) but
 did no
t signif
icantly
 affect 
VH:CD 
ratio. 
Czerwi
nski e
t 
al
.  (2012
) 
C: Cont
rol, T1
: 0.3 g/
kg B, T
2: 0.06
 g/kg s
alinom
ycin, 
T3: 0.3
 g/kg B
 and 0.
06 g/k
g salino
mycin.
 
B signi
ficantly
 increa
sed jeju
nal VH
 (+5.7%
) but d
id not s
ignifica
ntly aff
ect vill
us 
width, 
CD, VH
:CD rat
io or tu
nica m
uscular
is widt
h. None
 of thes
e param
eters w
as 
signific
antly a
ffected
 by die
tary tre
atment
s at ileu
m leve
l. 
Blend o
f mono
-, di- 
and tri
-butyri
ns 
 
Leeson
 
et
 
al
. 
(2005)
 
Exp. 1:
 C: Con
trol, T1
: 11 pm
 virgini
amycin
 in SGF
, T2: 
2 g/kg 
BB in S
GF, T3:
 4 g/kg
 BB in S
GF.  
Exp. 2:
 C: Con
trol, T1
: 50 pm
 batria
cyin m
ethylen
e 
disalicy
late in 
SGF, T2
: 1 g/kg
 BB in S
GF, T3:
 2 g/kg
 
BB in S
GF. 
VH and
 CD we
re mea
sured i
n expe
riment
 2 but n
o signi
ficant e
ffect of
 B was 
detecte
d 
Antong
iovann
i 
et
 a
l. (2009
) 
C: Cont
rol; T1
: 2 g/kg
 BB in S
GF; T2:
 3.5 g/k
g BB in
 
SGF; T3
: 5 g/kg
 BB in b
oth SGF
 and T4
: 10 BB
 g/kg in
 
only S.
 
VH was
 reduce
d by B 
in both
 jejunu
m and 
ileum (
T1: NS
 and -2
2.1%; T
2: -16.6
% 
and -22
.3%; T3
: -10.7%
 and -3
6.7%; T
4: -20.1
% and 
-28.5%
 respec
tively).
 Numb
er 
of villi 
per len
gth uni
t was s
ignifica
ntly inc
reased
 by T4 
(+19.3
%) in t
he ileu
m but 
not affe
cted by
 B in th
e jejun
um. Jej
unal m
icrovill
us leng
th was
 impro
ved in 
T1 
(+57%
) but u
naffect
ed in th
e ileum
. Jejuna
l CD wa
s signif
icantly
 increa
sed in T
1 
(+26.9
%) and
 ileal cr
ypts w
ere sig
nifican
tly dee
per in T
1 (-24.
1%), T
2 (-19.
3%) an
d 
T4 (-37
.7%). 
Sayrafi
 
et
 
al
. 
(2011)
 
C: Cont
rol, T1
: 1 g/kg
 prebio
tic, T2:
 3 g/kg
 BB in S
 
and 2 g
/kg in 
G, T3: 0
.5 g/kg
 bacitra
cin in S
 and 0.
25 
g/kg ba
citracin
 in GF. 
Duode
nal, jeju
nal and
 ileal V
H and w
idth we
re unaf
fected 
by B. B
 induce
d deep
er 
duoden
al cryp
ts (+25
.4%) w
ithout 
changi
ng VH 
in the j
ejunum
 or the
 ileum.
 
1 B: But
yrate; B
B: Buty
rins Bl
end; CD
: Crypt
 Depth
; Exp.: 
Experi
ment; F
: Finish
er feed
; G: Gro
wer fee
d; S: St
arter fe
ed, SCF
A: Shor
t chain
 fatty a
cid; T: 
Treatm
ent; VH
: Villus
 Height
. 
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Effects on carcass traits Supplementation of a broiler chicken diet with 2, 4 and 6 g/kg of unprotected butyrate results in a significant reduction of abdominal fat percentage and in an increase of dressed carcass weight (Panda et al., 2009). In another study using butyrins at inclusion levels ranging from 2 to 10 g/kg and measuring carcass traits such as dressing percentage, breast, thigh, drumstick and abdominal weights, no significant effects of supplementation was detected (Antongiovanni et al., 2009). Similarly, Leeson 
et al. (2005) did not find any significant effect of the inclusion of 2 or 4 g/kg of butyrins in both starter and grower/finisher diets on breast meat percentage of 42 d old broilers. Zhang et al. (2011a) also reported that supplementation of broiler diets with 0.4 g/kg of fat coated butyrate did not result in significantly different carcass characteristics in comparison to non-supplemented diets. However, in the same experiment, butyrate supplementation reduced drip loss of the breast muscle. Based on these studies it can be concluded that carcass characteristics are inconsistently affected by butyrate supplementation. Carcass quality might be influenced by an interaction between the presence of nutritional, environmental and immunological stressors and butyrate supplementation, as explained below.  
Effects on nutrient digestibility Information is scarce regarding the effect of dietary butyrate supplementation on nutrient digestibility in broiler chickens. Smulikowska et al. (2009) reported that dietary inclusion of fat coated butyrate at 0.3 g/kg significantly increased apparent total tract digestibility of nitrogen and organic matter without affecting crude fat digestibility in broiler chickens. In the same study, nitrogen retention was improved while apparent metabolisable energy content of the diet was unaffected by butyrate supplementation. Improvements in nitrogen digestibility are in line with findings of Qaisrani (2014) who reported a trend for higher proventricular proteolytic activity in broilers fed the same butyrate additive. Finally, Swiatkiewicz et al. (2014) reported that inclusion of 0.7 g/kg of fat coated butyrate in broiler chicken diets containing high levels of dried distillers grains with solubles did not improve apparent total tract digestibility of the various measured nutrients. Collectively, these results indicate that butyrate might improve protein digestibility whereas improvements in energy digestibility are uncertain.  
MODES OF ACTION OF BUTYRATE ADDITIVES ON THE AVIAN GASTROINTESTINAL TRACT Figure 1 depicts putative and confirmed modes of action of butyrate on the GIT. It can be concluded that butyrate has effects on immune responses and gut integrity, elicits shifts in microbiota composition and might influence the endocrine control of digestive processes. Each category of effect will be discussed below.   
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Immuno-modulatory properties Butyrate down-regulates pro-inflammatory pathways by inhibiting cytoplasmic IκB kinase (IKK) (Moeinian et al., 2013). IKK initiates the translocation of a transcription 
factor from the cytoplasm to the nucleus, the nuclear factor κB (NF-κB), resulting ultimately in the production of pro-inflammatory cytokines such as tumor necrosis factor 
α (TNF-α) or interleukins (IL) 1β, 2 and 6 (Barnes and Karin, 1997). In poultry, these pro-inflammatory cytokines induce a homeorhetic response that modifies nutrient portioning. During inflammatory responses, dietary nutrients are used to support immune responses and disease resistance via numerous metabolic processes while skeletal muscle deposition and growth are reduced (Klasing and Johnstone, 1991). Additionally, inhibiting NF-κB activation reduces the level of reactive oxygen species and up-regulate the expression of genes involved in antioxidant synthesis (Hamer et al., 2009; Maa et al., 2010; Moeinian et al., 2013).   Such changes might protect the organism from DNA, lipid and protein damage induced by reactive oxygen species upon oxidative stress (Canani et al., 2011). Butyrate might, therefore, contribute to an improved nutrient utilization while protecting the organism from oxidative stress.  
 Butyrate also appears to affect mammalian immune cell chemotaxis in a species, dose and immune cell-dependent manner (Meijer et al., 2010). Until now, the influence of dietary butyrate supplementation on avian cell chemotaxis has never been studied. However, Sunkara et al. (2011) demonstrated that feeding 1 g/kg unprotected butyrate to broiler chicken leads to a significant increase in expression of genes encoding for antimicrobial peptides (AMP), which could subsequently induce chemotaxis of avian innate immune cells. These results should be nuanced by the fact that correlation between mRNA and protein abundances is sometimes poor (Maier et al., 2009). Butyrate is an epigenetic modulating agent inhibiting nuclear histone deacetylase (HDAC) enzymes, resulting in hyperacetylation of histones (Smith et al., 1998). Pre-treatment of human antigen-presenting cells with butyrate reduces their capacity to stimulate T-cell responses in a dose-dependent manner due to effects on cell adhesion and production of stimulatory molecules (Böhmig et al., 1997). Modulation of T-cell function by dietary butyrate supplementation varies depending on the type of butyrate additive considered (Böhmig et al., 1999). It can be concluded that butyrate can prevent inflammation and infiltration of immune cells in peripheral tissues by influencing cell adhesion and chemotaxis (Meijer et al., 2010). Such changes are associated with differences in gene expression that could indicate that the observed effects are mediated through the known inhibitory activity of butyrate on HDAC.   Once converted in any of its intermediate metabolites in the mitochondria, butyrate cannot return to the cytosol. On the other hand, a sufficient intracellular concentration of butyrate is required to induce effects on gene expression (Astbury and Corfe, 2012) and NF-κB inhibition (Moeinian et al., 2013). Current research on human colon cell carcinoma strongly suggests that mitochondrial oxidation of butyrate plays a crucial role in the regulation of its intracellular concentration (Andriamihaja et al., 2009). As a consequence, both the favoured energy substrate of the cell type and type of metabolic substrates available might influence gene-modulating properties of butyrate. Chicken enterocytes 
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do not favour butyrate as an energy source and do benefit from the availability of other energy sources such as glucose, glutamate or glutamine (Watford et al., 1979). In contrast, butyrate is known to be the primary energy substrate of colonocytes in mammals (Sunkara et al., 2011). For these reasons, it can be hypothesised that the GIT segment wherein butyrate is released modulates the observed immuno-modulatory properties.  Literature about the ability of butyrate to regulate the innate immune response of broiler chickens is relatively scarce. Unchallenged broiler chickens given 1 g/kg unprotected butyrate had reduced serum TNF-α and IL-6 levels at 21 d of age while serum antioxidant indices were increased (Zhang et al., 2011b). At 42 d of age, only IL-6 levels were significantly reduced while serum antioxidant indices were increased. When the entire growth period was considered, there was no significant effect of butyrate supplementation on growth performance. This is not unexpected, because any positive effect of butyrate on growth performance is likely to be more evident when chickens are subjected to a stressor. Loss of body weight induced by a subcutaneous injection of corticosterone at 42 d of age can be partially alleviated in broiler chickens fed 0.4 g/kg fat coated butyrate (Zhang et al., 2011a). A shift from an antioxidant to a pro-oxidant system under stressor exposure is prevented by butyrate supplementation, thus illustrating the ability of butyrate to decrease catabolism and oxidative injury of tissues. Similarly, body weight gain and feed intake could be maintained in broilers challenged by LPS injection at 16, 18 and 20 d of age due to the prevention of a rise in pro-inflammatory cytokines (Zhang et al., 2011b).   As indicated by Klasing and Johnstone (1991), pro-inflammatory cytokines such as IL-1, IL-6 or TNF-α have a pronounced effect on avian lipid metabolism. Immunological challenges are associated with fat carcasses (Klasing et al. 1987, cited by Klasing and Johnstone, 1991). Due to its ability to decrease TNF-α and IL-6 levels, butyrate might alleviate adipose tissue accumulation when broilers are subjected to environmental and immunological stressors. As indicated earlier, butyrate supplementation affects carcass characteristics in an inconsistent manner. Discrepancies might be explained by the occurrence of subclinical infections or mild environmental stressors in certain experiments.  
Intestinal integrity support In addition to its effects on immunity, butyrate is able to improve the integrity of the epithelial cell layer (Canani et al., 2011; Ploger et al., 2012). This epithelial barrier is essential for a normal intestinal function and impairment may lead to inflammation, because bacterial components will activate inflammatory signalling cascades after binding to Toll like receptor at the basolateral surface of the epithelial cells (Yilmaz et 
al., 2005; Lewis et al., 2010). Two structures are important to maintain intestinal integrity: the tight junctions (TJ), forming a seal between adjacent epithelial cells, and the mucus layer, covering the epithelial cell luminal surface (Canani et al., 2011; Ulluwishewa et al., 2011). Butyrate has been reported in the literature to affect barrier function by increasing the formation of mucin glycoproteins, which improves the protection against luminal agents (Willemsen et al., 2003). Increased expression of MUC2 gene has been shown in vitro (Barcelo et al., 2000) and the effect is dose dependent (Gaudier et al., 2004). Mentschel and Clause (2003) described an increase in thickness of the mucous layer after administration of butyrate. AMP such as 
Butyrate in broiler diets 
26  
cathelicidin, heat shock proteins and trefoil factors, produced by epithelial cells, are induced by butyrate, influencing the viscoelasticity of the mucous layer (Hamer et al., 2008). Up-regulation of antimicrobial peptides by butyrate was also reported in chicken jejunal and caecal explants (Sunkara et al., 2011). Like in piglets and humans, butyrate has also been reported in chickens to affect TJ (Peng et al., 2009; Ma et al., 2012; Wang et al., 2012). Butyrate increases the expression of TJ proteins and, therefore, the intestinal epithelial integrity (Peng et al., 2009). The permeability of TJ is measured by transepithelial electrical resistance (TEER) (Schneeberger and Lynch, 2004). In the presence of 2 mM butyrate, an increase in TEER could be measured in Caco-2 cell monolayers (Peng et al., 2009). Wang and co-authors (2012) reported increased TEER and stimulation of the transcription of TJ protein claudin-1 by 4mM sodium butyrate in a cdx2-IEC cell monolayer. In summary, butyrate has beneficial effects in maintaining the intestinal integrity and barrier through its effect on TJ and mucin production. These phenomena in turn will reduce inflammation and possibly also microbial translocation (Lewis et al., 2010). Increased mucin production, however, may lead to increased requirements of specific amino acids. 
Shifts in microbiota composition  Butyrate is a weak acid with a pKa equal to 4.8 (Guilloteau et al., 2010a). The foregut of broilers is acidic, with pH values ranging from 4.5 (crop) to 2.5 (gizzard) (Denbow, 2015). As a consequence, butyrate is mainly protonated rather than in an ionic form in the crop, proventriculus and gizzard of birds (Smith et al., 2012). Cherrington et al. (1991) hypothesised that the dissociation of short chain fatty acids (SCFA) in a bacterial cytoplasm disrupts the proton motive force across the membrane and lowers the cytoplasmic pH, resulting in bacteriostatic or bactericidal effects. Nevertheless, some bacterial species have evolved to become acid-tolerant and are commonly characterized by an important internal potassium pool that can be used as a countercation to balance the effects of organic acids dissociation (Russell and Diez-Gonzalez, 1998).  The control exerted by butyrate on the microbial population in the proximal part of the GIT might sustain the development of a beneficial microbiota in the more distal segments, as suggested by studies in rabbits (Ribeiro et al., 2012). Finally, it has been suggested that butyrate-induced enhancements of digestibility and absorption processes can affect microbial diversity in the cecum and distal colon of pigs by modulating the nature and quantity of substrate left for microbial growth (Castillo et 
al., 2006).    
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 Panda et al. (2009) found that supplementation of broiler diets with 4 and 6 g/kg unprotected butyrate is similar to the use 0.5 g/kg furazolidone in reducing Escherichia 
coli counts in the crop and small intestine. In addition, supplementation of broilers with 2 g/kg unprotected butyrate from 1 to 21 days of age significantly reduced Lactobacillus 
spp. counts in jejunal chyme (Hu and Guo, 2007). Supplementation of broilers with 3 g/kg fat coated butyrate from 1 to 30 days of age, however, did not result in significant changes in total numbers of bacteria nor in Lactobacillus spp. and Enterococcus spp. counts in ileal and caecal digesta (Czerwinski et al., 2012). Butyrate is also known to down-regulate the expression of genes involved in the pathogenicity of Salmonella 
typhimurium (Lawhon et al., 2002) and also to reduce caecal colonization and fecal shedding of Salmonella enteritidis (Van Immerseel et al., 2005).  Most of the studies concerning the effects of butyrate on microbiota of the broiler are focused on the reduction of specific pathogenic bacteria. Literature data on the effect of butyrate on the entire microbiome composition using molecular methods are scarce. Supplementation of a rapeseed meal-based diet with 2 g/kg fat coated butyrate from 1 to 34 days of age had a significant effect on the broiler caecal microbiota as 16S rRNA analysis showed a reduced Shannon’s diversity index (Qaisrani, 2014). Furthermore, analysis revealed that butyrate supplementation promotes the average relative contribution of Clostridium lactifermentans and Ruminococcus bromii while reducing the relative abundance of Clostridium perfringens. It is hitherto unclear what the contribution of these specific microbes to the overall beneficial effects of butyrate might be. 
Modifications of endocrine control of digestive processes.  There are no publications addressing the effects of dietary butyrate supplementation on endocrine control of digestive processes in poultry. There is, however, a body of evidence indicating that butyrate can influence several key gut hormones in mammals, as indicated in Table 3.   Summarizing these data, butyrate presence in the GIT can lead to a rise in cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide (GLP) 2 levels and to a decrease in pancreatic peptide (PP) level. Such changes could support intestinal and gastric mucosa development, increase gastric retention time and stimulate gastric and pancreatic secretions. As a consequence, nutrient digestibility and absorption could be improved. Such putative changes in endocrine regulation would be consistent with improvements in growth performance, intestinal morphology, proteolytic activity and nutrient digestibility observed in broiler chickens fed butyrate.
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3.
 Effect 
of buty
rate on
 gut ho
rmona
l regula
tion1  
Hormo
ne 
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ut-rela
ted effe
cts 
Refere
nces 
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CCK 
Stimula
tion of 
gallbla
dder co
ntracti
ons 
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rine pa
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Inhibit
ion of g
astric e
mptyin
g 
Kotuni
a et al. 
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te sign
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ased 
plasma
 CCK co
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ation in
 sucklin
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ts 
Guillot
eau et 
al
. (2010
b) 
Dietary
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mentat
ion wit
h 3 g/k
g unpr
otected
 butyra
te sign
ificantl
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plasma
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0 min a
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utyrate
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a et al. 
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.5 hour
 period
 post-in
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Butyrate has potential to affect neuro-hormonal control of the gut in different ways. It can bind to free fatty acid receptors (FFAR) 2 and 3 that are present at the apical membrane of several types of enteroendocrine cells (Sykaras et al., 2012; Nohr et al., 2013). It is worth noticing that FFAR can be expressed without necessarily inducing functional cellular responses to SCFA sensing (Liou, 2013). For instance, butyrate-induced regulation of GLP-1 appears to be FFAR3 independent (Lin et al., 2012). Nevertheless, FFAR sensing pathways might influence hormone production and release. Secreted hormones can have multiple functions including paracrine functions on adjacent cells or reach general circulation to exert endocrine functions (Engelstoft 
et al., 2008) as well as a direct influence on efferent nerve endings that express FFAR (Lal et al., 2001; Nohr et al., 2013). It is postulated that in rats the autonomic nervous system can transmit a butyrate-induced nervous signal from the caecum or colon to the central nervous system, resulting in the release of trophic signals such as gastrin (Sakata, 1989; Reilly et al., 1995). Based on their experimental work, Vidrine et al. (2014) suggest that butyrate release location affects the release of gut hormones. This could be due to the localization of the various specialised enteroendocrine cells. It is also likely that butyrate-induced modifications of endocrine regulation are local and not systemic. SCFA (70 mM acetate, 20 mM butyrate, 20 mM butyrate at 1.5 ml/h) infusion in the colon of rats results in an increase in jejunal gastrin concentration (Frankel et al., 1994; Reilly et al., 1995) without significantly affecting plasma gastrin concentration (Reilly et al., 1995). Similarly, Kotunia et al. (2004) could not find any effect of unprotected butyrate supplementation on plasma gastrin in piglets whereas Mazzoni et al. (2008), using a similar dose, reported a trend for increased gastrin mRNA in piglet gastric mucosa.  
CONCLUSION This review summarizes evidence-based results originating from recent poultry studies and proposes putative mechanisms derived from research in mammals. Improvements of growth performance observed in broilers fed butyrate are attributable to a lower pro-inflammatory response to nutritional, environmental and immune challenges, associated with improved digestibility and absorption of dietary nutrients. The latter can be explained by the modulating effects of butyrate on gut microbiota but also by assumed effects of butyrate on gut endocrine regulation. Most of the mechanisms are likely to be affected by the delivery site of butyrate within the GIT, for example bacteriostatic properties require an acidic environment. Additionally, an elevated intracellular butyrate concentration is required to observe modulating effects on gene expression and immune response. Thus, both the favoured energy substrate of the cell and type of energy available might have an influence on butyrate-induced effects. In addition, neuro-hormonal mechanisms might also play a role. Each enteroendocrine cell type is defined by its location within the GIT and by its response to FFAR stimulation. Therefore, neuro-endocrine responses to luminal butyrate presence may vary depending on the GIT segment considered. Factors such as inclusion level, diet composition, age and health status of the bird are known to modulate the effects of dietary butyrate supplementation. The GIT segment wherein butyrate is released may also modulates the observed effects. Unfortunately, commercially available butyrate additives offer poorly documented release kinetics. In order to better 
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understand the effect of butyrate on avian GIT physiology, development of targeted-release butyrate formulations as well as characterization of commercially available products appears to be an inevitable step.  
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ABSTRACT An in vitro model of the poultry gastro-intestinal tract (GIT) was used to compare the release profiles of experimental butyrate formulations. Two processes were applied: 1) melt-extrusion/grinding to produce four types of continuous protective matrices differing in the embedding materials and 2) wet-extrusion/spheronization to produce non-protective butyrate-loaded cellulose pellets that were subsequently coated with a pH-sensitive polymer in a fluidized bed reactor. Release profiles of these five new formulations and of five commercially available butyrate additives were evaluated in triplicate in a three-step (pre-gastric, gastric and enteric) in vitro digestion procedure. The pre-gastric step had a pH of 5.8, contained α-amylase and lasted for 35 min. The gastric step had a pH of 2.7, contained pepsin and lasted for 35 min. The enteric step had a pH of 6.5, contained pancreatin and bile salts and lasted for 10, 80 or 170 min if the digestion until the end of the duodenum, jejunum or ileum was simulated, respectively. Aliquots were drawn at the five stages of digestion representing the end of the crop, proventriculus-gizzard, duodenum, jejunum and ileum. The percentage of the initial butyrate dose solubilized was calculated for each stage. Significant differences were found among formulations for each digestion stage (P<0.001). Commercial fat-coated products showed heterogeneous release profiles, some products being non-protective whereas others displayed a sustained release profile. Wax matrices, with or without starch inclusion, showed a sustained release profile, being generally more protective than commercial fat-coated products. Tributyrin and coated pellets had a release profile targeting enteric segments. Behenic and stearic acid matrices released most of their content at the crop stage. Results of this study can aid to develop experimental contrasts suitable to study the effects of butyrate release location on avian digestive physiology.  
Keywords: In vitro, poultry, butyrate, coating, matrix 
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INTRODUCTION Butyrate elicits stimulatory, albeit inconsistent, effects on growth performance of broiler chickens (Cerisuelo et al., 2014; Leeson et al., 2005; Van Immerseel et al., 2005; Zhang et al., 2011). Release location may affect the observed effects of butyrate throughout the gastrointestinal tract (GIT) of broilers given the diversity of cell types and pH conditions encountered, and the differences in microbiota composition in the different gut segments (Moquet et al., 2016).  Formulations which vary in their release profile of butyrate in the GIT are important tools to allow investigation of effects in vivo. Targeted release refers to the localized delivery of an active compound based on organ-specific characteristics such as pH value or enzymatic activity. This can be achieved using pH-dependent protections such as free fatty acid matrices or non-protective matrices coated with pH-sensitive polymers (Ji et 
al., 2007; Vervaeck et al., 2013). Also tributyrin, the triglyceride analogue of butyrate, can be considered as a targeted release formulation due to the low pre-duodenal lipolytic activity of broiler’s GIT (Cherif et al., 2006; Moreau et al., 1988). Sustained release refers to the prolonged release of an active compound over time based on enzymatic or mechanic erosion and diffusion mechanisms. This can be achieved, for example, by wax matrices where inclusion of starch additives influences the release rate of the active molecule (Zhou et al., 1996). Embedding butyrate in vegetable fat matrices is commonly used by the feed industry to offer a partial protection against gastric absorption (Moquet et al., 2016) which leads to a sustained release of butyrate in the broilers’ GIT (van den Borne et al., 2015).   The release profile of butyrate in the GIT can be determined in vivo by measuring the content in the chyme at different locations (Sotak et al., 2013) or by measuring the oxidation of labelled butyrate in respiratory chambers (Smith et al., 2012; van den Borne et al., 2015). The first technique does not allow discrimination between dietary and microbial derived butyrate, while the costs of the latter prohibits routine screening of formulations. In vitro models are interesting alternatives to the aforementioned techniques as they are relatively rapid, cost-effective, and the results are a not confounded by endogenous fermentation end-products or biological variation. Release profiles influenced by physical and chemical characteristics of the GIT, e.g. pH, temperature, enzymatic activity or retention time can be investigated through such an 
in vitro approach. Specific conditions encountered in the avian GIT are well documented in the literature (Long, 1967; Philips and Fuller, 1983; Żyła et al., 1999; Denbow, 2015). Current in vitro models stimulating digestive processes in poultry, however, are not based on these specific conditions and as such are open for improvements.   The present work was undertaken to compare the release profiles of experimental and commercially available butyrate additives, using an improved in vitro poultry digestion simulation model. It was hypothesised that pH- and enzyme-sensitive protections would provide targeted release properties whilst wax and triglyceride matrices would provide sustained release profiles. 
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MATERIAL AND METHODS 
Development of butyrate formulations 
Preparation of continuous matrices by melt-extrusion and grinding. Different sodium butyrate (Adimix C, Nutri-Ad International NV, Dendermonde, BE) formulations were prepared according to Table 1. Behenic and stearic acid powders were provided by Chempri Oleochemicals (Raamsdonksveer, NL), hydrogenated palm fat flakes by Nutri-ad International NV, Luncera M wax beads by Füller GmbH (Lüneburg, DE) and S2004 soluble potato starch powder by Sigma-Aldrich (Saint-Louis, USA). Prior to mixing, palm fat flakes and wax beads were ground at 15,000 rpm with a ZM-1000 grinder (Retsch, Haan, DE) equipped with a 12-tooth rotor and without screen. Three kg batches of each formulation were mixed with a pedal mixer model 305 (Dinissen, Sevenum, NL) at 50 % of the maximum speed for 5 min and subsequently extruded with a twin screw extruder (M.P.F.50, Baker Perkins Ltd., Peterborough, UK). During a preliminary trial, extrusion settings were adjusted for each formulation in order to obtain homogenous, smooth-surfaced, non-melted extrudates. Screw configuration was identical to the one described by De Vries and coworkers (2014). No die face cutter was used. Final extrusion settings are indicated in Table 1.  
Table 1. Composition and extrusion settings used for the production of continuous matrices   Experimental Formulation   Behenic Stearic Wax Wax + starch 
Composition (g/kg)         Behenic acid 700 - - - Stearic acid - 700 - - Lunacera M - - 700 600 Sodium butyrate 300 300 300 300 Potato starch - - - 100 
Extruder configuration     Dies (n x mm) 2 x 3 1 x 3 1 x 3 2 x 3 Feeding rate (% of maximum rpm) 8 8 8 8 Screw speed (% of maximum rpm) 10 20 10 10 Load (%) 12 20 22-25 28-30 
Temperature settings (°C)     Zone 1 29 25 30 30 Zone 2 37 47 45 37 Zone 3 57 54 60 43 Zone 4 61 55 60 50 Zone 5 56 56 60 49 Zone 6 52 58 61 53 Zone 7 55 51 59 54 Zone 8 82 68 37 55 Zone 9 61 50 55 52 
Product temperature at the die 49.4 48.2 52-53 41  Extrudates were cooled to room temperature overnight and subsequently ground at 10.000 rpm with a ZM-1000 grinder (Retsch) equipped with a 12-tooth rotor without screen. Ground extrudates were sieved manually in order to obtain the 1.2-1.4 mm fraction.   
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Preparation of microencapsulated pellets by wet-extrusion, spheronization and 
fluidized-bed reactor coating. Avicel PH-101 (850 g/kg; FMC BioPolymer, Philadelphia, USA) microcrystalline cellulose and sodium butyrate (150 g/kg; Admix C, Nutri-Ad International NV) were mixed with a commercial mixer (Kenwood Chef, Kenwood Belgium, Mechelen, BE). Demineralized water (720 ml/kg dry powder mix) was added to the dry powder mix in a drop-wise manner while mixing. The wet mixture was subsequently extruded with a dome granulator (model DG-L1, Fuji-Paudal, Osaka, JPN) and spheronized for 5 min (model 15, Sturminster Newton, UK). Microcrystalline cellulose butyrate pellets were dried overnight at room temperature and sieved in order to obtain the 800-1200 µm fraction. Wet powder formulation was determined on the basis of a preliminary trial aimed at obtaining homogenous, non-brittle, smooth-surfaced pellets. Eudragit® FS 30 D (Evonik Industries, Essen, DE) was applied as coating on the pellets using a fluidized-bed reactor (model GPCG1, Glatt GmbH, Binzen, DE) including a Wurster module. Eudragit® FS 30 D is a polymer that dissolves at pH > 7. Coating solution was prepared using glycerol monostearate as an anti-tacking agent according to the technical information provided by the supplier. Recorded weight gain was 20 % (w/w). The resulting product is referred to as microencapsulated pellets. The fluidized-bed reactors settings are provided in Table 2.   
Table 2. Fluidized bed reactor settings used for the production of microencapsulated pellets Nozzle diameter 0.8 mm Tubing diameter 1.6 mm Sprayed air pressure 0.8 bar Microclimate 0.4 bar Inlet air temperature 35 °C Air flow 35 m3/h Product temperature during coating phase 28 °C Drying phase temperature 40 °C Spraying phase duration 30 min Drying phase duration 120 min 
In vitro evaluation of butyrate formulations 
Experimental design. The four experimental matrices, microencapsulated pellets, tributyrin (T8626, Sigma-Aldrich) and four commercially available fat-protected butyrate additives: Adimix Precision (Nutri-ad International NV), Ding Su (Singao, Xiamen, China), Sodium Butyrate 300 and 500 (Vega Pharma Limited, Hangzhou, China) were evaluated in triplicate in the in vitro digestion procedure as one batch. All formulations were submitted to the butyrate content determination described below, except for tributyrin, for which the butyrate content was known.  
Butyrate content determination procedure. Butyrate formulations were ground with a mortar and a pestle. Approximately 0.25 g ground product was accurately weighed in triplicate into 80 ml centrifuge tubes containing a stirring magnet and 20 ml of 1 M HCl solution was added to each tube. The centrifuge tubes were then closed with a rubber stopper and placed on multipoint stirrers in thermostatically-controlled heating chamber at 40 ± 0.1°C for 24 hours at a stirring rate of 360 rpm. Aliquots drawn at the end of this procedure were used to determine the average butyrate content of each formulation. 
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In vitro digestion procedure. The in vitro simulation of the digestive locations of poultry consisted of pre-gastric, gastric and enteric steps. The enteric step had three different durations, resulting in a total of five digestion stages. Approximately 0.25 g of sample was accurately weighed into an 80 ml centrifuge tube containing a stirring magnet. To each tube, 20 ml of a 1 M tris-HCl buffer solution (pH 5.8) containing 1 g/l 
NaCl and 0.5 g/l of α-amylase from porcine pancreas (10 U/mg solid; A3176, Sigma-Aldrich) was added. Thereafter the tube was closed with a rubber stopper and placed on a multipoint stirrer in a thermostatically-controlled heating chamber for 35 min. When only the pre-gastric stage was considered, the procedure was terminated by transferring the tube to ice. Otherwise, digestion was continued by adding 2 ml of a 0.085 M HCl solution containing 11 g/l of pepsin from porcine gastric mucosa (250 U/mg solid; P7000, Sigma-Aldrich). If necessary, pH was adjusted to 2.7 ± 0.05 with drops of 6 M HCl or 6 M NaOH. The second stage of digestion then proceeded for 35 min and the procedure was stopped when only the gastric digestion was considered by transferring the tubes to ice. Otherwise, 4 ml of a 1 M tris-buffer solution (pH 6.5) containing 1.875 g/l porcine pancreatin (8 × USP specifications; P7545, Sigma-Aldrich) and 0.7 g/l bile salts (48305, Sigma-Aldrich) was added to each tube. If necessary, pH was adjusted to 6.5 ± 0.05 with drops of 6 M HCl or 6 M NaOH. The digestion was terminated by placing the tubes on ice, 10, 80 or 170 min after addition of pancreatin for simulation of duodenal, jejunal or ileal digestion, respectively. Aliquots were drawn at the end of each digestion stage. The pH value at the end of the final digestion stage was recorded. A temperature of 40 ± 0.1°C and a stirring rate of 360 rpm were maintained throughout the different stages of digestion. 
Chemical and statistical analysis 
Butyrate determination. Aliquots were diluted with phosphoric acid containing iso-caproic acid as an internal standard. Samples were centrifuged for 5 min at 14,000 rpm at 5°C. Butyrate was separated by gas chromatography (Trace GC Ultra, ThermoFischer Scientific, Waltham, MA, USA) using an EM-1000 (30 m x 0.53 mm) column from Alltech (Deerfield, IL, USA), helium as the mobile phase and detected by flame ionization detector. Quantification was based on a chemical standard solution after internal standard correction.  
Statistical analysis. Total amount of butyrate added to the assay was calculated by multiplying the sample weight by the butyrate content. Butyrate release was expressed as the percentage of the initial butyrate dose that was solubilized at a certain digestion stage. In case release values above 100% were recorded, the highest value was corrected to 100%, with all other values adjusted accordingly within formulation. Butyrate release values within simulated digestion stages and pH values at the simulated ileum were analysed by the PROC GLM procedure of SAS® version 9.2 (SAS Institute Inc., Cary, NC, USA), using the following model:  
𝑌𝑌𝑌𝑌𝑖𝑖𝑖𝑖 = 𝜇𝜇𝜇𝜇 + 𝐹𝐹𝐹𝐹𝑖𝑖𝑖𝑖 + 𝑒𝑒𝑒𝑒𝑖𝑖𝑖𝑖  where 𝑌𝑌𝑌𝑌𝑖𝑖𝑖𝑖  is the dependent variable, 𝜇𝜇𝜇𝜇 the overall mean, 𝐹𝐹𝐹𝐹𝑖𝑖𝑖𝑖  the formulation effect (i= 1 to 10) and 𝑒𝑒𝑒𝑒𝑖𝑖𝑖𝑖  the residual error of the model. Fisher’s least significant difference test was used as a post-hoc test. Results were considered significant at a probability level below 5%. 
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RESULTS AND DISCUSSION Table 3 presents the butyrate release values, expressed as the percentage of initial dose, solubilised at each digestion stage. The pH value observed at the simulated ileal digestion stage was significantly lower for tributyrin than for the other butyrate additives (P<0.05). 
 
Table 3. In vitro butyrate release at different simulated gastrointestinal locations (% of the initial butyrate dose)   Gastrointestinal locations  Simulated ileal pH Item1 Crop Gastric region Duodenum Jejunum Ileum   
Commercial butyrate formulations   Adimix Precision 54.1c 73.6c 77.9cd 84.9bc 89.1bc  5.86c Vega 300 54.1c 70.4c 80.9bc 87.2bc 90.7ab  5.97ab Vega 500 97.8a 96.5ab 95.2a 96.5ab 95.8ab  5.97ab Ding Su 79.5b 88.0b 94.8a 89.3ab 89.8abc  5.93abc Tributyrin 13.4d 13.9f 20.1f 34.0e 41.2e  5.66d 
Experimental butyrate formulations   Behenic 84.8b 89.1ab 84.3b 94.8ab 91.6abc  5.97ab Stearic 98.0a 97.6a 94.4a 99.0a 96.1ab  5.89bc Wax  51.3c 61.6d 76.4cd 68.5d 76.3d  5.93abc Wax + starch 53.8c 70.3c 72.7d 76.5dc 84.6c  5.97ab Micropellets 12.7d 25.6e 58.6e 98.9a 96.8a  6.01a 
Statistical analysis SEM 2.2 2.9 2 3.9 2.5  0.03 
P-value <0.001 <0.001 <0.001 <0.001 <0.001   <0.001 a,b,c,d,e,fMeans within a column lacking a common superscript are significantly (P<.05) different. 1Averages of three replicates. 
Fat-coated commercial butyrate formulations Van den Borne and coworkers (2015) demonstrated in an in vivo study that fat-coated butyrate had an extended release profile in broiler chickens. In the present in 
vitro study, only half of the tested commercial fat-protected butyrate products (Adimix 30C and Vega 300) had a similar release profile. Differences can be attributed to variations in industrial processes as numerous technologies can be used to achieve spray chilling (Oxley et al., 2012). Such variability of release profiles among products that had similar macroscopic shapes, colours and particle sizes could contribute to inconsistencies in performance data and intestinal morphology responses of broilers fed different fat-coated butyrate additives (Smulikowska et al., 2009; Czerwinski et al., 2012; Jerzsele et al., 2012).  
Tributyrin With a simulated average release of 41.2 % for tributyrin at the ileum, results may contrast with findings of Schwarzer and Bjork (2015), who established in vitro and in 
vivo that two third of the butyrate contained in tributyrin is released in the very proximal part of the small intestine of pigs. In the present study, tributyrin digestion significantly reduced the pH in the ileum compared to the other additives (P<0.05). Cleavage of tributyrin’s ester bonds by pancreatic lipase leads to the release of butyric acid. The resulting acidification is known to negatively affect lipase activity (Borgstrom, 1975), which could contribute to the lower release reported in the present study. 
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Experimental butyrate formulations The novel butyrate additives assayed displayed diverse release profiles. Behenic and stearic acid matrices did not provide any gastric protection, in contrast to published 
in vitro work in humans (Vervaeck et al., 2013). For such matrices, release is triggered by increased ionization rates occurring when chyme pH becomes higher than the pKa of the considered acid. Due to their respective pKa of 4.70 and 4.75, behenic and stearic acids were already ionized at the crop digestion stage (pH 5.8), resulting in an early butyrate release. Microencapsulated pellets showed a partial gastric protection followed by a rapid release in the enteric segments that is consistent with the type of coating used. Finally, the wax matrices showed a sustained release profile and appeared to be highly effective in releasing butyrate at the simulated ileum. Inclusion of starch in such matrices led to a higher (P<0.05) release at the ileum. This is in agreement with data in the literature and can be due to a change of matrix solubility and to an increased exchange surface resulting from starch digestion (Zhou et al., 1996).  
CONCLUSION Several butyrate additives were shown to have potential for establishing experimental contrasts in butyrate release within the avian GIT. Several formulations had sustained release properties (Adimix 30 C, Vega 300, wax matrices), while others allowed to target enteric segments (tributyrin, microencapsulated pellets). Additionally, despite being macroscopically similar, commercial fat-coated butyrate products show variations in release properties in vitro. This could explain part of the inconsistencies observed in vivo in the scientific literature of these products.  
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ABSTRACT The hypothesis was tested that butyrate presence in the digesta of distinct gastrointestinal tract (GIT) segments of broilers leads to differential effects on digesta retention time, gut morphology and proteolytic enzymatic activities, ultimately resulting in differences in protein digestibility. A total of 320 male day-old Ross 308 broilers were randomly assigned to 5 dietary treatments: 1. control (no butyrate), 2. unprotected butyrate (main activity in the crop and gastric regions), 3. tributyrin (main activity in the small intestine), 4. fat-coated butyrate (activity in the whole GIT) and 5. unprotected butyrate combined with tributyrin, each replicated 8 times. Rapeseed meal was used in combination with a fine dietary particle size in order to challenge the digestive capacity of young broilers. Birds were dissected at 22, 23 and 24 d of age and samples of digesta at various GIT locations as well as tissues were collected. Butyrate concentration varied significantly across GIT segments depending on treatment, indicating that the dietary contrasts were successful. The apparent ileal digestibility of methionine tended to increase when butyrate and/or propionate was present in colonic and cecal contents, possibly due to modifications of GIT development and digesta transit time. Butyrate presence in the digesta of the crop, proventriculus and gizzard, on the contrary, tended to decrease the apparent ileal digestibility of several amino acids (AA). In addition, butyrate presence beyond the gizzard elicited anorexic effect that might be attributable to changes in intestinal enteroendocrine L-cells secretory activities. The present study demonstrates that, in broilers, effects of butyrate on digestive processes are conditioned by the GIT segment wherein the molecule is present and indicates its influence on digestive function and bioavailability of AA.  
Key words: Butyrate, broiler, digestibility, digesta retention time, location effect    
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INTRODUCTION The short-chain fatty acid (SCFA) butyrate is commonly used as a feed additive to enhance growth performance of broiler chickens. The mode of action of butyrate is not fully understood and broiler performance response to dietary butyrate supplementation is inconsistent (Cerisuelo et al., 2014). Mammalian research indicates that luminal butyrate elicits changes in the endocrine regulation of digestive processes (Dumoulin et al., 1998; Kotunia et al., 2004; Mazzoni et al., 2008; Vidrine et al., 2014). These changes could influence digesta transit time, gut morphology and digestive enzymes activities in a manner where it can affect nutrient digestibility. Significant improvements in nitrogen digestibility and trends for higher proventricular proteolytic activities in broilers fed butyrate are consistent with putative changes in digestive physiology (Smulikowska et al., 2009; Qaisrani et al., 2015).   Subsets of enteroendocrine cells are characterized by their localization within the gastrointestinal tract (GIT) and by their response to luminal butyrate sensing. Therefore, it can be hypothesized that the GIT segment wherein butyrate is present modulates the activation of the enteroendocrine cells and their associated physiological effects. The use of different butyrate additives allows to test this hypothesis as unprotected butyrate is active in the crop, proventriculus and gizzard whereas tributyrin provides butyrate to the small intestine (Moquet et al., 2016). In addition, several fat-coated butyrate additives display a sustained release profile, possibly increasing butyrate availability in the colon and ceca (Van den Borne et al., 2015; Moquet et al., 2016). Previous research has highlighted that a lesser digestible protein source, such as rapeseed meal, in association with a fine diet structure, is particularly challenging for the GIT development of broilers (Qaisrani et al., 2014). Using such a feed challenge in young broilers could aid to distinguish possible effects of butyrate on protein digestibility and GIT development.  The present work was undertaken to investigate the effect of butyrate presence in distinct GIT segments on digestive processes of broilers and to attribute possible changes in protein digestibility to changes in gut morphology, digesta transit time or enzymatic activities. In this paper, the term “butyrate presence” is used to emphasize that it is not known whether the active molecule has an endogenous or exogenous origin. It was hypothesized that butyrate-mediated changes in gastric and enteric retention time, gut morphology and enzymatic activities would result in improvements of protein digestibility. In addition, it was hypothesized that the response of broilers to butyrate supplementation would differ depending on the GIT segment wherein the molecule is present.  
MATERIAL AND METHODS 
Experimental design A completely randomized design consisting of 5 dietary treatments was used: 1. control (CTR; no butyrate), 2. unprotected butyrate (UP; butyrate mainly available in the crop/proventriculus/gizzard), 3. tributyrin (TB; butyrate mainly available in the small intestine), 4. fat-coated butyrate (FCB; butyrate available in the whole GIT) and 
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5. A 50:50 mixture of UP and TB (butyrate radical C4H7O2- weight basis; UPTB). Butyrate-supplemented diets contained 1 g/kg of butyrate radical (as is basis). Ingredient constituents used as carrier in the butyrate additives such as palm fat or silica were present in similar amounts across diets. Sodium bicarbonate was used to maintain equal sodium supply across diets. Diets were formulated to meet or exceed the requirements of broiler chickens (CVB, 2007) and contained chromium sesquioxide (Cr2O3) as an indigestible marker of the solid phase fraction. Ingredient and analysed nutrient compositions of the diets are provided in Table 1.  
Table 1. Ingredient and analysed nutrient compositions of the control diet (CTR) and diet containing unprotected butyrate (UP), tributyrin (TB), fat-coated butyrate (FCB) and a mixture of UP and TB (UPTB) Item CTR UP TB FCB UPTB 
Ingredient (g/kg; as in basis)       Corn 292.05 292.05 292.05 292.05 292.05  Wheat 200.00 200.00 200.00 200.00 200.00  Rapeseed meal  350.00 350.00 350.00 350.00 350.00  Fishmeal  75.00 75.00 75.00 75.00 75.00  Soybean oil 55.29 55.03 54.13 55.03 54.58  Premix1 5.00 5.00 5.00 5.00 5.00  Lime fine 9.00 9.00 9.00 9.00 9.00  Monocalcium phosphate 5.50 5.50 5.50 5.50 5.50  Salt 0.90 0.90 0.90 0.90 0.90  NaHCO3 2.80 1.80 2.80 1.80 2.30  L-Lysine HCl 0.50 0.50 0.50 0.50 0.50  Fat-coated butyrate2 0.00 0.00 0.00 4.21 0.00  Tributyrin on silica support3 0.00 0.00 1.78 0.00 0.89  Compacted sodium butyrate4 0.00 1.40 0.00 0.00 0.70  Ground palm fat 2.95 2.95 2.95 0.00 2.95  Silica 0.62 0.62 0.00 0.62 0.31  Dextrin 0.14 0.00 0.14 0.14 0.07  Chromic sesquioxide 0.25 0.25 0.25 0.25 0.25 
Calculated nutrient composition  Crude protein (g/kg) 215.4 215.4 215.4 215.4 215.4  Metabolisable energy (MJ/kg) 12.36 12.36 12.36 12.36 12.36  Calcium (g/kg) 9.1 9.1 9.1 9.1 9.1  Available Phosphorus (g/kg) 4.0 4.0 4.0 4.0 4.0  Methionine (g/kg) 4.67 4.67 4.67 4.67 4.67  Lysine (g/kg) 12.16 12.16 12.16 12.16 12.16 
Analysed nutrient composition (g/kg DM)  Starch 333.6 326.1 327.4 314.6 325.6  Fat 96.8 98.8 98.4 99.1 99.1  Nitrogen 38.1 37.8 38.0 38.3 38.4  Crude fibre 67.6 66.6 71.1 65.5 66.0   Ash 63.5 64.8 64.5 64.3 64.5 1Provided per kg of diet: vitamin A, 12.000 IU; vitamin D3, 2.500 IU; vitamin E, 50 mg; vitamin B2, 7.5 mg; vitamin B6, 3.5 mg; vitamin B1, 2.0 mg; vitamin K3, 1.5 mg; vitamin B12, 20 μg; choline chloride, 460 mg; antioxidant (oxytrap PXN),125 mg; niacin, 35 mg; pantothenic acid, 12 mg; biotin, 0.2 mg; folic acid, 1 mg; Mn, 85 mg; Fe, 80 mg; Zn, 60 mg; Cu, 12 mg; I, 0.8 mg; Se, 0.15 mg. 2Adimix Precision (Nutriad International, Dendermonde, Belgium). Contains 700 g/kg palm fat; 237 g/kg C4H7O2-; 63 g/kg Na+. 3Experimental Tributyrin (Nutriad International); contains 650 g/kg tributyrin; 350 g/kg silica. 4Adimix Easy (Nutriad International); contains 712 g/kg C4H7O2-; 188 g/kg Na+, 100 g/kg dextrin. 
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Birds and experimental procedures The experiment was conducted at the research farm Carus of Wageningen University. All the experimental procedures were approved by the Animal Care and Use Committee of Wageningen University. A total of 320 male, one-day-old broilers (initial BW 42.1 ± 3.3 g; Ross 308, Aviagen Group, Newbridge, United Kingdom) were obtained from a commercial hatchery (Kuikenbroederij Morren B.V., Lunteren, the Netherlands). Upon arrival, birds were wing-tagged, individually weighed and randomly assigned to one of the 40 floor pens in a single climate-controlled room. Each of the 5 treatment diets was fed to 8 replicate pens of 8 birds per pen. Each pen had a dimension of 1.85 × 1 m (L × W) and was enriched with a perch. Pelleted lignocellulose (Softcell; Agromed Austria GmbH, Kremsmünster, Austria) was used as a bedding material to prevent confounding effects of coarse litter ingestion on GIT development. Ambient temperature was maintained at 32°C until d 3 and thereafter gradually reduced to 22°C at d 23. A 23L:1D photoperiod was applied until d 3 and was changed thereafter to 16L:8D until the end of the study. Birds were allowed ad libitum access to feed and water. Individual and pen body weights, as well as pen feed intake, were recorded weekly. Each 20 kg bag of feed used in the experiment was sampled at the top, middle and bottom. Feed samples were pooled by treatment group and kept at 4°C.  At d 22 and 23, 5 birds per pen were euthanized by intravenous (i.v.) sodium pentobarbital injection. Feeding status was synchronized across pens by applying 3 hours of fasting followed by 3 hours of feed access and continuous light prior to euthanasia to allow later comparison of gene expression data. The feeding of birds was staggered such that birds were sampled at the same time after the start of feeding. The birds in half of the pens per treatment were sampled on one day and the remaining pens on the other day. Slaughter weights were recorded, the body cavity was carefully opened and the content of the following GIT segments were isolated using tie-wraps: crop, proventriculus, gizzard, duodenum (from the pyloric junction to the hepatopancreatic duct), jejunum (from the hepatopancreatic duct to Meckel’s diverticulum), ileum (from Meckel’s diverticulum to the ileocecal valve), colon and ceca. Ileal contents of the 5 birds per pen were gently flushed with ice-cold saline solution, pooled in a plastic bottle and frozen at -20°C. The bird with an individual BW closest to the pen average was sampled for transcriptomic analysis. For the 4 other birds of each pen, empty digestive organ weights were recorded, the empty proventriculus was collected and frozen at -20°C. Jejunal content was collected by gentle finger stripping, pooled per pen and frozen at -20°C. Finally, 5 mm pieces of the middle of the duodenum and jejunum were sampled, fixed in buffered formaldehyde solution (pH = 7.0; 9713, VWR International, Amsterdam, Netherlands) during 4 days and thereafter stored in demineralized water.  At d 24, 15 birds with an individual body weight at 14 d close to their respective pen average were selected per treatment group and dosed orally with 3 gel capsules containing 150 mg titanium (Ti) oxide each (equivalent to 90 mg of Ti; Apotheek Diergeneeskunde Utrecht University, Utrecht, Netherlands). Birds were euthanized by i.v. sodium pentobarbital injection at 5 different time points after dosing (30, 90, 180, 270 and 360 min; 3 birds per treatment group and time point) following the method developed by van Krimpen and coworkers (2011) to determine digesta mean retention 
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time. For each bird, digesta content of the crop, proventriculus-gizzard, small intestine (from the pyloric junction to the ileocecal valve) and colon-ceca were quantitatively collected by gentle finger stripping and frozen at -20°C. Differences in GIT development and digestive function are more susceptible to be observed during the starting period. As such, the experiment was conducted during the 0-24 d period.  
Analytical methods A representative fraction of the digesta content taken for mean retention time determination was analysed for dry matter (DM), Ti and SCFA contents (15 birds per treatment group, 4 GIT segments per bird). DM was measured according to standard methods (method ISO 6496; ISO, 1999), Ti according to the method described by Short and colleagues (1996) and SCFA contents were determined according to the method described by Qaisrani and coworkers (2014).  Feed and freeze-dried ileal samples were ground to pass a 1 mm sieve and analysed for DM (method ISO 6496; ISO, 1999) , ash (method ISO 5984; ISO, 2002), N (method ISO 5983-1; ISO, 2005a) and amino acids (AA) by HPLC after acid hydrolysis (method ISO 13903; ISO, 2005b) contents. The Cr2O3 content was determined in feed and ileal samples after ashing and acid hydrolysis as described by Williams et al. (1962). Apparent ileal digestibility of DM, AA, organic matter (OM) and N was calculated using Cr2O3 as a solid phase marker (Kotb and Luckey, 1972). Amino acid N and non-AA N were calculated using the N content of samples, molar weights of AA and assuming that Asp and Glu molecules have 1.5 N atoms. Diets were analysed for starch, crude fat and crude fibre contents according to standard methods (AOAC, 2012).  Duodenal and jejunal tissue samples were dehydrated in increasing concentrations 
of alcohol, embedded in paraffin and sectioned at 5 μm thickness. Six cross-sections per sampled organ per bird were stained with haematoxylin and eosin. Villus height (from tip to crypt mouth) and crypt depth (from crypt mouth to base) were measured using a Microphot-FXA light microscope (Nikon, Tokyo, Japan) equipped with a DP 50 digital camera (Olympus, Tokyo, Japan). Images were analysed using the AnalySiS Extended Pro 3.1 software (Soft Imaging System GmbH, Berlin, Germany). Averages represent 3 to 4 birds per pen; in each slide 10 well-oriented, intact villi and crypts were measured.  Proteolytic activity in the proventriculus was evaluated according to the method described by Qaisrani and coworkers (2015). Proteolytic activity in the jejunum was evaluated according to the method developed by Rada and coworkers (2016).    
Butyrate and digestive functions 
57  
Statistical analysis 
Rationale for the use of contrast analysis. Separated (UP, TB, FCB) and combined (UPTB) use of different additives may allow changes in butyrate concentration in distinct GIT segments while keeping butyrate inclusion level constant across diets. Assuming that such conditions are met, comparison of growth performance and digestive function data between appropriate treatment groups using pre-defined contrasts may reveal the effect of butyrate presence in specific GIT segments. Theoretical considerations underlying such statistical approach need, however, to be supported by observed changes in butyrate concentration along the GIT. Hence, a two-step analysis of experimental data was carried out. First an analysis of SCFA concentrations along the GIT was performed using a set of contrasts testing for overall butyrate and additives-specific effects, thereby addressing the validity of the experimental approach. Thereafter, growth and digestive function data were analyzed using a set of pre-defined contrasts testing for the effect of butyrate presence in different GIT segments.  
Step one: Effects of butyrate additives on SCFA concentration along the GIT. SCFA data were analyzed separately for each GIT location using the PROC GLM of SAS (version 9.3, SAS Institute Inc., Cary, NC) using the following model:  Y𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 = 𝜇𝜇𝜇𝜇 + D𝑖𝑖𝑖𝑖 +  𝜀𝜀𝜀𝜀𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  where Y𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  is the observed butyrate concentration of the jth replicate (j = 1 to 15) fed the 
ith diet (i = CTR, UP, TB, FCB or UPTB), 𝜇𝜇𝜇𝜇 is the overall mean response, D𝑖𝑖𝑖𝑖  is the ith fixed diet effect and 𝜀𝜀𝜀𝜀𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  the residual term associated with the jth replicate fed the ith diet. Model assumptions were checked by visual inspection of the residuals. When a significant dietary effect was detected, multiple pairwise comparisons were performed using the LSD test. Additionally, contrasts were used to assess the overall butyrate supplementation effect (But: CTR vs UP+TB+FCB+UPTB) and the specific effects of including different butyrate additives in butyrate supplemented diets (effect of unprotected butyrate Un-but: UP+UPTB vs TB+FCB, effect of tributyrin Tri-but: TB+UPTB vs UP+FCB, effect of fat-coated butyrate F at-but: FCB vs UP+TB+UPTB). Contrasts were not orthogonal, resulting in correlation among tests indicated in Table 2.   
Table 2. Pearson’s correlation coefficient (R) among contrasts in the statistical analysis of SCFA concentrations Contrasts1 Butyrate Un-but Tri-but Fat-but Butyrate 1 0 0 0 Un-but 0.5 1 0 0.5 Tri-but 0.5 0 1 0.5 Fat-but 0 0 0 1 1Contrasts: Butyrate (overall effect of butyrate: CTR vs UP+TB+FCB+UPTB), Un-but (effect of unprotected butyrate: UP+UPTB vs TB+FCB), Tri-but (effect of tributyrin: TB+UPTB vs UP+FCB), Fat-but (effect of fat-coated butyrate: FCB vs UP+TB+UPTB). 
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Step two: Contrast analysis of growth performance and digestive function data. Body weight gain (BWG), average daily feed intake (ADFI), feed conversion ratio (FCR) and bodyweight variation coefficient (CV) were calculated and analysed using the PROC GLIMMIX of SAS using the following model:  Y𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 = 𝜇𝜇𝜇𝜇 + D𝑖𝑖𝑖𝑖 + A𝑖𝑖𝑖𝑖 + A × D𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 + 𝜀𝜀𝜀𝜀𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  where Y𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  is the observed response of the kth replicate (k = 1 to 40) fed the ith diet (i = CTR, UP, TB, FCB or UPTB) during the jth measurement period (j = 1-7, 8-14, 15-21), D𝑖𝑖𝑖𝑖  is the ith fixed diet effect, A𝑖𝑖𝑖𝑖 is the jth random effect of measurement period, and A × D𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  the interaction effect between the diet and measurement period, and 𝜀𝜀𝜀𝜀𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  is the residual error term of the kth replicate fed the ith diet at the jth measurement period. Visual inspection of the residuals indicated that the normal distribution fitted best the BWG data whereas ADFI, FCR and CV were analysed with a lognormal distribution. Contrasts were used to assess the overall effect of butyrate supplementation (But: CTR vs UP+TB+FCB+UPTB) and the effect of butyrate presence in different GIT segments (Crop, proventriculus and Gizzard, C+P+G: TB vs UPTB; Duodenum, jejunum and ileum, D+J+I: UP vs UPTB; Colon and ceca, Co+Ce: FCB vs UPTB). Contrasts were not orthogonal, resulting in correlations among tests indicated in Table 3.  
Table 3. Pearson’s correlation coefficients (R) among contrasts in the statistical analysis of performance parameters Contrasts1 Butyrate C+P+G D+J+I Co+Ce Butyrate 1 0 0 0 C+P+G 0.25 1 0.25 0.25 D+J+I 0.25 0.25 1 0.25 C+C 0 0 0 1 1Contrasts: Butyrate (overall effect of butyrate: CTR vs UP+TB+FCB+UPTB); C+P+G (effect of presence in the crop, proventriculus and gizzard; TB vs UPTB); D+J+I (effect of presence in the duodenum, jejunum and ileum: UP vs UPTB); C+C (effect of presence in the colon and ceca: FCB vs UPTB).  Digestive tract organs relative weights, enzymatic activities, histological measurements and digestibility coefficients were analyzed with the same procedure as SCFA and the same contrasts as performance parameters. Digesta mean retention time was calculated using the model developed by van Krimpen and coworkers (2011) and analyzed using the same contrasts as performance parameters.  
RESULTS 
SCFA Table 4 shows the effect of dietary treatments on SCFA concentrations in the content of the different GIT segments of broilers at 24 d of age. Significant diet effects were observed for butyrate concentration in all the GIT segments except the colon and ceca (P<0.001) and for propionate concentration in colonic and cecal contents (P=0.031). Contrast analysis indicated that butyrate concentration in crop, proventriculus, gizzard and small intestine contents were significantly lower in birds fed control diets compared to their butyrate-fed counterparts (P<0.001).   
Bu
ty
ra
te
 a
nd
 d
ig
es
ti
ve
 fu
nc
ti
on
s 59 
     Table 
4.
 Effect 
of dieta
ry trea
tments
 on ace
tate, pr
opiona
te and 
butyra
te conc
entrati
ons in 
the dig
esta of
 differe
nt gast
rointes
tinal se
gments
 of bro
ilers at
 24 d o
f 
age  Fatty a
cid con
centrat
ion 
Dietary
 treatm
ent me
ans1  
Pooled
 
SEM 
Diet effect  
Contra
sts2  
 Loca
tion 
CTR 
UP 
TB 
FCB 
UPTB 
Butyra
te U
n-but 
Tri-but
 Fa
t-but 
A
ce
ta
te
 (
μ
m
ol
/g
 D
M
) 
Crop 
20.9 
15.2 
18.0 
20.6 
20.2 
8.7 
0.691 
0.543 
0.484 
0.741 
0.390 
Proven
triculu
s and g
izzard 
4.3 
3.9 
4.1 
2.9 
3.4 
2.4 
0.364 
0.354 
0.700 
0.926 
0.184 
Small i
ntestin
e 
8.8 
11.4 
9.1 
8.4 
9.3 
4.8 
0.152 
0.634 
0.139 
0.277 
0.206 
Colon a
nd ceca
 
25.7 
28.4 
27.9 
26.6 
29.9 
17.9 
0.912 
0.597 
0.698 
0.866 
0.463 
P
ro
p
io
n
at
e 
(μ
m
ol
/g
 D
M
) 
Crop 
0.45 
0.57 
0.47 
0.44 
0.55 
0.12 
0.146 
0.153 
0.
04
5 
094 
0.
06
2 
Proven
triculu
s and g
izzard 
0.14 
0.22 
0.17 
0.10 
0.13 
0.16 
0.118 
0.664 
0.209 
0.589 
0.
07
9 
Small i
ntestin
e 
0.43 
0.61 
0.48 
0.42 
0.55 
0.39 
0.363 
0.377 
0.
09
2 
0.908 
0.167 
Colon a
nd ceca
 
1.5ab  
1.1b  
1.5ab  
1.8a  
1.4b  
1.3 
0.
03
1 
0.820 
0.
01
0 
0.423 
0.
00
3 
B
u
ty
ra
te
 (
μ
m
ol
/g
 D
M
) 
Crop 
0.9b  
10.2a  
8.3a  
8.8a  
10.5a  
0.9 
<0
.0
01
 
<0
.0
01
 
0.
02
3 
0.504 
0.012 
Proven
triculu
s and g
izzard 
0.29c  
4.56a  
3.28b  
2.37b  
3.08b  
0.42 
<0
.0
01
 
<0
.0
01
 
0.
04
2 
0.941 
0.381 
Small i
ntestin
e 
0.31b  
0.35b  
1.79a  
0.40b  
1.46a  
0.14 
<0
.0
01
 
<0
.0
01
 
0.177 
<0
.0
01
 
<0
.0
01
 
Colon a
nd ceca
 
20.2 
21.1 
21.6 
27.9 
25.4 
4.3 
0.676 
0.432 
0.890 
0.818 
0.204 
1 Dietar
y treat
ments 
groups
: CTR (
no buty
rate su
ppleme
ntation
); UP (b
utyrate
 radica
l provi
ded as 
unprot
ected s
alt); TB
 (butyr
ate rad
ical pro
vided a
s tribu
tyrin); 
FCB (b
utyrate
 radica
l provi
ded as 
fat-coa
ted but
yrate);
 UPTB 
(butyra
te radi
cal pro
vided a
s a 50:5
0 w/w
 mixtur
e of un
protect
ed salt
 and tr
ibutyri
n). But
yrate w
as 
provid
ed at 1
 g/kg a
s in bas
is. Valu
es are m
eans of
 15 bird
s per tr
eatmen
t. 
2 Contra
sts use
d: Buty
rate (o
verall e
ffect of
 butyra
te: CTR
 vs UP+
TB+FC
B+UPT
B), Un-
but (ef
fect of 
unprot
ected b
utyrate
: UP+U
PTB vs
 TB+FC
B), Tri-
but (ef
fect of 
tributy
rin: TB
+UPTB
 vs UP+
FCB), F
at-but 
(effect 
of fat-c
oated b
utyrate
: FCB v
s UP+T
B+UPT
B). 
Means 
within 
a row l
acking 
a comm
on sup
erscrip
t differ
 (P<0.0
5). 
Butyrate in broiler diets 
60  
In addition, contrast analysis showed that UP significantly increased propionate concentration in the crop content (P=0.045) in comparison to the other butyrate additives. A similar trend was observed in the small intestine (P=0.092) whereas propionate concentration in colonic and cecal contents was reduced by UP supplementation (P=0.010) in comparison to the other additives. The UP additive also significantly increased the butyrate concentration in the crop (P=0.023) and in the proventriculus-gizzard (P=0.042) content in comparison to the other additives. The TB additive did not affect acetate or propionate concentration along the GIT but significantly (P<0.001) increased butyrate concentration in the small intestine content compared to the other additives. The FCB additive tended to reduce propionate concentration in the crop (P=0.062) and in the proventriculus-gizzard (P=0.079) content while significantly (P=0.003) increasing propionate concentration in colonic and cecal contents compared to the other butyrate additives. The FCB additive numerically increased the butyrate concentration in colonic and cecal contents compared to the other butyrate additives (+22.9 %; P=0.204). 
Performance responses Table 5 shows the effect of butyrate presence in distinct GIT segments on growth performance of broiler chickens during the 1-21 d period. Addition of butyrate to the diet tended (P=0.090) to decrease feed intake compared to the control group. In butyrate-supplemented birds, feed intake tended (P=0.075) to be higher when butyrate was present in the crop, proventriculus and gizzard whereas presence in the colon and ceca tended (P=0.086) to reduce the FCR.   
Table 5. Effect of dietary treatments on performance parameters of broiler fed a control diet or the same diet supplemented with 4 butyrate preparations during the 0-21 d period 
 Dietary treatment1 SEM Contrasts2 Item CTR UP TB FCB UPTB But C+P+G D+J+I Co+Ce Initial BW, g 42.3 41.8 42.1 42.2 42.2 - - - - - 
Performance parameters (0-21d)3 Mortality, % 4.7 1.6 3.1 4.7 0 - - - - - WG, g/bird 679 676 644 669 674 6 0.514 0.242 0.946 0.831 FI, g/bird 975 938 906 913 976 6 0.090 0.075 0.191 0.214 BW CV 11.2 12.3 11.0 12.8 11.4 0.1 0.497 0.835 0.436 0.432 FCR, g:g 1.44 1.39 1.41 1.37 1.45 0.03 0.101 0.777 0.154 0.086 1Dietary treatments groups: CTR (no butyrate supplementation); UP (butyrate radical provided as unprotected salt); TB (butyrate radical provided as tributyrin); FCB (butyrate radical provided as fat-coated butyrate); UPTB (butyrate radical provided as a 50:50 w/w mixture of unprotected salt and tributyrin). Butyrate was provided at 1 g/kg as in basis. Means are averages of 8 replicate pens per treatment. 2Contrasts used: But (overall effect of butyrate: CTR vs UP+TB+FCB+UPTB); C+P+G (effect of butyrate presence in the crop, proventriculus and gizzard; TB vs UPTB); D+J+I (effect of butyrate presence in the duodenum, jejunum and ileum: UP vs UPTB); Co+Ce (effect of presence butyrate and/or propionate in the colon and ceca: FCB vs UPTB). 3Performance parameters abbreviations: Weight gain (WG); Feed intake (FI); Body weight coefficient of variation (BW CV); Feed conversion ratio (FCR).    
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Digestive traits responses The effects of butyrate presence in different GIT segments on several digestive trait parameters are presented in Table 6.   
Table 6. Effect of dietary treatments on digestive tract development, digesta retention time, proteolytic activities and intestinal morphology of 22-23 d old broilers fed a control diet or the same diet supplemented with 3 butyrate preparations during the 0-23 d period   Dietary treatment1 SEM2 Contrasts3   CTR UP TB FCB UPTB But C+P+G D+J+I Co+Ce 
Digestive segment weight (% of slaughter weight)           Crop 0.40 0.39 0.42 0.40 0.38 0.01 0.957 0.038 0.508 0.270 Proventriculus 1.42 1.43 1.38 1.40 1.49 0.03 0.782 0.930 0.984 0.794 Gizzard 1.53 1.55 1.62 1.52 1.54 0.04 0.686 0.181 0.865 0.805 Duodenum 1.07 1.05 1.1 1.07 1.02 0.02 0.810 0.019 0.397 0.127 Jejunum 2.04 1.96 2.04 2.06 1.92 0.04 0.299 0.036 0.444 0.010 Ileum 1.70 1.63 1.74 1.71 1.65 0.03 0.575 0.030 0.650 0.133 Ceca 0.24 0.24 0.25 0.24 0.24 0.01 0.603 0.272 0.138 0.545 Colon 0.33 0.32 0.36 0.34 0.34 0.01 0.537 0.117 0.950 0.791 Total GIT 7.94 7.77 8.15 7.98 7.72 0.11 0.790 0.004 0.741 0.072 
Mean retention time (min)         Crop 72 86 112 104 89 19 0.241 0.416 0.591 0.913 Prov+Gizz4 24 28 37 25 22 7 0.621 0.124 0.743 0.485 Small intestine 91 83 76 151 142 17 0.262 0.020 0.705 0.032 Colon/Ceca 4 6 9 13 16 5 0.258 0.383 0.672 0.235 Total 191 204 235 292 268 17 0.010 0.183 0.340 0.022 
Proteolytic activity          Proventriculus5 5.64 6.42 5.08 5.95 6.6 0.4 0.418 0.012 0.759 0.261 Jejunum6 0.23 0.22 0.23 0.20 0.23 0.02 0.645 0.839 0.730 0.213 
Intestinal morphology (μm)         Duodenum           Villi length 1464 1466 1490 1447 1470 40.63 0.928 0.726 0.945 0.702 Crypt depth 313 314 329 303 300 12.65 0.916 0.109 0.417 0.858 Villi:Crypt 4.68 4.67 4.53 4.78 4.90 0.17 0.685 0.210 0.368 0.593 Jejunum           Villi length 1050 968 1033 1050 1016 26.74 0.265 0.655 0.212 0.380 Crypt depth 211 205 206 210 204 6.47 0.458 0.846 0.895 0.544 Villi:Crypt 4.98 4.72 5.01 5.00 4.98 0.14 0.863 0.492 0.165 0.944 1Dietary treatments groups: CTR (no butyrate supplementation); UP (butyrate radical provided as unprotected salt); TB (butyrate radical provided as tributyrin); FCB (butyrate radical provided as fat-coated butyrate); UPTB (butyrate radical provided as a 50:50 w/w mixture of unprotected salt and tributyrin). Butyrate was provided at 1 g/kg as in basis. Means are values of 15 birds per treatment group for passage rate and 32 birds per treatment group for the other read-out parameters. 2Pooled standard error of the mean. 3Contrasts used: Butyrate (overall effect of butyrate: CTR vs UP+TB+FCB+UPTB); C+P+G (effect of butyrate presence in the crop, proventriculus and gizzard; TB vs UPTB); D+J+I (effect of butyrate presence in the duodenum, jejunum and ileum: UP vs UPTB); Co+Ce (effect of presence butyrate and/or propionate in the colon and ceca: FCB vs UPTB). 4Prov+Gizz: Proventriculus + gizzard. 5Expressed in mmol tyrosine released per min per g fresh organ. 6Expressed in difference in absorbance measured at 366 nm.  Dietary butyrate significantly (P=0.010) increased total tract retention time. Crop, duodenum, jejunum, ileum and total GIT relative weights were decreased by butyrate presence in the crop, proventriculus and gizzard (P=0.038, 0.019, 0.036, 0.030 and 0.004; respectively). Additionally, butyrate presence in the crop, proventriculus and gizzard significantly increased proteolytic activity of the proventriculus (P=0.012) and 
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small intestinal retention time (P=0.020). Butyrate presence in the small intestine did not affect any of the measured responses. Presence of butyrate and/or propionate in colonic and cecal contents increased jejunum relative weight (P=0.010), small intestinal (P=0.032) and total tract retention times (P=0.022) and tended (P=0.072) to increase total GIT relative weight. Measured intestinal morphology traits were unaffected by dietary butyrate supplementation.  None of the aforementioned changes resulted in significant differences in OM, DM or N apparent ileal digestibility coefficients, but the digestibility coefficient of several AA tended to be affected by the presence of butyrate in different GIT segments (Table 7). Increased butyrate concentration in the crop, proventriculus and gizzard tended to decrease the apparent ileal digestibility of Ile, Leu, Phe, His and Lys (P=0.080, 0.076, 0.061, 0.094 and 0.080; respectively). Increased butyrate and/or propionate concentration in the colonic and cecal contents tended to increase the apparent ileal digestibility of Met and His (P=0.079 and 0.069; respectively).   
Table 7. Effect of dietary treatments on apparent ileal digestibility of nutrients of 22-23 d old broilers fed a control diet or the same diet supplemented with 3 butyrate preparations during the 0-23 d period   Dietary treatment1 SEM Contrasts2   CTR UP TB FCB UPTB But C+P+G D+J+I Co+Ce 
Component (%)  DM 53.1 54.5 54.5 54.6 53.7 1.3 0.433 0.667 0.653 0.643 OM 59.7 60.7 61.2 61.1 59.7 1.3 0.503 0.457 0.600 0.483 Nitrogen (N) 76.6 75.2 77.0 76.7 76.2 0.6 0.691 0.357 0.267 0.583 AAN3 79.8 81.0 82.0 80.2 80.6 1.2 0.377 0.410 0.792 0.833 NPN4 56.6 41.8 50.9 59.6 51.7 4.8 0.320 0.912 0.168 0.263 
Amino acids (%) Cysteine 70.0 68.6 70.8 70.6 69.2 1.1 0.907 0.345 0.708 0.398 Methionine 89.5 89.5 89.9 90.1 88.5 0.6 0.971 0.103 0.256 0.079 Aspartic acid 76.7 75.3 77.5 77.1 75.9 0.9 0.817 0.206 0.614 0.345 Threonine 73.4 72.6 74.7 73.9 72.7 0.8 0.934 0.108 0.927 0.316 Serine 75.8 75.1 77.1 76.2 75.3 0.8 0.852 0.151 0.877 0.474 Glutamic acid 86.2 85.4 86.7 86.4 85.7 0.6 0.861 0.515 0.750 0.365 Proline 76.7 76 77.4 76.8 76.2 0.8 0.900 0.314 0.867 0.624 Glycine 76.7 75.6 77.7 77.5 75.7 0.9 0.907 0.131 0.953 0.175 Alanine 82.2 81.3 83.2 82.8 81.6 0.7 0.978 0.110 0.828 0.218 Valine 78.7 77.9 79.5 79.2 78.1 0.7 0.980 0.164 0.831 0.271 Isoleucine 80.1 79.1 81.2 80.5 79.4 2.6 0.981 0.080 0.764 0.25 Leucine 83.7 82.9 84.7 84.2 83.0 0.7 0.984 0.076 0.902 0.212 Phenylalanine 82.5 81.9 83.9 82.9 82.1 0.6 0.795 0.061 0.866 0.393 Histidine 80.1 79.2 80.5 80.7 78.8 0.6 0.738 0.094 0.659 0.067 Lysine 81.2 80.2 82.0 81.7 80.6 0.7 0.846 0.080 0.605 0.157 Arginine 85.5 84.3 86.1 85.9 84.5 0.5 0.737 0.119 0.871 0.155 1Dietary treatments groups: CTR (no butyrate supplementation); UP (butyrate radical provided as unprotected salt); TB (butyrate radical provided as tributyrin); FCB (butyrate radical provided as fat-coated butyrate); UPTB (butyrate radical provided as a 50:50 w/w mixture of unprotected salt and tributyrin). Butyrate was provided at 1 g/kg as in basis. Means are pooled samples of 4 birds per replicate pen.  2Contrasts used: Butyrate (overall effect of butyrate: CTR vs UP+TB+FCB+UPTB); C+P+G (effect of butyrate presence in the crop, proventriculus and gizzard; TB vs UPTB); D+J+I (effect of butyrate presence in the duodenum, jejunum and ileum: UP vs UPTB); Co+Ce (effect of presence butyrate and/or propionate in the colon and ceca: FCB vs UPTB). 3AAN: Amino acid N. 4NPN: Non protein N. 
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DISCUSSION 
Presence of butyrate in distinct GIT segments The current study aimed to unravel effects of butyrate presence in distinct GIT segments on digestive processes and protein digestion in young broilers. Differences in luminal butyrate concentration across GIT segments were achieved using three different dietary butyrate additives. Unprotected butyrate is taken up by passive absorption under acidic conditions as present in the proventriculus-gizzard (Ichikawa 
et al., 2002; Denbow and Scanes, 2015). Logically, unprotected butyrate increased butyrate concentration in the crop and proventriculus-gizzard but not beyond this segment of the GIT in the current study. This is in agreement with other published results on broilers (Hu and Guo, 2007; Smith et al., 2012). Tributyrin, the triglyceride of butyrate, only increased enteric butyrate concentration in the present study due to a low pre-duodenal lipolytic activity in the broiler GIT (Moreau et al., 1988; Cherif et al., 2006). Finally, fat-coated butyrate numerically increased butyrate concentration in the pooled colon and ceca contents when compared to birds fed other butyrate additives (+22.9 %; P=0.204). This is in agreement with the suggestion that fat-coating extends butyrate release beyond the small intestine in broilers (Van den Borne et al., 2015). The lack of statistical significance of this result could be attributed to the large variation observed across individual birds when colonic and cecal butyrate concentrations were considered. In addition, propionate concentration in colonic and cecal contents was significantly higher in birds fed fat-coated butyrate compared to birds fed other butyrate additives (P=0.003). Collectively, these results indicate that the dietary contrasts in digesta butyrate concentration were successfully achieved in this experiment with the notable exception of the colon and ceca. For these distal GIT segments, the observed increase in butyrate concentration failed to reach statistical significance and was confounded with a higher propionate concentration. As a consequence, testing the effect of butyrate presence in distinct GIT segments by means of statistical contrasts is possible up until the ileum. In addition, a statistical contrast testing for the effect of butyrate and/or propionate presence in the colon and ceca is possible. 
Anorexic effect of butyrate In the current study, butyrate tended to have an anorexic effect. Such effect is unusual in broilers fed 1 g/kg of different butyrate additives (UP: Hu and Guo, 2007; FCB: Smulikowska et al., 2009) but have been reported at higher supplementation levels (2 g/kg butyrins: Leeson et al., 2005). Mammalian studies have demonstrated that colonic L-cells producing peptide YY (PYY) and glucagon like peptide 1 (GLP-1) are mediating the anorexic effect of luminal SCFA (Lin et al., 2012; Chambers et al., 2015). Such mechanism has never been studied in avian species but the possibility to extrapolate insights in gut endocrinology from rodents to production animals has been advocated recently (Bravo, 2015; Furness et al., 2015). It is, however, worth mentioning that L-cells are distributed along the small intestine in chickens (Rawdon and Andrew, 1999; Monir et al., 2014) whereas in rodents the distribution is extended to the colon (Hansen et al., 2013). The latter is traditionally regarded as the main site for triggering anorexic effects (Chamber et al., 2015). In addition, PYY has orexigenic properties in chickens and anorexic properties in rodents (Batterham et al., 2002; Denbow and Cline, 
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2015). Such differences make the extrapolation between murine and poultry species challenging. Interestingly, anorexic effects tended to be reduced when butyrate was delivered to the crop, proventriculus and gizzard compared to more distal segments. This observation is congruent with a putative role of intestinal L-cells in mediating the anorexic effects of butyrate in poultry. 
Amino acids digestibility and digesta retention time Butyrate and/or propionate presence in the colon and ceca resulted in significantly heavier jejuna and longer small intestinal and total tract retention times. Feed efficiency is associated with longer total tract retention time and lighter jejuna in 29 d old broilers (Rougière and Carré, 2010). In the present study, observed changes have accumulated into a trend for lower FCR values. Discrepancies in the effect of intestinal weights on feed efficiency confirm that a consistent relationship between measured read-out parameters and intestinal functionalities is sometimes difficult to establish across broiler studies (Svihus, 2014). Improved feed efficiency could be related to the trend for higher digestibility of methionine, the first limiting AA in practical poultry diets (Scanes, 2015). The relationship between digesta transit time and rapeseed meal digestibility is scarcely discussed in the literature, as most of the strategies proposed to improve rapeseed meal digestibility rely on enzymatic treatment and physical processing (Kozłowski and Jeroch, 2014) rather than on modifications of digestive physiology. Digesta retention time in poultry is controlled by a set of complex and poorly understood neuroendocrine mechanisms (Denbow, 2015). It is, therefore, difficult to speculate on the exact mechanism underlying the observed effect of butyrate and/or propionate presence in colonic and cecal contents on transit time. In mammals, only one study has demonstrated a link between hindgut butyrate concentration and colonic motility (Soret et al., 2010). 
Butyrate and intestinal microbiota Higher butyrate concentration in the crop, proventriculus and gizzard was associated with a trend for lower apparent ileal digestibility coefficients of Ile, Leu, Phe, His and Lys. Such changes were associated with a higher propionate concentration in the intestinal digesta which may indicate changes in microbiota activity. In chickens, intestinal microbiota dominated by Lactobacillus spp., a genus whose auxotrophy for the aforementioned AA is well documented (Morishita et al., 1981; Ruiz-Barba and Jimenez-Diaz, 1994). Luminal AA taken up by intestinal microbiota can be incorporated into microbial protein that bypasses ileal digestion (Apajalahti and Vienola, 2016). In the present study, higher butyrate concentration in the crop, proventriculus and gizzard digesta was associated with significant increases in intestinal retention time and proteolytic activity in the proventriculus. In addition, up-regulation of antimicrobial peptides by butyrate has been reported in chicken jejunal and caecal explants (Sunkara et al., 2011). Both digesta retention time and antimicrobial peptides are known to influence intestinal microbiota activity in chickens (Apajalahti and Vienola, 2016). Unfortunately, the absence of quantitative insights into intestinal microbiota composition in the present study hinders the complete understanding of the intricate relationship between intestinal microbiota and ileal AA bioavailability. Butyrate provision to the crop, proventriculus and gizzard also significantly reduced the relative weight of each intestinal segment. It is known that villous enterocytes 
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growth is primarily supported by luminal AA absorption rather than plasma AA (Fuller and Reeds, 1998). An overgrowth of Lactobacillus spp. could have exacerbated the competition between bacteria and host cells for the absorption of luminal AA, thus hampering intestinal development. 
Future research work Future work could be directed to an improved understanding of the possible endocrine effects and host-microbe interactions that mediated such changes. In addition, effects of butyrate presence in distinct GIT segments on other parameters, e.g. immune functions and microbiota composition, should be investigated. 
CONCLUSION The present study demonstrates that different butyrate additives can be used to create a contrast in luminal butyrate concentrations throughout the GIT of broilers. The effect of butyrate on several parameters such as GIT development, proteolytic activity or digesta retention time was found to vary depending on the GIT segment wherein the molecule was present. When butyrate and/or propionate was present in colonic and cecal contents, such effects tended to improve the digestibility of Met, the first limiting AA in practical poultry diets. In contrast, butyrate presence in the digesta of the crop, proventriculus and gizzard decreased the digestibility of several AA, possibly due to an increase in intestinal microbiota activity. In addition, butyrate presence beyond the gizzard elicited anorexic effects that might be attributable to changes in intestinal enteroendocrine L-cells secretory activities. The effect of butyrate on digestive functions and bioavailability of AA is therefore conditioned by the GIT segment wherein the molecule is present.  
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ABSTRACT Butyrate is known to influence energy metabolism and endocrine regulation in the mammalian gastrointestinal tract (GIT). Such effects may also occur in broilers in a location-dependent manner and could condition intracellular butyrate concentration along the GIT. An experiment was conducted to investigate at the mRNA level the effect of providing butyrate to distinct GIT segments on energy metabolism and endocrine regulation of broilers. A total of 320 male one day-old Ross 308 broilers were randomly assigned to 5 dietary treatment groups, each replicated 8 times: one control group and four groups supplemented with 1 g/kg butyrate in the form of feed additives having markedly different butyrate release profiles. Diets were based on rapeseed meal, corn and wheat and were fed ad libitum. At 22-23 d of age, birds were sacrificed. The GIT of the bird having its BW the closest to the pen average was sampled at five different locations, i.e. proventriculus, pylorus, duodenum, ileum and colon. For each location, the control without added butyrate was compared to the butyrate-supplemented diet that resulted in the largest increase in digesta butyrate concentration. Expression levels of genes related to the uptake, sensing and metabolism of butyrate as well as hormonal regulation were quantified by qPCR. Mucosal and digesta butyrate concentrations were measured by gas chromatography. Our results suggest that butyrate uptake is a passive process in the gastric region while being facilitated by putative (sodium-dependent) monocarboxylate transporters in the small and large intestine. Increasing digesta butyrate concentration in the gastric region seemed to increase the β-oxidation of lipids. A similar effect was observed in the ileum and colon. Increasing digesta butyrate concentration in the duodenum seemed, however, to promote glycolysis. Butyrate has, therefore, a location-dependent effect on energy metabolism in the gut. Despite such specificities, intracellular butyrate concentration remained low across GIT segments and diets. This may prevent the negative effects of intracellular butyrate accumulation on gut cells functions. butyrate increased the expression of preprocholecystokinin in the duodenum. This may explain the anorectic effect of dietary butyrate supplementation in poultry.  
Keywords: Butyrate, broilers, sensing, uptake, metabolism, hormones   
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INTRODUCTION Research in the late 1970s demonstrated that the accumulation of butyrate in human cell cultures inhibited altered gene expression and cell functioning by inhibiting the chromatin-remodelling activity of histone deacetylases (HDAC) (Riggs et al., 1977; Sealy and Chalkley, 1978). Two decades later, novel G protein-coupled receptors (GPR) were discovered (Sawzdargo et al., 1997). Butyrate and other short chain fatty acids (SCFA) were subsequently identified as potent ligands activating GPR 41, 43 and 109a (Brown et al., 2003; Le Poul et al., 2003; Singh et al., 2014). G proteins-coupled receptors 43 and 41 were coined free fatty acid receptors (FFAR) 2 and 3, respectively, and their role in modulating the secretory activity of different enteroendocrine cells was established in mammals (Liou, 2013). Changes in the secretory activity of enteroendocrine cells may affect energy homeostasis at the gut and systemic levels (Murphy and Bloom, 2006). The capacity of butyrate to modulate endocrine regulation and energy metabolism in distinct gastrointestinal tract (GIT) segments through HDAC inhibition or GPR sensing is, therefore, well documented in mammals (e.g. Tabuchi et 
al., 2006; Nohr et al., 2013).  In contrast to mammals, such effects have been scarcely investigated in the avian GIT. Earlier research was focused on the effect of supplementing broiler diets with butyrate on intestinal host defence peptides production (Sunkara et al., 2011; Sunkara 
et al., 2012; Sunkara et al., 2014) and, more recently, on hepatic lipid metabolism (Yin 
et al., 2016). Little is, however, known about the intricate relationships existing between digesta butyrate concentration and the expression of genes regulating the sensing, uptake and metabolism of butyrate in the avian GIT. Such relationships have been speculated to vary in distinct GIT segments due to differences in cell metabolism and luminal pH along the GIT (Moquet et al., 2016).  Besides, changes in the secretory activities of G-, I- and L-type enteroendocrine cells have been proposed as underlying mechanisms mediating the physiological changes associated with the presence of butyrate in the GIT of chickens, such as increased pepsin secretion (Onrust et al., 2015; Moquet et al., 2016). We demonstrated recently, using butyrate feed additives having markedly different release kinetics, that butyrate and/or propionate presence in the distal GIT (colon and ceca) of broilers resulted in alterations of digesta retention time and feed intake that were congruent with putative changes in the secretory activities of L-cells (Moquet et al., 2018).  The present study is an extension of our previous work in which gut tissues collected during the cited experiment (Moquet et al., 2018) are used to address a twofold objective: first, to study in five distinct GIT segments the effect of increasing digesta butyrate concentration on the expression level of genes associated with butyrate uptake and energy metabolism, and to assess the mucosal butyrate concentration. Second, to investigate the effect of increasing digesta butyrate concentration on the expression of genes related to the hormonal regulation of gut functions. It was hypothesised that butyrate catabolism would  be more effective in the distal GIT (e.g. ileum or colon) compared to more proximal GIT segments as a result of differences in cell metabolism (Moquet et al., 2016). We hypothesised that increasing digesta butyrate concentration in the distal GIT would result in an upregulation of genes 
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involved in butyrate catabolism and in a lower mucosal butyrate concentration compared to more proximal GIT segments (e.g. proventriculus or duodenum). It was further hypothesized that increasing digesta in distinct GIT segments would modulate the expression of FFAR2 and upregulate the expression of gut hormones that are produced by the different enteroendocrine cells.  
MATERIAL AND METHODS All the experimental procedures were approved by the Animal Care and Ethics Committee of Wageningen University & Research and conducted under the Dutch Law on Animal Experiments.  
Experimental design, management and sample collection The experiment described in the present manuscript was part of a larger study published by Moquet and colleagues (2018). A brief summary of this experiment is presented below.   
Experimental design. The effect of providing butyrate to distinct GIT segments on pre-cecal protein digestibility of broilers was investigated using a complete randomized design. A total of 320 male day-old Ross 308 broilers were randomly assigned to 5 dietary treatment groups: 1) Control (CTR; no butyrate), 2) unprotected butyrate (UP; activity in the crop and gastric regions), 3) tributyrin (TB; activity in the small intestine), 4) fat-coated butyrate (FCB; activity in whole GIT) and 5) a 50:50 mixture of unprotected butyrate and tributyrin (UPTB; butyrate radical C4H7O2- weight basis), each replicated 8 times. Butyrate radical was included to a rapeseed meal based diet at 1 g/kg, as fed basis. Ingredient and analyzed nutrient compositions of the diets are provided in Chapter 4, Table 1. 
 
Management. Birds were allowed ad libitum access to feed and water. Each pen had a dimension of 1.85 × 1 m (L × W) and was enriched with a perch. Pelleted lignocellulose (Softcell; Agromed Austria GmbH, Kremsmünster, Austria) was used as bedding material. 
 
Sample collection. At d 22 and 23, 5 birds per pen were euthanized by intravenous (i.v.) sodium pentobarbital injection. Feeding status was synchronized across pens to allow later comparison of gene expression data by applying 3 hours of fasting followed by 3 hours of feed access and continuous light prior to euthanasia. The feeding of birds was staggered such that birds were sampled at the same time after the start of feeding. The birds in half of the pens per treatment were sampled on one day and the remaining pens on the other day. From the bird having its BW the closest to the pen average, the following GIT tissue segments were sampled for gene expression analysis: proventriculus, pylorus, middle of the duodenum (halfway between the pyloric junction and the hepatopancreatic duct), proximal ileum (first third between Meckel’s diverticulum to the ileocecal valve) and middle of the colon (halfway between the ileocecal junction and the cloaca). Collected tissues were gently rinsed with ice-cold 0.9% NaCl, placed in cryogenic vials, snap frozen in liquid nitrogen and stored at -80°C until further processing.  
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Remaining birds were euthanized and dissected at 24 d of age for the determination of SCFA in the digesta of different GIT compartments and for the determination of digesta retention time. 
Analytical Methods 
Rationale for the selection of tissues. Table 1 presents the changes in luminal butyrate concentration, expressed as percentage of the control, induced by dietary intervention.  
 
Table 1. Effect of dietary treatments on butyrate concentration expressed as a percentage of the control 
(%; μmol/g DM basis) in the digesta of different gastrointestinal segments of broilers at 24 d of age  
Data adapted from Moquet and coworkers (2018) Location Dietary treatment means1 Diet effect UP TB FCB UPTB Crop 1033a 822a 878a 1067a <0.001 Proventriculus and gizzard 1472a 1031b 717b 962b <0.001 Small intestine 13b 477a 29b 371a <0.001 Colon and ceca 4 7 38 26 0.676 1Dietary treatments groups: UP (butyrate radical provided as unprotected salt); TB (butyrate radical provided as tributyrin); FCB (butyrate radical provided as fat-coated butyrate); UPTB (butyrate radical provided as a 50:50 w/w mixture of unprotected salt and tributyrin). Butyrate was provided at 1 g/kg on an as is basis. Values are means of 15 birds per treatment. a,bMeans within a row having a superscript differ significantly from the control (no butyrate supplementation). Means within a row lacking a common superscript differ significantly (P<0.05).  For each GIT segment sampled, it was decided to compare the control without added butyrate to the butyrate-supplemented diet that resulted in the largest increase in digesta butyrate concentration. Consequently, following treatment groups were selected for comparison: CTR and UP for the proventriculus and pylorus, CTR and TB for the duodenum, and CTR and FCB for the colon. For the distal part of the small intestine (ileum) it was decided to compare CTR and FCB despite the fact that CTR and TB showed a larger contrast in butyrate concentration in pooled intestinal digesta. This was decided because TB is known to release butyrate in the proximal part of the small intestine in pigs (Schwarzer and Bjork, 2015) and poultry (unpublished results from our lab) while FCB is known to extend the effect of butyrate to the entire small intestine in chickens (van den Borne et al., 2015).  
Short chain fatty acids determination in tissue samples. Frozen tissue samples were ground in liquid nitrogen with a pestle and mortar. A fraction of ground tissue was analysed for short chain fatty acids (SCFA) determination by gas chromatography according to the method described by Qaisrani and colleagues (2014). 
 
RNA extraction and real time quantitative PCR. Total RNA was extracted from 1-2 mg fraction of ground tissue using Trizol reagent (ThermoFisher Scientific, Bleiswijk, Netherlands). Isolated RNA was subsequently subjected to an on-column DNase digestion to eliminate possible DNA contamination (NucleoSpin RNA II kit; Macherey-Nagel GmbH & Co. KG, Düren, Germany). Total nucleic acid concentration and purity were determined by optical density measurement using a NanoDrop ND-1000 (Thermofisher Scientific) while RNA integrity and size was assessed using a 
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Bioanalyzer 2100 and RNA 6000 Nano LabChip kit (Agilent, Santa Clara, California). The average RNA integrity number value was 9.9, ranging between 9.7 and 10. First-strand cDNA synthesis was performed with 250 ng of total RNA per 20-mL sample reaction with Superscript III reverse transcriptase (Thermofischer Scientific), deoxyribonucleotide triphosphate (Roche Diagnostics, the Netherlands), and random hexamer primers (Roche Diagnostics, the Netherlands) for 1 h at 50 °C, according to the manufacturer’s protocol (Thermofischer Scientific). Real-time quantitative PCR was carried out with a ABI 7500 Real-time PCR System (Applied Biosystems, Foster City, California) by using the SensiMix SYBR Low-ROX mix (Bioline UK Ltd., London, UK). Amplification conditions were 95°C for 10 min, followed by 40 cycles of 95°C for 15 s, 60°C for 15 s and 72°C for 35 s each. A final melting protocol of increasing temperature from 60°C to 95°C with 0.5°C increments of 5 s each was applied. 
 The primer sequences used in this study are listed in Table 2. Quantitative mRNA measurement was performed by establishing a linear calibration using 10-fold serial dilutions of cDNA template for corresponding genes. We designed primers for 5 genes, commonly used as reference genes in mammalian species, namely ACTB, EFF2, IPO8, PPIA and RPLPO. Analysis of the measured values with the Normfinder algorithm (Andersen et al., 2004) revealed that IPO8 was the most suitable housekeeping gene across locations and diets.  
Table 2. Primers used for real-time quantitative PCR Gene1 Forward primer (5’-3’) Reverse primer (5’-3’) Normalization genes  
IPO8 ACCTCCGAGCTAGATCCTGT GGCTCTTCTTCGCCAACTCT 
ACTB GCCCTGGCACCTAGCACAAT GCGGTGGACAATGGAGGGT 
RPLP0 TTGGGCATCACCACAAAGATT CCCACTTTGTCTCCGGTCTTAA 
PPIA CCCGTCGTGTTCTTCGACAT CCCTTGTAGCCAAATCCCTTCT 
EEF2 CAGTTGGCTTTGGTTCTGGC AAAGTATCTGTCTCCCCACAGC Transporters  
SMCT1 GGCACACCTTCTGGACGATT TAGAGGGACATTTTTGCGTGGA 
SMCT2 TTGGGGGAACCTTTACGTGG AAGTGCCATCTTTGCATGCTT 
MCT1 CGGTGCTGTTTGAAACCCTG GTCGTTGAGCTTACCGAGCA 
MCT2 AGCCGACCAGTGATGATAGC GGTCAAGGCAGGCTGTAAGT 
MCT8 TCGTGAGCATCTTCACTGACC CTTCCAGAGACTTGGTGAAGGAG 
MCT9 TCAACAGGCTCAAGTGTTGGA GGTCTCATTAGGCTGCCACA 
MCT10 TTCTTTTGTAAGCACCATCGAGCC TGCCCAAGGATGACCAAAGAT 
MCT14 AGTAACAGCTGGCATTGGGA CCAAACCCTGTTCCTGTGGT Energy metabolism  
ACSM3 GTTGTCAGCAGTCCAGACCC GCTCTCGAACAAACTCCATTTTCC 
ACSM4 TGGTTTTAGACCCCTGTTATGTGA GGAAGCTGCAGAGTGTATTTAGG 
ACSM5 CAGTAGCAGGCACTGGATGAA GCAGAAGACGGTGATAGGGT 
CS TTACCGCAACCTTTACCGGG GAACTGCGGGTCGGTGTAA 
DLAT TTCGGAGGGTCATTGCTCAG CGTAGCACCAGTACTTCTCCC 
G6PC TGGTCCTGCACCTCTTTGATG ACATGAAGCTGCCCCTAGAC 
GADPH ATCCCTGAGCTGAATGGGAAG AGCAGCCTTCACTACCCTCT 
GPI AAGGGAGGTCCACGTGTTTG GGTGGTGAAGGTCTTTGATGC 1IPO8: Importin 8; ACTB: Actin beta; RPLP0: 60S acidic ribosomal protein P0; PPIA: Peptidylprolyl Isomerase A; EEF2: Eukaryotic elongation factor 2; SMCT: Sodium-coupled monocarboxylate transporter; 
MCT: Monocarboxylate transporter; ACSM: Acyl-CoA synthetase medium chain family member; CS: Citrate synthase; DLAT: Dihydrolipoamide S-acetyltransferase; G6PC: Glucose-6-phosphatase catalytic subunit; 
GADPH: Glyceraldehyde-3-phosphate dehydrogenase; GPI: Glucose-6-phosphate isomerase.    
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Table 2. (Continued) Gene1 Forward primer (5’-3’) Reverse primer (5’-3’) Sensing and hormonal regulation 
FFAR2 GGCTACCACTGCTACGATGA CCCCAAAGTTGACCATGGTG 
preproCCK CAAGCCCGGAAAGGTTCCA GTATTCTTCAGCACTGCGGC 
preproGastrin GTTCCTCGGCCTCATCCTC TAGAAGTGGTCGTGCAGGG 
GCG-A CCCTTTTTCTCTGCCTCTGTAGT CTGGGAATGATCACCAGAGCA 
GCG-B TGGCTGCCAAAGAGTTCCTAA TGGCAGTTGAGGCAGTGAAG 
PC1/3 GCACTGATACCCAGCCTGAA TGTGTGGTATGGTCCTCTGC 
PC2 ACCCCCGCTATACAGATGACT CGAATACCTGCCACCTTGGA 1; FFAR: Free fatty acid receptor; preproCCK: Preprocholecystokinin; preproGastrin: CGC-A: Proglucagon A; 
GCG-B: Proglucagon B; PC1/3: Proprotein convertase subtilisin/kexin type 1/3; PC2: Proprotein convertase subtilisin/kexin type 2 
Statistical analysis 
SCFA Data. SCFA data were analyzed separately for each GIT location using the PROC GLM of SAS (version 9.4, SAS Institute Inc., Cary, NC) using the following model:  Y𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 = 𝜇𝜇𝜇𝜇 + D𝑖𝑖𝑖𝑖 +  𝜀𝜀𝜀𝜀𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 , where Y𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  is the observed butyrate concentration of the jth bird (j = 1 to 8) fed the ith diet (i = CTR, UP, TB, FCB or UPTB), 𝜇𝜇𝜇𝜇 is the overall mean response, D𝑖𝑖𝑖𝑖  is the ith fixed diet effect and 𝜀𝜀𝜀𝜀𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  the residual term associated with the jth bird the ith diet. Model assumptions were checked by visual inspection of the residuals.   
Gene expression Data. Differences in gene expression were tested for each gene and location with the Mann-Whitney U test using PROC NPAR1WAY of SAS 9.4. 
RESULTS AND DISCUSSION In the present paper, we refer to the genes using their abbreviated protein names. Abbreviated gene names are mentioned upon their first appearance in the text if they differ from the abbreviated protein name. 
Butyrate uptake along the avian GIT  
Monocarboxylate transporters. Astbury and Corfe (2012) summarized in an authoritative review the uptake and metabolism of butyrate in the mammalian GIT. Briefly, early research works reported that butyrate uptake in the mammalian colon increased with HCO3- gradient and was reduced by the presence of acetate and propionate (Mascolo et al., 1991). This suggested the involvement of a carrier-mediated anion exchange process in the absorption of SCFA in the gut (Mascolo et al., 1991). The monocarboxylate transporter 1 (MCT1, gene name SLC16A1) was later characterized in hamsters (Garcia et al., 1994) and its role as HCO3-/butyrate exchanger was confirmed in humans (Harig et al., 1996). Next to its function as HCO3-/butyrate exchanger, MCT1 was also characterized as a proton-linked cotransporter for SCFA, pyruvate, lactate and ketone bodies in mammals (Halestrap and Price, 1999). The MCT family contains fourteen members (Halestrap, 2013). In this family, there are three alternative SCFA transporters with characteristics overlapping those of MCT1, namely MCT2, 3 and 4 (gene names SLC16A7, SLC16A8 and SLC16A3, respectively; Halestrap, 2013). In mammals, MCT1 proteins are almost absent from the duodenal and jejunal 
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brush border membrane (BBM), but are highly present in the ileal and colonic BBM (Gill 
et al., 2005; Welter and Claus, 2008). To date, there is no report describing the distribution, cellular localization and functions of the MCT family members along the avian GIT.  
Sodium-coupled monocarboxylate transporters. After functional characterization of MCT1, additional butyrate transporters were discovered. Coady and coworkers (2004) demonstrated with frog oocytes that butyrate uptake could also be facilitated by the sodium-coupled monocarboxylate transporter 1 (SMCT1, gene name SLC5A8). Such features are shared with SMCT2 (gene name SLC5A12; Gopal et al., 2007). MCT1 and SMCT1 share the same distribution and cellular localization in the mammalian GIT (Takebe et al., 2005; Borthakur et al., 2010). Because of its higher substrate affinity, SMCT1 is believed to play a more important role than MCT1 in the uptake of butyrate 
when digesta SCFA concentration is within the μM range (Astbury and Corfe, 2012). This view is also supported by the fact that Na+ gradient is far greater than pH or HCO3- gradients in the GIT (Gupta et al., 2006). The expression of several SLC5 genes has been investigated in the GIT of poultry (Garriga et al., 2006; Gilbert et al., 2007). Such research was, however, only focused on sodium-dependent glucose transporters. The distribution, cellular localization and functions of SMCT1 and 2 remain undocumented in the avian GIT. 
 
Types of (S)MCT expressed in broilers GIT. We tried to address a part of this gap of knowledge by investigating the expression of SMCT1, SMCT2 and of the fourteen MCT family members in the chicken GIT. Complementary DNA samples were pooled across diets and locations and subsequently screened for the presence of mRNA of provisional avian SMCT1, SMCT2 and MCT family members using PCR. Gel electrophoresis confirmed the presence of amplicons coding for SMCT1, SMCT2, MCT1 and MCT2. In addition, we also detected MCT8, MCT9, MCT10 and MCT14 amplicons (Data not shown; gene names SLC16A2, SLC16A9, SLC16A10 and SLC16A14, respectively). The expression of detectable genes was quantified by qPCR at five GIT locations. For each location, the CTR without dietary butyrate supplementation was compared to the butyrate supplemented diet (UP, TB or FCB) that resulted in the highest increase in digesta butyrate concentration (Table 3). 
 
Butyrate does not affect (S)MCT expression in the gastric region. Changes in digesta butyrate concentration in the gastric region (proventriculus and pylorus) did not influence significantly the expression of any of the measured (S)MCT genes. The pH of the digesta found in the gastric region is usually lower than the pKa of butyrate (Denbow, 2015). Consequently, butyrate exist mostly in a non-ionized (protonated) form in the gastric region of birds (Moquet et al., 2016). Non-ionized butyrate can diffuse passively through the gastric wall (Walter and Gutknecht, 1984). This may explain why, in the present experiment, we observed no significant effect of butyrate concentration in the gastric digesta on the expression of putative butyrate transporters.  
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Table 3. Effect of dietary treatments1 on expression of sodium-coupled monocarboxylate transporters (SMCT) and monocarboxylate transporters (MCT) genes in different gastrointestinal tract segments of broilers at 22-23 d of age 
  Average gene expression2  SMCT  MCT  SMCT1 SMCT2  MCT1 MCT2 MCT8 MCT9 MCT10 MCT14 
Proventriculus CTR 0.01 0.01  2.91 29.76 0.57 0.62 1.95 0.32 UP 0.02 0.01  3.00 30.54 0.61 0.61 2.09 0.41 
P-value 0.418 0.479  0.479 0.793 0.713 0.479 0.437 0.396 
Pylorus CTR 14.79 0.03  12.45 1.16 0.60 9.38 15.85 0.21 UP 14.05 0.03  14.20 1.29 0.64 9.03 13.60 0.25 
P-value 0.500 0.215  0.282 0.114 0.282 0.437 0.078 0.135 
Duodenum CTR 17.99 0.04  12.73 0.63 0.47 10.03 18.09 0.12 TB 25.26 0.08  18.95 1.04 0.74 15.98 29.89 0.24 
P-value 0.247 0.012  0.001 0.005 0.007 0.005 0.001 0.020 
Ileum CTR 3.61 100.00  13.95 1.43 0.73 12.02 12.98 0.20 FCB 3.46 86.39  12.80 1.62 0.67 10.70 10.87 0.21 
P-value 0.215 0.247  0.159 0.064 0.159 0.042 0.114 0.396 
Colon CTR 6.59 0.02  17.22 8.05 1.12 15.62 9.86 2.44 FCB 6.02 0.02  20.57 9.97 1.15 16.07 12.64 3.12 
P-value 0.500 0.437   0.033 0.078 0.357 0.437 0.078 0.007 1Dietary treatments groups: UP (butyrate radical provided as unprotected salt); TB (butyrate radical provided as tributyrin); FCB (butyrate radical provided as fat-coated butyrate). Butyrate was provided at 1 g/kg as in basis. Values are means of 8 birds per treatment. 2Arbitrary units. Quantitative mRNA measurement was performed by establishing a linear calibration using 10-fold serial dilutions of cDNA templates. Data were standardized using IPO8 as housekeeping gene. The highest average gene expression of the table was set to 100.   
Butyrate upregulates various (S)MCT in the duodenum. Historically, intestinal SCFA absorption was thought to be mediated by passive diffusion mechanisms in mammals and poultry (Sudo and Duke, 1980; Walter and Gutknecht, 1984). Intestinal digesta has, however, a pH higher than the pKa of butyrate (Denbow, 2015). This means that butyrate exists mostly in a ionized form in this GIT segment (Moquet et al., 2016). Transporters such as MCT1 or SMCT1 may, therefore, be required to move butyrate across the intestinal wall (Astbury and Corfe, 2012). Such transporters are, however, almost completely absent from the duodenal BBM of mammals fed diets without supplemented butyrate (Gill et al., 2005; Takebe et al., 2005; Welter and Claus, 2008; Borthakur et al., 2010). Expression of (S)MCT in the BBM of the mammalian duodenum may be constitutively low and induced by the presence of butyrate in the lumen.  In the present experiment, we observed that increasing digesta butyrate concentration in the duodenum resulted in a significant increase in the expression of genes coding for MCT1, MCT2 and SMCT2 (P=0.001, P=0.005 and P=0.012, respectively). As stated earlier, butyrate is known to be a substrate for such transporter in mammals. In addition, we observed that increasing digesta butyrate concentration in the duodenum resulted in a significant increase in the expression of MCT8, 9, 10 and 14 genes (P=0.007, P=0.005, P=0.001 and P=0.020, respectively). In mammals, physiological roles of the latter MCT are related to the transport of thyroid hormones 
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and their metabolites (MCT8 and 10), of aromatic amino acids (MCT10 and 14) and of carnitine (MCT9) (Suhre et al., 2011; Halestrap, 2013; Roshanbin et al., 2016). It would be relevant to investigate in future research the cellular localization and exact functions of the avian (S)MCT that are reported in Table 3.   
Butyrate modulates MCT expression in the ileum and colon. We observed that the expression of MCT9 was significantly reduced (P=0.042) when digesta butyrate concentration was increased in the ileum. This transporter is still considered as orphan in mammals (Halestrap, 2013) although a possible role in carnitine transport has been reported (Suhre et al., 2011). The expression of other (S)MCT was not significantly affected by dietary intervention. We found that total (S)MCT expression was significantly higher in the ileum than in any other measured GIT segment (P<0.001; Data not shown). Overall, our results suggest that (S)MCT expression in the ileum was constitutively sufficient to cope with the changes in luminal butyrate concentration that were incurred by our dietary intervention.   Concerning the colon, our results indicated that the expression of MCT1 and 14 (P=0.033 and P=0.007) increased with digesta butyrate concentration. In mammals, the Michaelis constant (Km) of SMCT1 is far lower than the Km of MCT1 (50-100 μM vs 10 mM; Coady et al., 2004; Cuff et al., 2002). Because of such difference, Astbury and Corfe (2012) speculated that SMCT1 has a lower maximum rate (Vmax) than MCT1 in mammals. Physiological concentration of butyrate reaches 50 mM in the colon of mammals (Astbury and Corfe, 2012; Hamer et al., 2008). Under such circumstances, the Vmax of SMCT1 is likely to be reached and, consequently, the uptake of butyrate via this transporter may be limited (Astbury and Corfe, 2012). This could explain why only MCT1 expression has been reported to be regulated by digesta butyrate concentration in the distal GIT of mammals (Borthakur et al., 2010; Cuff et al., 2002). The physiological concentration of butyrate in the digesta of the colon and ceca of broilers reaches the mM range (Moquet et al., 2018). Provided that enzymes kinetics are conserved across phylogenetic classes, this would mean that the capacity of SMCT1 to facilitate the uptake of butyrate in the distal GIT of birds is more limited than the one of MCT1. This rationale may explain why several MCT but no SMCT were upregulated in the present experiment when butyrate concentration was increased in the ileum and in the colon. 
Butyrate metabolism along the avian GIT 
Key steps in butyrate metabolism. There is a gap of knowledge concerning the mechanisms mediating the transport of butyrate from the cytosol to the mitochondria of mammalian cells (Astbury and Corfe, 2012). Upon entry in the mitochondria, a five steps reaction allows the activation and catabolism of butyrate (Figure 1).   
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First, butyrate is ligated to acetyl-CoA to form butyryl-CoA (Step 1 in Figure 1). This initial activation step is conducted in the mitochondria by broadly specific (C4-11) medium chain acetyl-CoA synthetase enzymes (ACSM; Aas and Bremer, 1968). Following steps (Steps 2 to 5 in Figure 1) also take place in the mitochondria and 
correspond to the actual catabolism of butyrate in the β-oxidation pathway. There is little consensus in the literature concerning the enzymes carrying out the oxidation of butyrate intermediates (steps 2 and 4 in Figure 1; for review, see Astbury and Corfe, 2012). The hydration step is carried by enoyl-CoA hydratase, a broadly specific enzyme (C4-16; step 3 in Figure 1). The final splitting step is carried out by a thiolase that is 
identical in the β-oxidation of all fatty acid molecules (step 5 in Figure 1; Astbury and Corfe, 2012). 
  
Types of medium chain acetyl-coa synthetase expressed in the avian GIT. Energy metabolism is primarily regulated at the transcriptional level in intestinal cells (Chang 
et al., 2008). Messenger RNA are, therefore, good proxy to study energy metabolism in the gut. As mentioned previously, enzymes involved in the catabolism of butyrate are either well characterized (i.e. steps 1, 3 and 5 in Figure 1) or poorly defined (i.e. steps 2 and 4 in Figure 1). Among well characterized enzymes, ACSM family members have the most narrow substrate specificity. Hence, we decided to use the expression of ACSM family members as proxy for the catabolism of butyrate in the present study. Complementary DNA samples were pooled across diets and locations and subsequently screened for the presence of mRNA of provisional avian ACSM1, 2a, 2b, 3, 4 and 5 using 
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Figure 1. Summary of mechanisms and knowledge gaps for butyrate metabolism in the mitochondria  
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PCR. Gel electrophoresis confirmed the presence of amplicons coding for ACSM3, 4 and 5 (Data not shown). The expression of detectable genes was quantified by qPCR at five GIT locations. For each location, the CTR without dietary butyrate supplementation was compared to the butyrate supplemented diet (UP, TB or FCB) that resulted in the highest increase in digesta butyrate concentration (Table 4).  
Table 4. Effect of dietary treatments1 on the genetic expression of medium chain acetyl-CoA synthetase (ACSM), glucose metabolism and citric acid cycle enzymes in different gastrointestinal tract segments of broilers at 22-23 d of age 
 Average gene expression2,3  ACSM  Glycolytic and citric acid cycle enzymes  ACSM3 ACSM4 ACSM5  CS DLAT G6PC GAPDH GPI 
Proventriculus         CTR 1.67 94.45 76.85  92.07 100.00 0.70 26.63 25.58 UP 6.71 100.00 100.00  94.07 94.97 0.97 28.35 25.28 
P-value 0.053 0.772 0.159  0.437 0.095 0.159 0.282 0.479 
Pylorus          CTR 61.92 29.14 1.05  63.40 64.90 46.12 37.61 51.48 UP 41.06 n.d. n.d.  63.86 63.14 36.13 35.83 45.01 
P-value 0.247 0.191 0.183  0.282 0.396 0.052 0.479 0.026 
Duodenum         CTR 57.52 81.41 3.32  88.09 98.32 65.97 63.92 100.00 TB 100.00 n.d. n.d.  100.00 93.30 100.00 100.00 95.07 
P-value 0.282 - 0.191  0.078 0.215 0.003 0.001 0.159 
Ileum          CTR 21.47 n.d. 0.00  59.42 43.37 13.78 64.01 30.89 FCB 29.37 n.d. 2.55  59.80 39.29 8.46 56.98 26.59 
P-value 0.247 - 0.191  0.318 0.020 0.026 0.007 0.042 
Colon          CTR 27.66 n.d. 4.28  52.37 39.90 1.75 65.57 20.10 FCB 27.77 n.d. 0.15  62.16 38.09 1.86 72.30 22.14 
P-value 0.479 - 0.145  0.012 0.215 0.318 0.114 0.282 1Dietary treatments groups: UP (butyrate radical provided as unprotected salt); TB (butyrate radical provided as tributyrin); FCB (butyrate radical provided as fat-coated butyrate). Butyrate was provided at 1 g/kg as in basis. Values are means of 8 birds per treatment. 2Arbitrary units. Quantitative mRNA measurement was performed by establishing a linear calibration using 10-fold serial dilutions of cDNA templates. Data were standardized using IPO8 as housekeeping gene. For each gene, the highest average gene expression across location and treatments was set to 100. 3n.d. : not detectable.  At the cellular level, energy substrate selection is regulated by the so-called Randle (1963) and McGarry cycles (1977). Because of such mechanisms, glucose and lipids compete with each other for oxidation in the mitochondria. Changes in ACSM activity may, therefore, influence indirectly glucose metabolism in the gut. Such indirect effects were assessed by measuring, in addition to ACSM, the expression of several genes related to glucose metabolism (Table 4).  
Butyrate reduces glycolysis in the gastric region. We observed a tendency for a higher expression of ACSM3 (P=0.053) and for a lower expression of dihydrolipoamide S-acetyltransferase (DLAT; P=0.095) when digesta butyrate concentration increased in the proventriculus. As mentioned above, ACSM enzymes allow the ligation of coenzyme A to butyrate. DLAT is one of the three enzymes constituting the pyruvate dehydrogenase complex. This complex links the glycolysis to the citric acid cycle (CAC). The expression of citrate synthase (CS) was unaffected by the presence of butyrate in 
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the proventriculus and pylorus (P=0.437 and P=0.282, respectively). CS is a pace-making enzyme catalysing the first step of the CAC.  In addition, we observed a significant decrease of glucose-6-phosphate isomerase exprssion (GPI; P=0.026) and a tendency for a lower expression of glucose-6-phosphatase (G6PC; P=0.052) when digesta butyrate concentration was increased in the pylorus. Both GPI and G6PC are involved in glucose metabolism. The former is a glycolytic enzyme allowing the interconversion of glucose-6-phosphate and fructose-6-phosphate while the latter allows the conversion of glucose-6-phosphate to glucose, thereby affecting glucose homeostasis. Collectively, our results may suggest that the presence of butyrate in the gastric region shifted partly the origin of acetyl-CoA 
consumed in the CAC from glycolysis to β-oxidation, without significant effect on overall CAC activity. Hence, our results suggest that lipid oxidation, including butyrate oxidation, may have been increased by the presence of butyrate in gastric contents.  
Butyrate increases glycolysis in the duodenum. We observed significantly higher expression levels of G6PC (P=0.003) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; P=0.001) when digesta butyrate concentration was increased in the duodenum. These results suggest that glycolytic activity increased when digesta butyrate concentration was increased in the duodenum. An increase in glycolytic 
activity leads to a reduction of the β-oxidation of lipids due to the mechanisms described in McGarry’s cycle (1977). Hence, our results suggest that lipid oxidation, including butyrate oxidation, may have been reduced by the presence of butyrate in duodenal contents.  Butyrate reduces the apoptosis of healthy enterocytes while stimulating their differentiation and maturation (Guilloteau et al., 2010). This is why butyrate increases, although inconstantly, villus length when fed to broilers (Moquet et al., 2016). It is known that the expression of proteins related to glucose metabolism increases as enterocytes mature and move upwards along the crypt-villus axis (Chang et al., 2008; Yang et al., 2016). An increase in the maturation rate of enterocytes may explain why we observed an increase in glycolytic activity when butyrate was present in the duodenum.   The expression of DLAT was, however, unaffected by the presence of butyrate (P=0.215). This may suggest that the increase in glycolysis was not accompanied by a proportional increase in the transfer of pyruvate to the CAC via the pyruvate dehydrogenase complex. An uncoupling between glycolysis and CAC was further suggested by the rather limited increase in CAC activity (P=0.078) in comparison to the significant increase in G6PC and GAPDH expressions (P=0.003 and P=0.001, respectively). Such uncoupling may have led to the accumulation of pyruvate and, consequently, to the build-up of lactate via the anaerobic glycolysis pathway. Several MCT may also transport lactate and pyruvate in addition to SCFA, e.g. MCT1, 2, 3 and 4 (Halestrap, 2013). We observed a significant increase in MCT1 and 2 expression when butyrate was present in the lumen of the duodenum. Such changes may reflect lactate and pyruvate transport rather than butyrate uptake. 
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Butyrate reduces glycolysis in the ileum. We observed significantly lower expressions of DLAT (P=0.020), G6PC (P=0.026), GAPDG (P=0.007) and GPI (P=0.042) when digesta butyrate concentration increased in the ileum. Such changes clearly suggest a reduction 
of the glycolytic activity. Glycolytic activity can be reduced by an increase in β-oxidation activity due to the mechanisms described in Randle’s cycle (1963). Hence, our results suggest that lipid oxidation, including butyrate oxidation, may have been increased by the presence of butyrate in the ileum. The lack of significant upregulation of ACSM enzymes may indicate that the ileum is constitutively able to metabolize butyrate.  Butyrate presence in the ileum reduced glycolysis, while an opposite effect was observed in the duodenum. Research indicates that the preference of enterocytes for various energy substrates varies according to their location along the GIT. In mammals, glucose, glutamate and glutamine are the favoured energy substrates of healthy enterocytes obtained indistinctly from the entire small intestine (Watford et al., 1979). Butyrate is, however, the favoured energy substrate of healthy enterocytes obtained specifically from the distal ileum of mammals (Chapman et al., 1995). In mammals, enterocytes located in the distal ileum have, therefore, the same favoured energy substrate as colonocytes (Roediger, 1982). Such location-dependent specificities in the energy metabolism of enterocytes may also apply to the avian GIT. This may explain the divergence in energy metabolism response observed when digesta butyrate concentration was increased in the duodenum or in the ileum during the present experiment.   Such divergence in energy metabolism response carries significant implications for the efficiency of broiler production. There is an asynchrony in starch and protein digestion rates in the GIT of broilers (Riesenfeld et al., 1980; Sklan and Hurwitz, 1980; Osman, 1982). Such asynchrony results in glucose being less available than amino acids (AA) in the distal ileum of broilers (Liu and Selle, 2015). This situation is thought to impair feed efficiency by increasing AA catabolism (Weurding et al., 2003). So far, corrective strategies aimed at either increasing the rate of AA digestion in the proximal GIT, e.g. by feeding exogenous proteases or synthetic AA (Liu and Selle, 2017), or at reducing the rate of starch digestion in the proximal GIT, e.g. by feeding slow digestible starch (Weurding et al., 2003). Our work indicates similarities at the ileum level between mammalian and avian enterocytes, meaning that such cells may prefer butyrate over other energy substrates. Onrust and coworkers (2015) have formulated a series of dietary strategies that could promote butyrate production in the distal GIT of poultry. Such strategies may help to spare AA from catabolism in the distal GIT of poultry.   
Butyrate increases citric acid cycle activity in the colon. We observed in the present study that CS expression was significantly higher when butyrate was present in the lumen of the colon (P=0.012). This result indicates an increase in CAC activity. There was, however, no significant change in the expression of enzymes related to glucose metabolism or butyryl-CoA formation. This could indicate that the colon is constitutively able to metabolize butyrate. This is in line with the observations of Watford and colleagues (1979), who reported that avian colonocytes use preferentially butyrate as energy substrate. 
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Butyrate does not accumulate in gut tissues. Dietary intervention resulted in important changes in digesta butyrate concentration at different GIT segments (Table 1). We investigated the relationship between digesta butyrate concentration and intracellular butyrate concentration. Our results indicate that intracellular butyrate concentration was not affected by variations in digesta butyrate concentration (Table 5).   
Table 5. Effect of dietary treatments1 on intracellular short chain fatty acid concentration in distinct gastrointestinal tract segments of broilers at 22-23 d of age 
  Short chain fatty acids2 (mM)  Acetate Propionate Butyrate Iso-butyrate Valerate Iso-valerate 
Proventriculus      CTR 0.55 0.03 0.02 n.d. n.d. 0.01 UP 0.58 0.06 0.03 n.d. n.d. 0.01 
P-value 0.710 0.181 0.172 - - 1.00 
Pylorus       CTR 0.16 <0.01 0.01 n.d. n.d. n.d. UP 0.22 0.02 0.01 n.d. n.d. n.d. 
P-value 0.291 0.137 0.403 - - - 
Duodenum      CTR 5.54 1.73 0.03 0.06 0.05 0.08 TB 5.61 1.75 0.04 0.05 0.04 0.07 
P-value 0.786 0.701 0.484 0.096 0.740 0.430 
Ileum       CTR 4.58 1.42 0.01 0.04 0.02 0.08 FCB 4.75 1.47 0.01 0.04 0.04 0.07 
P-value 0.470 0.529 0.458 0.688 0.017 0.305 
Colon       CTR 4.93 1.38 0.08 0.05 0.04 0.08 FCB 5.16 1.25 0.11 0.05 0.03 0.08 
P-value 0.668 0.173 0.605 0.843 0.577 0.429 1Dietary treatments groups: UP (butyrate radical provided as unprotected salt); TB (butyrate radical provided as tributyrin); FCB (butyrate radical provided as fat-coated butyrate). Butyrate was provided at 1 g/kg as in basis. Values are means of 8 birds per treatment. 2n.d. : not detectable. 
 Intracellular butyrate concentration remained very low across GIT segments. This may indicate that intracellular butyrate concentration is tightly regulated. The importance of intracellular butyrate regulation is well established in colonocytes. Butyrate may act as a survival factor in healthy colonocytes or as an apoptotic agent in cancerous ones (Luciano et al., 2002). This paradox is explained by differences in energy metabolism existing between healthy and cancerous cells. Most cancerous cells rely on aerobic glycolysis due to the so-called Warburg effect (van der Heiden et al., 2009). This metabolic profile limits greatly the β-oxidation of lipids (McGarry et al., 1977). As a consequence, butyrate accumulates in most of cancerous colonocytes, thereby inhibiting HDAC activity and acting as an apoptotic signal (Donohoe et al., 2012). In contrast, butyrate is the primary energy source of healthy colonocytes (Roediger, 1982). Hence, healthy colonocytes do not accumulate butyrate but benefit from it as an energy substrate (Donohoe et al., 2012). Intracellular butyrate concentration may be tightly regulated in the avian GIT to avoid possible apoptotic effects, as seen in human colonocytes.  
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Such regulation can be achieved in several ways. Butyrate can be catabolized, incorporated in lipids through de novo lipogenesis, or transported out of the cell. In the present paper, we observed at the mRNA level direct (i.e. increased ACSM and CS expression) or indirect (i.e. decreased glycolytic enzymes expression) clues indicative of lipid catabolism when digesta butyrate concentration increased in the GIT of broilers. This was true for all measured GIT segments, except for the duodenum. For the latter, a clear increase in glycolytic activity was observed. Such metabolic shift was accompanied by an upregulation of numerous putative butyrate transporters. This may suggest that butyrate is not oxidized in the duodenum, but rather transported out of it.   In birds, lipids absorbed in the gut are packaged in portomicrons and transported to the liver via the portal vein (Denbow, 2015). Unpublished results from our lab indicate that feeding 1 g/kg butyrate in the form of UP, TB or FCB does not influence significantly butyrate concentration in the peripheral blood of 39 d old broilers. This suggests that butyrate escaping oxidation in the gut mucosa may be metabolised in the liver. Yin and coworkers (2016) supplemented broiler diets with TB, a butyrate glyceride that increases digesta butyrate concentration in the duodenum and jejunum, and reported significant changes in the hepatic transcriptome that evoked an increase in lipid catabolism. Such changes are consistent with the decreases in relative abdominal fat weight reported when broilers diets are supplemented with butyrate glycerides (Bedford et al., 2017a,b). 
 Collectively, these observations suggest that increasing digesta butyrate concentration in the proximal part of the intestines (i.e. duodenum and possibly jejunum) leads to the uptake and transport of butyrate to the liver, where it is oxidized. In contrast, increasing digesta butyrate concentration in the gastric region or in the distal part of the intestines (i.e. ileum and colon) leads to the uptake and oxidation of butyrate in the gut tissue itself. It remains unclear if the absorption of butyrate in the gastric region or distal part of intestines is followed by a complete oxidation in the gut or if a fraction of the absorbed butyrate escapes oxidation in the gut to reach the liver. Future studies may investigate the effect of increasing butyrate concentration in distinct GIT segment on gene expression in the liver.  
Butyrate sensing and endocrine regulation 
Types of butyrate receptors expressed in the Avian GIT. Three receptors are known to sense butyrate in mammals: FFAR2, FFAR3 and GPR109a (Brown et al., 2003; Le Poul et al., 2014). Sequences coding for FFAR2 have been identified in the avian genome (Meslin et al., 2015). To date, the comparison of avian and mammalian genomes did not allow the identification of FFAR3 and GPR109a orthologs in chickens (Lagerström et al., 2006; Meslin et al., 2015).   We observed that FFAR2 was expressed in all GIT segments sampled (Table 6). In addition, FFAR2 expression was reduced by the presence of butyrate in the digesta of the pylorus and of the ileum (P=0.007 and P=0.026, respectively). A similar trend was observed in the proventriculus (P=0.078). Such results suggest that an excess of ligand may down regulate FFAR2 expression.   
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Table 6. Effect of dietary treatments1 on the expression of genes related to the hormonal regulation of gut functions in different gastrointestinal tract segments of broilers at 22-23 d of age 
 Average gene expression2 
 FFAR2 CCK GAST CGC-A CGC-B PCSK1 PCSK2 
Proventriculus       CTR 17.25 15.54 96.65 n.m. n.m. n.m. n.m. UP 16.06 28.79 100.00 n.m. n.m. n.m. n.m. 
P-value 0.078 0.318 0.479 - - - - 
Pylor        CTR 52.61 35.02 49.13 n.m. n.m. n.m. n.m. UP 27.60 30.35 50.93 n.m. n.m. n.m. n.m. 
P-value 0.007 0.396 0.437 - - - - 
Duodenum        CTR 50.33 59.44 80.63 7.13 6.69 100.00 43.12 TB 54.64 100.00 81.52 8.10 6.62 87.65 61.20 
P-value 0.479 0.026 0.396 0.376 0.338 0.753 0.376 
Ileum        CTR 100.00 n.m. n.m. 100.00 100.00 86.41 59.96 FCB 68.95 n.m. n.m. 85.32 70.56 87.69 61.39 
P-value 0.026 - - 0.215 0.052 0.479 0.357 
Colon        CTR 63.06 n.m. n.m. 3.12 0.85 65.38 94.89 FCB 62.76 n.m. n.m. 4.21 1.04 84.11 100.00 
P-value 0.437 - - 0.435 0.282 0.157 0.318 1Dietary treatments groups: UP (butyrate radical provided as unprotected salt); TB (butyrate radical provided as tributyrin); FCB (butyrate radical provided as fat-coated butyrate). Butyrate was provided at 1 g/kg as in basis. Values are means of 8 birds per treatment. 2Arbitrary units. n.m.: not measured. Quantitative mRNA measurement was performed by establishing a linear calibration using 10-fold serial dilutions of cDNA templates. Data were standardized using IPO8 as housekeeping gene. For each gene, the highest average gene expression across location and treatments was set to 100. 
 
Expression of genes related to gut hormones. Butyrate is known to modulate the secretory activities of different enteroendocrine cells subsets in mammals, including gastrin-producing G-cells, cholecystokinin (CCK) producing I-cells and glucagon like peptides (GLP) producing L-cells in mammals (Guilloteau et al., 2010; Kimura et al., 2014) and, presumably, in birds (Onrust et al., 2015; Moquet et al., 2016; Moquet et al., 2018). Numerous articles have described the distribution of G-, I-, and L-cells along the GIT of chickens (Larsson et al., 1974; Rawdon and Andrew, 1999; Hiramatsu et al., 2005; Monir et al., 2014). We investigated in relevant GIT segments the effect of increasing digesta butyrate concentration on the expression of genes related to gut hormones (Table 6).   Our results indicate that the expression of preprogastrin (preproGAST) by G-cells was unaffected by digesta butyrate concentration in the proventriculus, pylorus and duodenum (P=0.479; P=0.437; P=0.396, respectively). The expression of preprocholecystokinin (preproCCK) by I-cells was increased when digesta butyrate concentration increased in the duodenum (P=0.003). Such effect was, however, not observed in the proventriculus or in the pylorus (P=0.318 and P=0.396, respectively). Most of the preproCCK is processed into CCK7 and 8 in the avian GIT (Jonson et al., 2000). The biological functions of CCK8 in the avian GIT have been extensively studied while those of CCK7 remain undocumented (Denbow, 2015). Intravenous infusion of CCK8 inhibits gastric emptying (Savory et al., 1981) while stimulating duodenal electric activity in a manner that suggests an increase in segmental contractions (Martinez et 
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al., 1993). Increased circulatory levels of CCK8 have been consistently associated with a reduction of voluntary feed intake in chickens (Honda et al., 2017). The physiological functions of CCK8 seem, therefore, to be conserved in birds and mammals (Denbow, 2015). A change in CCK activity may explain the increase in total tract retention time and the associated reduction in voluntary feed intake reported when broiler diets are supplemented with various butyrate additives (Moquet et al., 2018). Such change does not explain, however, the specific increase in intestinal retention time reported when digesta butyrate concentration is selectively increased in the colon and ceca (Moquet et 
al., 2018). The latter is thought to be mediated by changes in the secretory activities of L-cells (Moquet et al., 2018).  In L-cells, GLP1 and 2 are produced by the processing of preproglucagon (preproCGC) A and B by the prohormone convertase 1 enzyme (PC1/3, gene name PCSK1) (Lim and Brubaker, 2006). Processing of preproCGC A and B by the prohormone convertase 2 (PC2, gene name PCSK2) results, otherwise, in the production of other signalling peptides such as glucagon (Lim and Brubaker, 2006). We observed that increasing digesta butyrate concentration in the ileum tended to reduce the expression of preproCGC B (P=0.052). Such effect was not observed in the duodenum or colon (P=0.338 and P=0.282, respectively). Besides, the expression of preproCGC A, PC1/3 and PC2 remained unaffected by the changes in the digesta butyrate concentration in the duodenum, ileum and colon. Overall, our results indicate that digesta butyrate concentration had little direct effect on the regulation, at mRNA level, of GLP1 and 2 production. This is in contrast with the observations of Tappenden and colleagues (1998), who reported a positive effect of enteric SCFA on total preproGCG mRNA concentration in the ileum of rats.  Peptide hormone signalling involves several steps: expression of mRNA coding for the (pro)hormone, subsequent protein synthesis, post-translational modification of the (pro)hormone, secretion and finally binding to a receptor cognate (Denbow, 2015; Scanes, 2015). Gene expression of a (pro)hormone may be a poor proxy for the circulating levels of the said hormone due to the number of intermediary steps existing between mRNA expression and actual signalling effect. In the present experiment, we did not observe any clear relationship between digesta butyrate concentration and the regulation, at mRNA level, of gastrin, GLP1 and GLP2 production. Such relationship exists, however, at the protein level in mammals (Guilloteau et al., 2010) and, presumably, in birds (Moquet et al., 2016). Hence, additional insights on the effect of butyrate on the endocrine regulation of digestive functions may be seen at the protein level. Unfortunately, there are no commercially available antibodies directed against avian gut hormones to allow such investigation.  It was not possible to show the effect of butyrate presence in a given GIT segment on gene expression in a remotely distant GIT segment with the approach chosen in the present study (e.g. the effect of digesta butyrate concentration in the colon on gastrin expression in the pylorus). Based on the work of Reilley and coworkers (1995), such effects may be relevant. They reported that colonic SCFA increased jejunal gastrin concentration in rats. Such indirect effect may also exist in poultry and are beyond the scope of the present work.  
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CONCLUSION The present study indicates that increasing digesta butyrate concentration in the gastric region of the avian GIT results in a non-ionic, passive uptake followed by a catabolism of butyrate in the gastric wall. In contrast, increasing digesta butyrate concentration in the duodenum increases the expression of numerous putative butyrate transporters and glycolytic enzymes. This suggests that, in the duodenum, butyrate is taken up by transporters but not metabolized in the tissue itself. Duodenal butyrate may, therefore, be metabolized in the liver. Besides, MCT are the only transporters that are upregulated by digesta butyrate concentration in the ileum and colon. This suggests that MCT are more effective than SMCT in transporting butyrate when digesta concentration reaches the mM range. Butyrate seems to be catabolised, to some extent, in the ileum and colon. It remains unclear if the absorption of butyrate in the gastric region or distal part of the intestines is followed by a complete oxidation in the gut or if a fraction of butyrate escapes oxidation in the gut to reach the liver. Irrespective of the GIT segment considered, there is no relationship between digesta butyrate concentration and intracellular butyrate concentration. The latter remains overall very low. Intracellular butyrate concentration seems, therefore, to be tightly regulated. This may protect gut cells from the adverse effects of high intracellular butyrate on HDAC activity. The butyrate receptor FFAR2 seems to be present along the entire GIT of poultry. Its expression can decrease when digesta butyrate concentration increases. There are indications at mRNA level that butyrate affects the activity of CCK producing I-cells in the duodenum. Such effects may underlie the observed anorectic effects of butyrate in poultry, as well as changes in total tract retention time associated with dietary butyrate supplementation. The present study investigated direct, local effects of increasing digesta butyrate concentration on the expression of a selected set of genes in gut tissues originating from distinct GIT segments. Future research could investigate indirect effects at the protein level as well as effects on hepatic metabolism.  
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ABSTRACT Dysbiosis is a condition related to an imbalanced gut microbiota composition that can negatively impact the health and growth performance of broilers. Butyrate has been shown to exert multiple effects on host-microbiota interactions in distinct gastrointestinal tract (GIT) segments which may influence the onset of dysbiosis. An experiment was conducted to study the effects of providing butyrate to distinct GIT segments on cecal microbiota composition and gut health of broilers. A total of 320 male day-old Ross 308 broilers were randomly assigned to 5 dietary treatment groups, each replicated 8 times: one control group and four groups supplemented with 1 g/kg butyrate in the form of feed additives having markedly different butyrate release profiles. Diets were based on rapeseed meal, corn and wheat and were provided ad 
libitum. At 22-23 d of age, birds were sacrificed. Cecal contents of 5 birds per pen were analysed for microbiota composition with Illumina HiSeq analysis of 16S ribosomal RNA gene fragments. Ileal and colonic tissues of one bird per pen were analysed for gut health markers by RT-qPCR. Unprotected butyrate, which is mostly active in the crop, proventriculus and gizzard, promoted cecal microbiota dysbiosis (e.g. decreased microbial alpha diversity and increased Proteobacteria relative abundance). This was associated with activation of TLR-4 and inflammation in the distal GIT. Feeding tributyrin, which increases selectively butyrate concentration in the small intestine, did not induce bacterial dysbiosis in the ceca per se, and yet promoted inflammation in the distal GIT. Fat-coated butyrate, which has a sustained release profile with partial protection of butyrate against gastric and enteric absorption, did not significantly modify cecal microbiota composition and did not induce inflammation in the distal GIT. Observed changes in microbiota composition may be attributable to observed modulatory effect of butyrate on the expression of host defense peptides and mucus genes.  
Key words: Butyrate, broiler, cecal microbiota, dysbiosis, inflammation, location effect   
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INTRODUCTION The avian gastrointestinal tract (GIT) harbours a complex microbiota that influences host nutrition and health (Pan and Yu, 2014). A balanced and stable gut microbiota provides the bird with additional nutrients such as short chain fatty acids (SCFA) as well as protection against pathogens through a competitive exclusion process (Gabriel et al., 2006). Harmful alterations in gut microbiota composition -dysbiosis- may, however, arise in modern broiler production as a result of withdrawal of antimicrobial growth promoters, changes in diet composition or environmentally induced stress (Teirlynck et al., 2009a,b; Teirlynck et al., 2011; Wideman et al., 2012). Dysbiosis has been associated with inflammation and reduced health in poultry (Kogut, 2013). This condition negatively affects the digestibility and utilization of nutrients, resulting in a reduction in growth performance of broilers ( Kogut, 2013; Apajalahti and Vienola, 2016). As a consequence, establishing a balanced and stable gut microbiota is a key objective to ensure health and growth efficiency in modern broiler production.  Bacteria have to contend with numerous selection mechanisms exerted by the host in order to successfully colonize the GIT (Ley et al., 2006). In poultry, such selection mechanisms include, among others, the secretion of mucus, digestive enzymes and host defence peptides (HDP) by the gut mucosa (Pan and Yu, 2014; Lee et al., 2016). Such secretions are controlled by a succession of feedback loops between the host and the microbiota (Kogut, 2013; Pedroso and Lee, 2014). This crosstalk is thought to favour the onset of a healthy steady state (Lozupone et al., 2012) and mediated at the mucosal level by microbe-associated molecular patterns as well as microbial metabolites such as SCFA (Wells et al., 2011).  Among SCFA, butyrate has received much attention from poultry nutritionists. This molecule is commonly used as a feed additive to support intestinal health and enhance growth performance of broiler chickens (Moquet et al., 2016). Supplementing broiler diets with butyrate has been reported to modulate cecal microbiota composition (Qaisrani, 2014; Bortoluzzi et al., 2017;). Different underlying mechanisms may explain the effect of butyrate presence in the GIT on cecal microbiota composition. Firstly, butyrate is known to modulate the production of HDP and mucus in the GIT of birds and mammals (Mentschel and Claus, 2003; Sunkara et al., 2011). Secondly, butyrate modifies digestive processes in the proximal GIT segments of birds, thereby affecting the substrate left for microbial growth in the distal GIT (Moquet et al., 2018). The aforementioned effects of butyrate may influence the settlement of the microbiota in the ceca and, consequently, the occurrence of dysbiosis in poultry.   Until recently, it was unclear whether the presence of butyrate in the digesta of different segments of the GIT would differentially affect digestion and intestinal health. A recent study in our laboratory, however, showed that butyrate additives with markedly different release profiles differentially influenced growth performance and digestive processes of young broiler chickens (Moquet et al., 2018). The present study is an extension of the previous work using cecal contents and gut tissues collected during the latter experiment to address a three-fold objective. The first objective was to investigate the effect of butyrate presence in the digesta of distinct GIT segments on cecal microbiota composition. The second objective was to investigate whether changes 
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in cecal microbiota composition may be associated with changes in inflammation and gut integrity markers in the distal GIT. The third objective was to relate observed changes in cecal microbiota composition to possible causative factors (e.g. SCFA concentration across the GIT, nutrient digestibility or passage rate) using exploratory multivariate analysis. It was hypothesised that supplementing broiler’s diet with butyrate would modulate cecal microbiota composition and inflammation in the distal GIT. In addition, it was hypothesised that such effects would differ depending on the type of butyrate additive used. 
MATERIAL AND METHODS 
Experimental design The experiment described in the present manuscript was part of a larger study published previously (Moquet et al., 2018). The study investigated the effect of providing butyrate to distinct GIT segments on pre-cecal protein digestibility in broilers. A total of 320 male day-old Ross 308 broilers were randomly assigned to five dietary treatment groups: 1) control (CTR; no butyrate), 2) unprotected butyrate (UP; activity in the crop and gastric regions), 3) tributyrin (TB; activity in the small intestine), 4) fat-coated butyrate (FCB; activity in whole GIT) and 5) a 50:50 mixture of unprotected butyrate and tributyrin (UPTB; butyrate C4H7O2- weight basis), each replicated 8 times. Butyrate was included in a rapeseed meal based diet at 1 g/kg, as fed basis. Ingredient and analyzed nutrient compositions of the diets are provided in Chapter 4, Table 1.  Performance parameters were monitored on a weekly basis at a pen level during the first three weeks of the experiment. At 22 and 23 d of age, five birds per pen were selected in such a manner that the average bodyweight (BW) of the selected birds was close to the average pen weight, and sacrificed. Dissections were staggered in such a manner that half of the birds in a pen was dissected on d 22 and the other half on d 23. Cecal contents of four birds per pen were collected by gentle squeezing, snap-frozen in liquid nitrogen and stored at - 20 ⁰C pending further analysis. From the bird having its BW the closest to the pen average, the following GIT tissue segments were sampled for gene expression analysis: proventriculus, pylorus, middle of the duodenum (halfway between the pyloric junction and the hepatopancreatic duct), proximal ileum (first third between Meckel’s diverticulum to the ileocecal valve) and middle of the colon (halfway between the ileocecal junction and the cloaca). Collected tissues were gently rinsed with ice cold 0.9% NaCl, placed in cryogenic vials, snap frozen in liquid nitrogen and stored at -80°C until further processing. In addition and as reported by Moquet and coworkers (2018), the relative weights of GIT segments, the average villi length and crypt depth in the duodenum and jejunum, the proteolytic activity in the proventriculus and jejunum and the apparent ileal digestibility of amino acids were measured. Remaining birds were euthanized and dissected at 24 d of age for the determination of SCFA in the digesta of different GIT compartments and for the determination of digesta retention time. The data presented by Moquet and coworkers (2018) were related to microbiota composition and gene expression data reported here. 
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Cecal microbiota composition 
Microbial DNA extraction and purification. Total bacterial DNA was extracted by mixing 0.25 g of cecal content with 700 µL Stool Transport and Recovery lysis buffer (S.T.A.R. buffer, Roche Diagnostics Corporation, Indianapolis, IN), 0.5 g of 0.1 mm sterilized zirconia beads and 5, 2.5 mm sterilized glass beads in a sterile microfuge tube. 
Samples were homogenized in a FastPrep (MP Biomedicals, Santa Ana, CA) at 5.5 m∙s-1 for 3 cycles of 1 min each, then shaken at 100 rpm for 15 min at 95 ºC and subsequently centrifuged for 5 min at 20,000 × g at 4 ºC. The supernatant was mixed with 300 µL S.T.A.R. buffer and subjected again to the aforementioned homogenization, shaking and centrifugation procedures. Bacterial DNA was purified from 250 µL of the final supernatant using a Maxwell 16® Total DNA system (Promega, Madison, WI) and associated purification kit (AS1220, Promega) according to the manufacturer’s recommendations. Total nucleic acid concentration and purity were determined by optical density measurement using a NanoDrop ND-1000 (Nanodrop Technologies, 
Wilmington, DE) and subsequently adjusted to 20 ng∙µL-1 with nuclease free water (Qiagen, Hilden, Germany).   
PCR amplification and sequencing. For the 16S rRNA gene-based microbial composition profiling, barcoded amplicons from the V4 region of the 16S rRNA were generated using a barcoded primer PCR method. The PCR was performed in a total 
volume of 50 µL containing 20 ng of template DNA, 1 µL of 10 μM 515F (5´-GTGYCAGCMGCCGCGGTAA-3´) and 806R (5´-GGACTACNNGGGTATC TAAT-3´) barcoded-primers (10 µM/reaction), 10 µL of 5 × HF buffer (Finnzymes, Vantaa, 
Finland), 1 µL of a 10 μM dNTPs Mix (Roche Dianostics GmbH, Mannheim, Germany), 1 U Phusion® Hot start II DNA polymerase (Finnzymes, Vantaa, Finland) and 36.5 µL DNAse and RNAse free water (Qiagen). Thermocycling conditions included an initial denaturation step of 30 s at 98°C followed by 25 cycles consisting each of a 10 s long denaturation step at 98°C, followed by 20 s of annealing at 56°C and 20 s of final elongation at 72°C. The procedure was completed by a final extension step of 10 min at 72°C. The presence of PCR products was confirmed by agarose gel electrophoresis using the Lonza FlashGel® System (Lonza Group AG, Basel, Switzerland). High Pure PCR cleanup micro kit (MagBio Genomics, Alphen aan den Rijn, The Netherlands) was used for the purification of barcoded amplicons. Barcoded amplicons were quantified using the Qubit® dsDNA BR Assay Kit (Life Technologies, Leusden, Netherlands) and 70 samples, each labeled with a unique barcode, were equimolarly pooled. Pooled libraries were sequenced at GATC-Biotech AG (Konstanz, Germany) by Illumina Hiseq sequencing.  
 
Sequence analysis. The 16S rRNA gene sequencing data was processed and analysed using the NG-Tax analysis pipeline (Ramiro-Garcia et al., 2016). Libraries were filtered to contain only read pairs with matching barcodes used to separate reads per sample. Operational taxonomic units (OTU) were assigned using SILVA 111 16S rRNA database (Quast et al., 2013). Alpha diversity was estimated based on the phylogenetic diversity (PD) whole tree metric using QIIME (Lozupone and Knight, 2005; Caporaso et al., 2010). Rarefaction curves were constructed per dietary treatment group for PD whole tree index. Rarefaction curves reached a plateau at around 2000 reads for the PD whole tree 
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diversity index, thereby indicating that a cut-off point of 2500 reads per sample was sound (data not shown).  
Analysis of gene expression at gut tissue level 
Rationale for the selection of tissues. There was a twofold objective for the gene expression analysis of gut tissue samples. The first was to determine the effect of cecal microbiota composition on gut health in the distal GIT. It was, therefore, decided to compare the expression of genes related to immune system homeostasis, gut integrity, and oxidative stress metabolism in the ileum and colon of birds fed the CTR, UP, TB and FCB diets. It was decided to leave UPTB out of the analysis because preliminary observations indicated that feeding UP or UPTB diets resulted in similar microbiota compositions. The second objective was to determine the direct effect of butyrate presence in different GIT segment on the expression of mucus and host-defence peptides associated genes.  
Table 1. Effect of dietary treatments on butyrate concentration expressed as a percentage of the control 
(%; μmol/g DM basis) in the digesta of different gastrointestinal segments of broilers at 24 d of age 
Data adapted from Moquet and coworkers (2018) Location Dietary treatment means1 Diet effect UP TB FCB UPTB Crop 1033a 822a 878a 1067a <0.001 Proventriculus and gizzard 1472a 1031b 717b 962b <0.001 Small intestine 13b 477a 29b 371a <0.001 Colon and ceca 4 7 38 26 0.676 1Dietary treatments groups: UP (butyrate radical provided as unprotected salt); TB (butyrate radical provided as tributyrin); FCB (butyrate radical provided as fat-coated butyrate); UPTB (butyrate radical provided as a 50:50 w/w mixture of unprotected salt and tributyrin). Butyrate was provided at 1 g/kg on an as is basis. Values are means of 15 birds per treatment. a,bMeans within a row having a superscript differ significantly from the control (no butyrate supplementation). Means within a row lacking a common superscript differ significantly (P<0.05).   For each GIT segment sampled, it was decided to compare the control (without added butyrate) to the butyrate-supplemented diet that resulted in the largest relative increase in digesta butyrate concentration (Table 1). Consequently, the following treatment groups were selected for comparison: CTR and UP for the proventriculus and pylor, CTR and TB for the duodenum, and CTR and FCB for the colon. For the distal part of the small intestine (ileum) it was decided to compare CTR and FCB, despite CTR and TB presenting a larger contrast in butyrate concentration in pooled intestinal digesta because TB is known to release butyrate in the very proximal part of the small intestine in pigs (Schwarzer and Bjork, 2015) and of poultry (Moquet, unpublished results) while FCB is known to extend the effect of butyrate to the entire small intestine in chickens (van den Borne et al., 2015; Moquet et al., 2018). 
 
RNA extraction, reverse transcription and quantitative PCR. Total RNA was extracted from 1-2 mg fraction of ground tissue using Trizol reagent (ThermoFisher Scientific, Bleiswijk, Netherlands). Isolated RNA was subsequently subjected to an on-column DNase digestion to eliminate possible DNA contamination (NucleoSpin RNA II kit; Macherey-Nagel GmbH & Co. KG, Düren, Germany). Total nucleic acid concentration and purity were determined by optical density measurement using a NanoDrop ND-1000 
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(Thermofisher Scientific) while RNA integrity and size was assessed using a Bioanalyzer 2100 and RNA 6000 Nano LabChip kit (Agilent, Santa Clara, California). The average RNA integrity number value was 9.9, ranging between 9.7 and 10. First-strand cDNA synthesis was performed with 250 ng of total RNA per 20-mL sample reaction with Superscript III reverse transcriptase (Thermofischer Scientific), deoxyribonucleotide triphosphate (Roche Diagnostics, the Netherlands), and random hexamer primers (Roche Diagnostics, the Netherlands) for 1 h at 50 °C, according to the manufacturer’s protocol (Thermofischer Scientific). Real-time quantitative PCR was carried out with a ABI 7500 Real-time PCR System (Applied Biosystems, Foster City, California) by using the SensiMix SYBR Low-ROX mix (Bioline UK Ltd., London, UK). Amplification conditions were 95°C for 10 min, followed by 40 cycles of 95°C for 15 s, 60°C for 15 s and 72°C for 35 s each. A final melting protocol of increasing temperature from 60°C to 95°C with 0.5°C increments of 5 s each was applied. 
 Primers were designed with Primer Express Software (ThermoFisher Scientific, Bleiswijk, Netherlands), and recommended primers sets spanning at least one intron were selected (Table 2). Messenger RNA was quantified by establishing a linear calibration using 10-fold serial dilutions of cDNA templates for corresponding genes. We designed primers for 5 genes, commonly used as reference genes in mammalian species, namely ACTB, EFF2, IPO8, PPIA and RPLPO. Analysis of the measured values with the Normfinder algorithm (Andersen et al., 2004) revealed that IPO8 was the most suitable housekeeping gene across locations and diets.  
Table 2. Primers used for real-time quantitative PCR Gene1 Forward primer (5’-3’) Reverse primer (5’-3’) Normalization genes 
IPO8 ACCTCCGAGCTAGATCCTGT GGCTCTTCTTCGCCAACTCT 
ACTB GCCCTGGCACCTAGCACAAT GCGGTGGACAATGGAGGGT 
RPLPO TTGGGCATCACCACAAAGATT CCCACTTTGTCTCCGGTCTTAA 
PPIA CCCGTCGTGTTCTTCGACAT CCCTTGTAGCCAAATCCCTTCT 
EEF2 CAGTTGGCTTTGGTTCTGGC AAAGTATCTGTCTCCCCACAGC Pathogen recognition receptors and associated signal transducing adaptor protein 
Dectin-1 GTCTGCAATGCGGGAAGAAC TCAGCTGAGAGCTGCGTATC 
TLR-2 CCAGGGAATGGTTTCTGCAC CTCAGGGCTTGTTCTTCAGGG 
TLR-4 GCTGAAATCCCAAACACCACC TATGGATGTGGCACCTTGAAAGA 
MyD88 AAAGAAGGTGTCGGAGGATGG GAATCAGCCGCTTGAGACGA Cell signalling molecules  
IL-10 GCTGAGGGTGAAGTTTGAGGA TCTGTGTAGAAGCGCAGCAT 
IL-12b CCCAGATGCTGGCAACTACA GAACGTCTTGCTTGGCTCTTT 
IL-1b GACATCTTCGACATCAACCAG CCGCTCATCACACACGACAT 
IL-6 CAAGGTGACGGAGGAGGAC TGGCGAGGAGGGATTTCT 
COX2 ATTCCTGACCCACAAGGCAC AGTCAACCCCATGGCCGTAA Tight junction proteins  
CDH1 GGCAAGCCGTTTACCACATC CATAATCCAGGCCCTTGGCTG 
CLD3 TATGGGGCTGGAGATCGGT ACCACGCAGTTCATCCACAG 
JAM2 AGCCTCAAATGGGATTGGATT CATCAACTTGCATTCGCTTCA 
ZO1 CCGCAGTCGTTCACGATCT GGAGAATGTCTGGAATGGTCTGA 1IPO8: Importin 8; ACTB: Actin beta; RPLP0: 60S acidic ribosomal protein P0; PPIA: Peptidylprolyl Isomerase A; EEF2: Eukaryotic elongation factor 2; TLR: Toll-like receptor; MyD88: Myeloid differentiation primary response 88; IL: Interleukin; b: Beta; COX2: Cyclooxigenase 2; CDH1: Cadherin 1; CLD3: Claudin 3; 
JAM2: Junctional adhesion molecule 2; ZO1: Zona occludens 1.    
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Table 2. (Continued) Gene1 Forward primer (5’-3’) Reverse primer (5’-3’) Reactive oxygen species metabolism  
CAT GCCACATGGTGACTACCCTC TGTTGCTAGGGTCATACGCC 
NOS2 CTACCAGGTGGATGCATGGAA ATGACGCCAAGAGTACAGCC Host defence peptides  
AvBD1 ACCATTGTCAGCCCTGTGAAAA CCCATATTCTTTTGCAGCAGAGGT 
AvBD4 CATCTCAGTGTCGTTTCTCTGC ACAATGGTTCCCCAAATCCAAC 
AvBD5 CTGCCAGCAAGAAAGGAACCTG TGAACGTGAAGGGACATCAGAG 
AvBD6 AGGATTTCACATCCCAGCCGTG CAGGAGAAGCCAGTGAGTCATC 
AvBD7 CTGCTGTCTGTCCTCTTTGTGG CATTTGGTAGATGCAGGAAGGA 
AvBD10 TGGGGCACGCAGTCCACAAC ATCAGCTCCTCAAGGCAGTG 
AvBD12 CCCAGCAGGACCAAAGCAATG GTGAATCCACAGCCAATGAGAG 
CATH3 GCTGTGGACTCCTACAACCAAC TGGCTTTGTAGAGGTTGATGC Mucus   
MUC2 TGACATCAGGGCACACAGAT ATTGAAGCCAGCAATGGTGT 
MUC4 GACTTCAAGGTTTGGCAGCA TGGCACTCACATGTTCCTCT 
MUC5ac AACCAAGCTCTGTGACAGCAA GTTTGCCCTCCGCTTAGACT 
MUC5b AGGCGTACACTGGTGGAAAA GGCAGTTGAACTCTGTTGCTG 
MUC13 TCAGTAAGAGCCAAGCACAGT GGTCTGGACTCTGGGGAAGA 1CAT: Catalase; NOS2: Nitric oxide synthase 2; AvBD: Avian beta defensin; CATH3: Cathelicidin 3; MUC: Mucin 
Statistical analysis 
Microbial alpha diversity index. PD whole tree index was analyzed using the PROC MIXED procedure of SAS (version 9.4, SAS Institute Inc., Cary, NC), using the following model: Y𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 = 𝜇𝜇𝜇𝜇 + D𝑖𝑖𝑖𝑖 + P𝑖𝑖𝑖𝑖 + 𝜀𝜀𝜀𝜀𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  where Y𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  is the observed response of the kth chicken (k = 1 to 4) fed the ith diet (i = CTR, UP, TB, FCB or UPTB) in the jth pen (j = 1 to 8), 𝜇𝜇𝜇𝜇 is the overall mean response, D𝑖𝑖𝑖𝑖  is the 
ith fixed diet effect,  P𝑖𝑖𝑖𝑖  is the random pen effect and 𝜀𝜀𝜀𝜀𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  is the residual error term. Means were separated using Tukey’s HSD.  
Microbiota composition. The part of variation in microbiota composition attributable to the dietary treatments was visualized at both phylum and genus levels by redundancy analysis (RDA) in Canoco 5 (Microcomputer Power, Itahaca, NY). Differences were tested with an F-test. The effect of dietary intervention on cecal microbiota composition was further investigated at phylum and genus levels using permutation tests for the univariate analysis of variance. Tests were carried out using the lmPerm package of R (version 3.4.0; R Core Team, 2017). Means were separated using Tukey’s HSD test when a significant diet effect was detected. Finally, the variation in microbiota composition at phyla level was summarized by principle component analysis (PCA) in Canoco 5. Functional traits measured in the experiment were used as supplementary variables to interpret the PCA summary. Functional traits were grouped in categories (Table 3).    
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Table 3. Categories of functional traits used to interpret the PCA summary of the variation in microbiota species at phylum level Category  Traits Unit Observation levels Performance  Slaughter weight G Individual FCR g:g Pen Nutrient digestibility N apparent ileal digestibility (AID) % Pen N-corrected OM AID % Pen GIT2 development Crop, relative weight % BW Individual 
Proventriculus, relative weight % BW Individual 
Gizzard, relative weight % BW Individual 
Duodenum 
  Relative weight % BW Individual Villus length mm Individual Crypt depth mm Individual Villus length:Crypt depth ratio - Individual 
Jejunum 
  Relative weight % BW Individual Villus length mm Individual Crypt depth mm Individual Villus length:Crypt depth ratio - Individual 
Ileum, relative weight % BW Individual 
Colon, relative weight % BW Individual 
Ceca, relative weight % BW Individual SCFA1 Crop mmol/g DM Treatment group 
Proventriculus and gizzard mmol/g DM Treatment group 
Small intestine mmol/g DM Treatment group 
Colon and ceca mmol/g DM Treatment group Passage rate Crop min Treatment group 
Proventriculus and gizzard min Treatment group 
Small intestine min Treatment group 
Colon and ceca min Treatment group 1Gastrointestinal tract 2Short chain fatty acids: acetate, propionate, butyrate, iso-butyrate and iso-valerate concentrations in digesta. 
 
Gene expression data. Differences in the expression of genes related to tight junctions, innate immune system and oxidative stress were tested at ileal and colonic levels using Kruskal-Wallis test (4 treatment groups per location). Means were separated using Tukey’s HSD test when a significant diet effect was detected. Differences in the expression of mucus and host-defence peptide genes were tested for each location using Mann-Whitney U test (2 treatment groups per location). All the tests were carried out using the PROC NPAR1WAY procedure of SAS 9.4. 
RESULTS AND DISCUSSION 
Feeding unprotected butyrate induces cecal microbiota dysbiosis. 
 Microbial alpha diversity and biomarkers of dysbiosis at phylum level. PD, an alpha diversity index, was significantly affected by dietary intervention (P<0.001; Table 4). Post-hoc analysis revealed that birds fed the UP and UPTB diets had significantly lower PD indices than their CTR, TB and FCB fed counterparts.    
Butyrate in broiler diets 
106  
Table 4. Effects of dietary treatments1 on cecal microbiota phylogenetic diversity and composition at phylum level of 22-23 d old broilers   Dietary treatment Pooled SD Diet effect CTR UP TB FCB UPTB 
Alpha diversity index  PD2 4.8a 4.4b 5.0a 4.9a 4.4b 0.1 <0.001 
Composition at phylum level (%)  Actinobacteria 2.0 1.1 1.5 1.4 1.6 0.4 0.405  Bacteroidetes 8.3ab 6.5b 9.8a 7.8ab 7.4ab 0.8 0.048  Cyanobacteria 0.6 1.2 0.5 0.8 0.7 0.3 0.436  Firmicutes 86.4 86.1 84.8 86.5 85.9 1.0 0.777  Proteobacteria 0.5c 1.9a 0.9bc 0.6bc 1.4ab 0.2 <0.001  Tenericutes 1.7 1.9 1.8 2.0 1.6 0.3 0.885  Unknown 0.6b 1.3a 0.7b 0.8b 1.4a 0.1 <0.001 1Dietary treatments groups: CTR (Control, no butyrate added); UP (butyrate radical provided as unprotected salt); TB (butyrate radical provided as tributyrin); FCB (butyrate radical provided as fat-coated butyrate); UPTB (butyrate radical provided as a 50:50 w/w mixture of unprotected salt and tributyrin). Butyrate was provided at 1 g/kg on an as in basis. Values are means of a minimum of 30 birds per treatment. 2Phylogenetic diversity. a,b,cMeans within a row lacking a common superscript differ significantly (P<0.05).  Redundancy analysis indicated that dietary intervention had a significant effect on cecal microbiota composition at the phylum level (P=0.002, Figure 1, panel A) and accounted for 6.9% of the total observed variation. Plots derived from the RDA indicated that chickens could be grouped in two separate clusters based on the presence (UP, UPTB) or absence of unprotected butyrate in the diets (CTR, TB, FCB).  
Figure 1. Correlation biplot based on a redundancy analysis depicting the relationship between the cecal microbiota composition at phylum (panel A) and genus (panel B) levels of 22-23 d old broilers and diets differing solely by the type of butyrate additive used (CTR: none, FCB: fat-coated butyrate, TB: tributyrin, UP: unprotected butyrate, UPTB: mixture of unprotected butyrate and tributyrin)   Prevalence of Bacteroidetes and Proteobacteria were significantly affected by dietary intervention (P=0.048, P<0.001 and P<0.001, respectively; Table 4). Post-hoc analysis indicated that Proteobacteria relative abundance was significantly higher in 
A 
 
B 
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birds fed UP diets than in birds fed CTR diets. Birds fed the UP diets had, in addition, a significantly lower Bacteroidetes relative abundance than their TB fed counterparts.   Increased prevalence of the Proteobacteria phylum is a consistent hallmark of dysbiosis in adult mice fed high-fat diets (Geurts et al., 2011; Zhang et al., 2012; Everard 
et al., 2014). Similar results have been reported in obese human adults (Larsen et al., 2010; Verdam et al., 2013; Zhang et al., 2013). Such consistent findings have led Shin and colleagues (2015) to suggest using Proteobacteria prevalence in the gut as a diagnostic tool for dysbiosis. Other biomarkers of dysbiosis have been reported in the literature, such as loss of microbiota diversity in poultry (Kogut, 2013). Our results indicate that birds fed the UP diet displayed all the aforementioned signs of dysbiosis.  
Biomarkers of dysbiosis and of changes in hydrogen metabolism at genus level. Redundancy analysis indicated that dietary intervention had a significant effect on microbiota composition at a genus level (P=0.002) and explained 8.6% of the total observed variation (Figure 1, panel B). Plots derived from the RDA indicated that chickens could be grouped in two separate clusters based on the presence (UP, UPTB) or absence of unprotected butyrate in the diets (CTR, TB, FCB), in line with the separation observed when using phylum-level data as described above (Figure 1, panel B). Dietary intervention significantly influenced the relative abundance of 25 genera out of the 66 detected (Table 5). Interestingly, UP suppressed the strictly anaerobic 
Alistipes genus while promoting facultative anaerobes belonging to the Escherichia-
Shigella group. Such changes have been associated with gut inflammation and dysbiosis in both mammals and avian species (Kogut, 2013; Verdam et al., 2013; Jiang et al., 2015).  Butyrate production and hydrogen removal are microbial activities that are restrictively performed in the gut by well-defined sets of bacterial families. Butyrate production is of importance as this molecule seems to be a key inter-kingdom signalling molecule with pleiotropic effects in both mammals (Guilloteau et al., 2010) and poultry (Moquet et al., 2016). Hydrogen removal is also of importance as it conditions the availability of oxidized pyridine nucleotides and, consequently, the progression of saccharolytic fermentation (Cummings and Branch, 1986).  Butyrate production is realized by members of the Ruminococcaceae and 
Lachnospiraceae families in broilers (Onrust et al., 2015). Feeding UP had mixed effects on the relative abundance of these two families. Our results show that Ruminococcaceae 
anaerotroncus were suppressed while Lachnospiraceae copprococus, Ruminococcaceae 
anaerofilum, R. incertae sedis and R. oscillospira were promoted (Table 6). Overall, dietary intervention did not significantly affect the total relative abundance of 
Ruminococcaceae and Lachnospiraceae families in the present experiment (P=0.533 and P=0.364; respectively). As a consequence, it is difficult to infer any clear effect of UP on the butyrogenic capacity of the cecal microflora.
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Disposal of hydrogen in the hindgut through dissimilatory sulfate reduction is restrictively performed by bacteria belonging to the Desulfobacterales and 
Desulfovibrionales orders (Gibson et al., 1993). The former was not detected in the present experiment while the latter was only associated with the UP diet. Feeding the UPTB diet, and, to a lesser extent the UP diet, increased the relative abundance of 
Blautia. This genus contains several species such as Blautia hydrogenotrophica (formerly called Ruminococcus hydrogenotrophicus) which are associated with hydrogenotrophic acetogenesis (i.e. Wood-Ljungdahl pathway) (Bernalier et al., 1996; Liu et al., 2008). Collectively, our results suggest that the relative abundance of microbial groups known for their ability to perform dissimilatory sulfate reduction and acetogenesis in cecal hydrogen removal was increased when UP was added to the diet. Dissimilatory sulphate reduction results in the production of hydrogen sulphide (H2S) (Carbonero et al., 2012). This metabolite inhibits butyrate oxidation in colonocytes (Pitcher et al., 2000) and was, therefore, initially considered to be a toxic metabolite (Pitcher and Cummings, 1996). Later work indicated that low levels of H2S could also support gut tissue repair, thereby, illustrating the dual nature of H2S (Wallace et al., 2007a,b). It is, therefore, difficult to state whether the presence of Desulfovibrionales in the ceca of birds fed TB was harmful or beneficial to the health of the host. Increased acetogenesis by member of the Blautia genus may, on the other hand, benefit the host by increasing energy harvest.  
Feeding unprotected butyrate is associated with inflammation in the distal GIT We reported previously that increasing digesta butyrate concentration in the gastric region of broilers, e.g. by feeding unprotected butyrate, resulted in multiple signs of intestinal microbiota overgrowth, e.g. reduced intestinal weight, impaired AA digestibility and skewed intestinal SCFA profile (Moquet et al., 2018). Here, we quantified the expression of genes related to immune system homeostasis, gut integrity and oxidative stress metabolism in the ileum and colon to evaluate the intestinal health of birds fed different the control diet and the different butyrate additives (Table 6).  
TLR-4 expression and inflammation. Several innate immune receptors, including Dectin-1, TLR-2 and TLR-4, are anchored at the surface of various immune cells populating the gut associated lymphoid tissue (Smith et al., 2014). Fewer of these innate immune receptors (e.g. TLR-2 and TLR-4, but not Dectin-1) can also be found at the basolateral side of epithelial cells lining the gut wall (Beal et al., 2006). In the present experiment, TLR-4 expression was significantly affected by dietary intervention in the ileum (P=0.006, Table 6). Interestingly, TLR-4 expression was significantly higher in birds fed the UP diet in comparison to their control counterparts for this GIT segment. A similar trend was observed in the colon (P=0.094, Table 6).  Sensing of bacterial lipopolysaccharide by TLR-4 triggers the recruitment of the adaptor protein MyD88 and, subsequently, the activation of the transcription factor NF-
κB (Juul-Madsen et al., 2014). Our results indicate that dietary intervention had a significant effect on MyD88 expression in the ileum and colon (P<0.001, Table 6). For these two locations, birds fed the UP and TB diets had significantly higher expression of MyD88 than birds fed the CTR and FCB diets.
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In poultry, activation of the NF-κB pathway results in the release of the pro-inflammatory cytokines INF-γ, Il-1β and IL-6 (Kaiser and Stäheli, 2014). We observed that dietary intervention had a significant effect on IL-6 expression in the ileum (P=0.001, Table 6). A similar trend was observed in the colon (P=0.089, Table 6). Post-hoc analysis indicated that birds fed the UP and TB diets had significantly higher IL-6 expression in the ileum than birds fed the CTR and FCB diets. Biological functions of IL-6 are conserved across avian and mammalian species (Schneider et al., 2001). The pivotal role of this pro-inflammatory cytokine in orchestrating chronic intestinal inflammation is clearly described for humans (For review, see: Mudter and Neurath, 2007; Neurath and Finotto, 2011). Specifically, IL-6 exerts anti-apoptotic effects on CD4+ T-cells (Atreya et al., 2000). This contributes to the accumulation of CD4+ T-cells during chronic inflammatory diseases of the GIT such as Crohn’s disease or ulcerative colitis in humans (Mudter and Neurath, 2007). Higher expressions of TLR-4, MyD88 and IL-6 in the ileum and colon of birds fed the UP diet confirms the pro-inflammatory effects in the ceca of broilers.  Our results also indicate that TB led to significant increases in MyD88 and IL-6 gene expression compared to the control in the ileum and colon. Such results are intriguing because there were no significant differences between CTR and TB fed birds concerning most of the cecal dysbiosis markers, e.g. Proteobacteria relative abundance and microbial alpha diversity. Tributyrin increases butyrate concentration in the small intestine of broilers (Moquet et al., 2018). We compared the expression of the genes listed in Table 6 also in the duodenum of birds fed the CTR and TB diets to investigate the direct effect of butyrate presence on immune system regulation in the proximal intestine. These results showed that, in the duodenum, birds fed TB had lower IL-10 expression and higher COX2 expression than CTR birds (P=0.046 and P=0.002, respectively; data not shown).   Colonic expression of Dectin-1 tended to be suppressed when butyrate was added to broiler diets (P=0.070, Table 6). In addition, we observed changes in duodenal expression of both COX2, a prostaglandin-forming enzyme, and of IL-10 (data not shown), an alternatively activated macrophage cytokine, when birds were fed TB. Studies in mice indicate that reduced expression of Dectin-1, a major innate immune receptor of antifungal immunity, induces fungal dysbiosis and increases the susceptibility to colitis (Iliev et al., 2012). Fungal dysbiosis increases plasma prostaglandin E2 in a manner that alters systemic immunity and, more precisely, macrophage polarization (Kim et al., 2014). Fungal dysbiosis can also lead to mucosal inflammation (for review, see Iliev and Leonardi, 2017). Hence, our findings may suggest a role of fungal dysbiosis in TB-induced inflammation of the distal GIT of poultry. This should be further confirmed in future studies, adding analysis of abundance and composition of the intestinal mycobiota.   
Gut integrity and oxidative stress metabolism. Interleukin-6 is known to induce a remodeling of epithelial tight junction (TJ) proteins assembly, which results in a leaky gut (Desai et al., 2002; Yang et al., 2003; Al-Sadi et al., 2014). Gut integrity loss is mediated by increased expression and mislocalization of TJ proteins of the CLD and ZO families (Yang et al., 2003; Al-Sadi et al., 2014). Our results indicate that dietary intervention resulted in significant changes in the expression of several TJ proteins such 
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as CDH1, CLD3 and ZO1 at ileal or colonic level (Table 6). The UP diet was found to increase CDH1 and ZO1 expression compared to CTR in both the ileum and colon. Feeding TB resulted in a similar effect and, in addition, suppressed CLD3 expression in the colon. Hence, gut inflammation induced by IL-6 resulted in alterations of TJ proteins expression in the present experiment. Whether such alterations led to functional changes in terms of permeability of the gut was, however, not determined.   Interleukin-6 activates avian macrophages (Kaiser and Stäheli, 2014). Such activation results in the production of nitric oxide (NO) by the cytokine-inducible NOS2 enzyme (Klasing, 1998). We found that birds fed the UP and TB diets had significantly higher NOS2 expression in the ileum and colon than birds fed CTR or FCB diets (Table 6). Nitric oxide has a dual role in the gut. Constitutive NO production contributes to tissue homeostasis while increased NO production by cytokine-inducible NOS2 leads to oxidative stress (for review, see Barrachina et al., 2001). Indeed, NO can react with superoxide to form peroxynitrite, a potent reactive nitrogen radical (Koppenol, 1998).  We also found that birds fed UP and TB diets had significantly higher CAT expression in the colon than their CTR and FCB fed counterparts (P=0.012, Table 6). A similar trend was observed in the ileum (P=0.055, Table 6). The enzyme CAT catalyzes the decomposition of hydrogen peroxide, a potent reactive oxygen radical, in water and oxygen. The reaction catalyzed by CAT, therefore, protects cells against damage induced by oxidative stress. Concomitant increases in NOS2 and CAT expression indicate that the distal GIT of birds fed the UP and TB diet was subjected to oxidative stress. 
Factors explaining changes in microbiota composition and growth performance 
Changes in SCFA along the GIT correlate with the observed changes in microbiota. After observing that UP induced bacterial dysbiosis and inflammation in the distal GIT of broilers, we tried to unravel the mechanisms underlying the observed differences in microbiota composition. Variation in microbiota composition at phylum level was visualized using PCA. The first two PCA axes explained 40.8 and 24.9 % of the observed variation in cecal microbiota composition. Functional traits, summarized in Table 4, were used sequentially in an attempt to interpret the PCA summary.  
 Dietary treatment groups aligned along the second PCA axis, indicating that the relative abundance of unprotected butyrate in the UP and UPTB diets increased the relative abundance of cecal Proteobacteria. Butyrate additives used in the present study had markedly different release profiles (Moquet et al., 2018). Unprotected butyrate is quickly absorbed in the proventriculus while TB is predominantly released in the proximal small intestine under the action of pancreatic lipase (Moquet et al., 2016). Fat coated butyrate provides a partial protection against gastric and enteric absorption (van den Borne et al., 2015; Moquet et al., 2018). Hence, the alignment of dietary treatment groups along the second PCA axis indicates that butyrate presence in the crop and proventriculus increased cecal Proteobacteria relative abundance (Figure 2). This relationship was further confirmed by the use of a subset of SCFA data as supplementary variables (Figure 2). Such supplementary variables tended to be correlated with the second PCA axis (P=0.099; pseudo-canonical R2: 0.24). Cecal 
Proteobacteria expansion was associated with the presence of butyrate in the crop and gastric regions, i.e. proventriculus and gizzard, and also with the presence of propionate in the small intestine. Reduced cecal Proteobacteria relative contribution was 
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associated with the presence of propionate in the colon and ceca. Nutrient digestibility, GIT development and passage rate data showed little relevance in interpreting the variation in microbiota composition at phylum level (data not shown).  
 
 Figure 2. Correlation byplot based on principle component analysis (PCA) of the cecal microbiota composition at phylum level of 22-23 d old broilers. Axis one accounts for 40.8 % of the total variation while axis two accounts for 24.9 % of the observed variation. Interpretation of PCA axis is facilitated by short chain fatty acids data provided as supplementary variables.  Collectively, our findings demonstrate that dysbiosis induced by UP is independent from observed changes in digestive functions while being associated with changes in propionate and butyrate concentrations along the GIT. The presence of butyrate in the crop, proventriculus and gizzard may have triggered mechanisms at a mucosal level that influenced the settlement of the microbiota in the GIT. Differences in propionate concentration in the small intestine, colon and ceca may reflect resulting changes in microbiota composition. 
Expression of HDP and Mucus Genes. Mucosal secretion of HDP is one of the mechanisms by which birds can affect microbiota composition in the gut (Pan and Yu, 2014). Butyrate modulates the expression of numerous avian HDP genes in both cultured HD11 macrophages and gut tissues explants of broilers (Sunkara et al., 2011). We screened different GIT segments of birds (Proventriculus, pylorus, duodenum, ileum and colon) for the expression of known avian HDP and, for each GIT segment considered, we compared the expression of detectable HDP genes between the CTR diet and the butyrate-supplemented diet that resulted in the highest increase in local butyrate concentration. The results indicate that butyrate has a location-dependent effect on HDP gene expression, leading to either up- or downregulation of different HDP genes (Table 7).
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The type of HDP genes detected in the present experiment differed from those previously reported by Sunkara and coworkers (2011). Such discrepancies may be attributable to age-dependent effects on HDP gene expression (Cuperus et al., 2013).  Mucus secretion is another mechanism allowing the host to modulate microbiota composition (Pan and Yu, 2014). We screened different GIT segments of birds for the expression of known avian mucus genes and, for each GIT segment considered, we compared the expression of detectable mucus genes in the same way as HDP genes. Like HDP genes, expression of several mucus genes was found to be modulated by butyrate in a location-dependent manner (Table 7).   Bactericidal properties of avian HDP have been characterized for a few pathogenic bacteria but not for commensal ones (Cuperus et al., 2013). Besides, the interaction between mucus and microbiota composition has not been studied in birds (Pan and Yu, 2014). It is, therefore, difficult to discuss the possible implications of observed changes in the expression of HDP and mucus genes. In addition, the present approach fails to capture the effect of butyrate presence in a given GIT segment on HDP and mucus gene expression in a remotely distant GIT segment (e.g. effect of FCB on HDP gene expression in the proventriculus). This prevents the use of multivariate analysis to explore the relationships between cecal microbiota composition and the expression of HDP and mucus genes. Our work demonstrates nonetheless that butyrate has location-dependent modulatory effects on the expression of HDP and mucus genes in the gut of broilers. Such effects may have contributed to the observed differences in cecal microbiota composition.  
Association between cecal microbiota composition and growth performance. Using RDA, we found that microbiota composition at phylum level tended to explain a small part of the observed variation in growth performance (1.3 %; P=0.062). A similar trend was observed at genus level (0.9 %; P=0.096). Microbiota composition did not significantly explain the observed changes in feed conversion ratio. Overall, cecal microbiota composition had a rather limited influence on growth performance. Presence of butyrate and/or propionate in the distal GIT elicits changes in digestive processes that are positive for feed efficiency (Moquet et al., 2018). Increased butyrate presence in the distal GIT can be achieved by feeding FCB (van den Borne et al., 2015) or by steering endogenous butyrate production (Onrust et al., 2015). Aforementioned dietary strategies may improve feed efficiency while triggering minimal gut inflammation.  A major limitation of the present study is that it only depicts an instant snapshot of the microbiota and gut health status of birds at 22-23 d old. It is well known that dynamic processes contribute to immune system homeostasis and microbiota stability in the gut of broilers. Bacterial communities are rudimental and very similar across GIT segments around hatching (Lu et al., 2003). Distinct meta-communities develop gradually in later life (Pedroso and Lee, 2014). There is a critical immune window lasting a couple of days after hatching wherein birds develop oral tolerance to encountered bacteria (Klipper et al., 2004). This critical window is followed by several weeks of intestinal immune system maturation, wherein different cytokines and Ig isotypes are successively expressed (Lammers et al., 2010; Simon et al., 2014). Future 
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research should include time series to better understand the effect of butyrate on gut microbiota colonization and immune system maturation. 
CONCLUSION The present study demonstrates that supplementing broiler diets with distinct butyrate additives leads to differential effects on microbiota composition and gene expression as related to gut health in the distal GIT. Unprotected butyrate, mostly active in the crop, proventriculus and gizzard of birds, promotes cecal microbiota dysbiosis. This is associated with the activation of TLR-4, leading to inflammation in the distal GIT. Feeding TB selectively increases butyrate concentration in the small intestine. This does not induce bacterial dysbiosis in the ceca per se, and yet TB still promotes inflammation in the distal GIT. The inflammatory effect of TB may be related to fungal dysbiosis. Inflammation of the distal GIT alters the expression of genes involved in TJ proteins and oxidative stress metabolism. Fat coated butyrate with its sustained release profile that allows partial protection of butyrate against gastric and enteric absorption, does not significantly affect cecal microbiota composition and does not induce inflammation in the distal GIT. The precise mechanisms underlying the observed changes in microbiota composition in the distal GIT are independent from changes in digestive function in the upper GIT but are related to the release kinetics of the additives. The presence of butyrate in various GIT segments modulated expression of mucus and HDP genes. This may explain the observed differences in microbiota composition. 
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ABSTRACT The hypothesis was tested that butyrate presence in the digesta of distinct gastrointestinal tract (GIT) segments leads to different immune responses when broilers are subjected to non-infectious immune challenges. A total of 240 male day-old Ross 308 broilers were randomly assigned to 6 dietary treatments: 1) control (no butyrate), 2) unprotected butyrate (main activity in the crop and gastric regions), 3) tributyrin (main activity in the small intestine), 4) fat-coated butyrate (activity in the whole GIT, higher release in the proximal GIT), 5) wax-coated butyrate (activity in the whole GIT, higher release in the distal GIT) and 6) cellulose-acetate-butyrate (main activity in the colon and ceca), each replicated 5 times. At 21 and 22 d post-hatch, 2 birds per pen received intratracheally a human serum albumin (HuSA) challenge. HuSA-specific as well as natural antibody (NAb) levels were measured at d 0 (pre), 3, 7 and 18 d post-challenge. Birds challenged with HuSA were dissected at 39 d and digesta were analysed for butyrate concentration. At 42 d post-hatch, remaining birds received an intraperitoneal lipopolysaccharide (LPS; 0.5 mg/kg BW) injection. Body weight, nitrogen retention and AMEn were measured in the 24 h post LPS challenge. Dietary intervention resulted in significant changes in butyrate concentration across the GIT until the end of the jejunum. Butyrate increased IgY NAb titers, in particular when present in the duodenum and jejunum. Birds subjected to the in vivo LPS challenge had growth and nutrient utilisation impairments that were not alleviated by any of the dietary interventions. The present study demonstrates that, in broilers, effects of butyrate on IgY NAb levels are conditioned by the GIT segment wherein the molecule is present.  
Key words: Butyrate, broiler, immunization, natural antibody, lipopolysaccharide    
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INTRODUCTION 
In avian species, activation of the nuclear factor κ-B (NF-κB) pathway stimulates the production of pro-inflammatory cytokines, which can result in anorexia, increased basal metabolism and shifts in nutrient partitioning (Klasing and Johnstone, 1991). These physiological changes are associated with a negative nitrogen balance and a reduction in growth performance (Klasing and Johnstone, 1991; Lochmiller and Deerenberg, 2000). The NF-κB pathway is down-regulated by the presence of butyrate, a short chain fatty acid (SCFA), in the gut mucosa (Yin et al., 2001; Luhrs et al., 2002). Consequently, butyrate modulated the expression of pro-inflammatory cytokines IL-1β and IL-6 in chickens in both in vitro (Zhou et al., 2014) and in vivo (Li et al., 2015; Bortoluzzi et al., 2017) experiments. Dietary butyrate supplementation has also been shown to alleviate the negative effects of intraperitoneal (i.p.) injections of the potent NF-κB inducer E. coli lipopolysaccharide (LPS) on growth of broilers (Zhang et al., 2011). The positive effect of dietary butyrate supplementation on growth performance of broilers may, therefore, be partly attributable to its anti-inflammatory properties (Moquet et al., 2016b).   Immuno-modulatory properties of butyrate might extend beyond the sole dampening of gastrointestinal tract (GIT) inflammation in poultry. Dietary butyrate supplementation has been observed to improve specific antibody (SpAb) responses of broilers following immunization (Sikandar et al., 2017), probably because a decrease in NF-κB activity shifts the bird’s adaptive immunity from cell-mediated to humoral responses (Koutsos et al., 2014). In mammals, the presence of butyrate in the GIT increases IL-10 levels (Kim et al., 2014; Corrêa-Oliveira et al., 2016). The functions of IL-10 are conserved in birds and mammals, e.g. promoting B cell survival, proliferation and antibody production (Kaiser and Stäheli, 2014). As a consequence, butyrate presence in the GIT may influence not only SpAb response following immunization but also natural antibodies (NAb) levels of chickens. NAb have a fundamental role in the first line of defence and maintenance of physiological homeostasis (Panda and Ding, 2015; Boes, 2000).  Immunomodulatory properties of butyrate presumably vary depending on the GIT segment wherein the molecule is present because of metabolic differences among cell types along the avian GIT (Moquet et al., 2016b). Dietary supplementation with butyrate additives (e.g., unprotected sodium salt, tributyrin or fat coated butyrate) can have markedly different butyrate release patterns allowing contrasts in butyrate concentration in the digesta of broilers until the end of the small intestine to be created (Moquet et al., 2018). Use of such additives, however, fails to significantly increase butyrate concentration in cecal digesta. Novel protection methods, such as embedding in a wax matrix or butyrylation to a glucose polymer, may help delivering butyrate to the more distal GIT (Zhou et al., 1996; M'Sadeq et al., 2015).  This study aimed to evaluate how increasing butyrate concentrations in the digesta of distinct GIT segments affect the immune responses of broilers. We hypothesised that the presence of butyrate in the GIT of broilers would decrease NF-κB activation and, subsequently, the production of pro-inflammatory cytokines in a manner that could improve specific humoral response (SpAb), influence innate humoral status (NAb) and 
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reduce general inflammatory response (LPS challenge). Human serum albumin (HuSA) immunization was used to evaluate SpAb response and was considered to be indicative of adaptive humoral immunity responsiveness. Changes in NAb levels were used as indicator of innate humoral status while decreased responsiveness towards a LPS challenge was considered to be a sign of reduced pro-inflammatory response. We further hypothesised that the immunomodulatory properties of butyrate would be conditioned by the GIT segment wherein the molecule was present. 
MATERIAL AND METHODS 
Experimental design and dietary treatments 
Experimental design. A complete randomized block design consisting of 6 dietary treatment groups in 5 blocks was used to assess the effect of butyrate concentration in the digesta on immune responses of broiler chickens. A total of 30 pens were blocked on their location in the experimental room and pens within a block were randomly allocated to one of the 6 experimental diets. Dietary treatment groups were: control (CTR; no butyrate), unprotected butyrate (UP; main activity in the crop, proventriculus and gizzard), tributyrin (TB; main activity in the small intestine), fat-coated butyrate (FCB; activity in the whole GIT with a higher release in the proximal GIT), wax-protected butyrate (WAX; activity in the whole GIT with a higher release in the distal GIT) and cellulose-acetate-butyrate (CAB; main activity in the hindgut). These feed additives were chosen after in vitro and in vivo assessments (Moquet et al., 2016a; Moquet et al., 2018). 
 
Feed Additives and experimental diets. The UP (Adimix Easy) and FCB (Adimix Precision) feed additives were provided by Nutri-Ad International NV (Dendermonde, BE). The TB was prepared by mixing 600 g/kg of tributyrin (T8626, Sigma-Aldrich, Saint-Louis, MO, US) and 400 g/kg silica powder (S5130, Sigma-Aldrich). The WAX additive was produced as follows: Lunacera M wax beads (Füller GmbH, Lüneburg, DE) were ground at 15,000 rpm with a ZM-1000 grinder (Retsch, Haan, DE) equipped with a 12-tooth rotor and without a screen. A 3 kg batch consisting of 300 g/kg sodium butyrate (Nutri-Ad International NV, Dendermonde, BE) and 700 g/kg ground wax was mixed with a pedal mixer model 305 (Dinissen, Sevenum, NL) at 50 % of the maximum speed for 5 min. The wax-butyrate mix was subsequently extruded with a twin screw extruder (M.P.F.50, Baker Perkins Ltd., Peterborough, UK). Extrudates were cooled to room temperature overnight and subsequently ground at 10,000 rpm with a ZM-1000 grinder (Retsch) equipped with a 12-tooth rotor without a screen. Ground extrudates were sieved manually to obtain the 0.8-1.4 mm fraction. The CAB additive was purchased from Fisher-Scientific (10549813; butyryl content 50-54%; Waltham, USA). Basal starter, grower and finisher diets were formulated to meet or exceed the nutritional requirements of broiler chickens (CVB, 2007, Table 1). 
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 Table 1. Ingredients and calculated nutrient composition of the basal diets  
  Starter Grower Finisher 
Ingredients (g/kg as is basis)    Corn 467.27 412.06 371.86 Wheat 147.90 197.29 246.67 Soybean meal 266.67 271.61 271.61 Fish meal 24.69 14.82 0.00 Potato protein 19.75 9.88 9.88 Soybean oil 21.72 49.66 56.28 Vitamin and mineral premix1 4.94 4.94 4.94 Limestone 14.82 12.35 11.85 Monocalcium phosphate 10.86 6.42 5.43 Salt 1.58 1.78 1.98 Sodium bicarbonate 2.57 2.17 1.98 L-Lysine 1.48 1.58 1.88 DL-Methionine 2.57 2.47 2.37 L-Threonine 0.40 0.49 0.49 L-Valine 0.15 0.15 0.15 Natuphos 10000G 0.05 0.05 0.05 Chromic sesquioxide 0.25 0.25 0.25 Butyrate containing additives2 12.33 12.33 12.33 
Calculated nutrient composition (as is basis) Crude protein (g/kg) 221.70 209.70 201.00 Metabolisable energy (MJ/kg) 11.91 12.60 12.76 Calcium (g/kg) 9.20 7.20 6.50 Available phosphorus (g/kg) 4.40 3.10 2.60 Methionine (g/kg) 6.31 5.85 5.46 Lysine (g/kg) 13.42 12.50 11.97 
1Provided per kg of diet: vitamin A, 12,000 IU; vitamin D3, 2,500 IU; vitamin E, 50 mg; vitamin B2, 7.5 mg; vitamin B6, 3.5 mg; vitamin B1, 2.0 mg; vitamin K3, 1.5 mg; vitamin B12, 20 μg; choline chloride, 460 mg; antioxidant (oxytrap PXN), 125 mg; niacin, 35 mg; pantothenic acid, 12 mg; biotin, 0.2 mg; folic acid, 1 mg; Mn, 85 mg; Fe, 80 mg; Zn, 60 mg; Cu, 12 mg; I, 0.8 mg; Se, 0.15 mg. 2See Table 2.  Experimental diets were derived from the basal diets by adding the ingredients presented in Table 2. Butyrate-supplemented diets contained 1 g/kg of butyrate anion (C4H7O2-; as-is basis). Ingredient constituents used in the production of butyrate additives such as palm fat, cellulose or silica were present in similar amounts across diets. Sodium bicarbonate was used to maintain equal sodium supply across diets. Analysed nutrient values of the experimental diets are presented in Table 2. Birds were allowed ad libitum access to feed and water. Starter diets were fed during the 0-10 d period, grower diets during the 10-24 d and finisher diets during the reminder of the experiment.   
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Table 2. Ingredients added to the basal diets to derive the experimental diets and their analysed nutrient composition   Dietary treatment   Control UP TB FCB WAX CAB 
Ingredients added (g/kg as is basis) Soybean oil 1.16 0.86 0.00 0.86 0.86 0.16 Fat-coated butyrate2 0.00 0.00 0.00 4.21 0.00 0.00 Tributyrin3 0.00 0.00 1.78 0.00 0.00 0.00 Sodium butyrate4 0.00 1.40 0.00 0.00 0.00 0.00 Wax protected butyrate5 0.00 0.00 0.00 0.00 6.76 0.00 Cellulose acetate butyrate6 0.00 0.00 0.00 0.00 0.00 2.00 Cellulose 1.00 1.00 1.00 1.00 1.00 0.00 Palm fat 2.95 2.95 2.95 0.00 2.95 2.95 Lunacera M wax 5.50 5.50 5.50 5.50 0.00 5.50 Silica 0.62 0.62 0.00 0.62 0.62 0.62 Dextrin 0.14 0.00 0.14 0.14 0.14 0.14 Sodium bicarbonate 0.96 0.00 0.96 0.00 0.00 0.96 
Total 12.33 12.33 12.33 12.33 12.33 12.33 
Analysed nutrient composition of the experimental diets (as is basis) 
Starter       Dry matter (g/kg) 916.40 928.10 942.50 930.10 935.90 937.40 Fat (g/kg) 55.30 55.10 56.00 54.40 54.10 55.60 Crude protein (g/kg) 224.44 230.19 233.19 228.75 231.06 232.06 Crude fibre (g/kg) 27.70 29.50 31.50 29.30 27.60 28.40 Gross energy (MJ/kg) 17.49 17.74 17.94 17.69 17.77 17.87 
Grower       Dry matter (g/kg) 876.30 877.90 877.70 879.30 879.30 879.10 Fat (g/kg) 77.30 76.80 76.90 76.40 78.70 76.70 Crude protein(g/kg) 204.13 207.38 205.81 201.44 203.81 207.06 Crude fibre (g/kg) 28.50 26.60 27.80 26.50 27.20 27.00 Gross energy (MJ/kg) 17.41 17.52 17.46 17.53 17.53 17.54 
Finisher       Dry matter (g/kg) 875.30 879.00 878.90 879.40 868.40 877.80 Fat (g/kg) 79.80 81.00 84.80 80.70 78.50 81.30 Crude protein (g/kg) 196.81 193.63 194.19 194.88 194.38 195.94 Crude fibre (g/kg) 26.40 26.00 26.40 26.50 25.10 26.10 Gross energy (MJ/kg) 17.61 17.64 17.74 17.65 17.45 17.60 1UP: Unprotected butyrate, TB: Tributyrin, FCB: Fat-coated butyrate, WAX: wax-coated butyrate, CAB: Cellulose acetate butyrate. 2Adimix Precision (Nutriad International, Dendermonde, BE). Contains 700 g/kg palm fat; 237 g/kg C4H7O2-; 63 g/kg Na+. 3Contains 650 g/kg tributyrin (Sigma-Aldrich, Saint-Louis, MO, USA); 350 g/kg silica. 4Adimix Easy (Nutriad International, Dendermonde, BE); contains 712 g/kg C4H7O2-; 188 g/kg Na+, 100 g/kg dextrin. 5Contains 813 g/kg Lunacera M wax (Füller GmbH, Lüneburg, DE); 147.73 g/kg C4H7O2-, 39.27 g/kg Na+. 6Fisher-Scientific (Waltham, USA). Contains 500-540 g/kg C4H7O2-. 
Experimental procedures 
Birds and housing conditions. The experiment was conducted at the research farm Carus of Wageningen University (Wageningen, NL). All the experimental procedures were approved by the Animal Care and Use Committee of Wageningen University. A total of 240 one-day-old male broilers (initial BW 43.4 ± 3.4 g; Ross 308, Aviagen Group, Newbridge, UK) were obtained from a commercial hatchery (Kuikenbroederij Morren B.V., Lunteren, NL). Day-old chicks originated from a single breeder flock, were hatched in the same incubator and were transported in the same truck to minimize initial variation in microbiota composition. Upon arrival, birds were individually weighed, 
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neck-tagged and randomly assigned to one of the replicate pens. Each pen housed 8 birds, had a dimension of 1.85 × 1 m (L × W) and was enriched with a perch. Birds were kept 15 cm above the ground floor on a slatted floor covered with cardboard and pelleted lignocellulose (Softcell; Agromed Austria GmbH, Kremsmünster, AT) as bedding material. Ambient temperature was maintained at 32°C until d 3 and thereafter gradually reduced to 22°C at d 23. A 23L:1D photoperiod was applied until d 3 and was changed thereafter to 16L:8D. Individual and pen BW as well as pen feed intake (FI) were recorded every week. Each 20 kg bag of feed used in the experiment was sampled at the top, middle and bottom. Feed samples were pooled by diet type and kept at 4°C.  
Human serum albumin immunization. Two birds per pen having an individual BW closest to the pen average at d 14 were selected and marked with aerosol paint. At d 21 and 22 post-hatch, these birds received an immunological challenge consisting of intratracheal administration of HuSA (0.5 mg/d in 0.5 ml physiological saline solution on two consecutive days). Marked birds remained with the unchallenged birds in their respective pens after HuSA administration. The HuSA was obtained from Sigma-Aldrich (A8763) and dissolved in physiological saline at the concentration of 1 mg/ml. Blood was collected from the wing vein before initial HuSA administration (d 0) and at d 3, 7 and 18 post initial challenge. On d 39 post-hatch (i.e. d 18 post initial challenge), HuSA-challenged birds were euthanized by intravenous injection of sodium pentobarbital. Slaughter weights were recorded, body cavities were opened and different GIT segments were carefully separated using tie-raps: crop, proventriculus + gizzard, duodenum + jejunum (from the pyloric junction to Meckel’s diverticulum), ileum (from Meckel’s diverticulum to the ileocecal valve), colon, and ceca. Contents of each GIT segment were collected by gentle finger stripping and frozen at -20°C pending further analysis.  
LPS challenge and nutrient balance. Immediately after the blood sampling at 42 d, all birds received an i.p. injection of E. coli LPS (0.5 mg/kg BW, E. coli serotype 055:B5; L2880, Sigma-Aldrich) dissolved in a phosphate-buffered saline solution at the concentration of 0.5 mg/ml. The LPS dose injected was, therefore, adjusted to the BW of each bird. Bedding and cardboard were concomitantly removed from the slatted floor in order to transform the pens into metabolic cages. A balance period was conducted during the 24 h following i.p. LPS injection wherein FI, BW gain and mortality were recorded. Droppings were collected at 12 and 24 h following i.p. LPS injection, pooled per pen and stored at -20°C. 
Analytical methods 
Short chain fatty acids. A representative fraction of the digesta content taken from birds dissected at 39 d post-hatch (i.e. 18 d post initial HuSA challenge, but 3 d prior to LPS challenge) was analysed for DM and SCFA contents (15 birds per treatment group, 6 GIT segments per bird). Dry matter was measured according to standard methods (ISO 6496; ISO, 1999) and SCFA contents were determined according to the method described by Qaisrani and coworkers (2014). Blood samples taken from these birds were analysed according to the aforementioned procedure. 
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Immunoglobulins binding HuSA or KLH. Blood samples taken before initial HuSA administration (d 0) and at d 3, 7 and 18 relative to the initial HuSA challenge were analysed for IgM and IgY binding HuSA and keyhole limpet hemocyanin (KLH). Immunoglobulin titers were determined by ELISA, as described previously (Simon et 
al., 2014). 
Nitrogen and energy balance during the LPS challenge. Finisher feed samples and freeze-dried droppings collected during the 24 h post i.p. LPS injection were ground to pass a 1 mm sieve and analysed for DM (ISO 6496; ISO, 1999), nitrogen (method ISO 5983-1; ISO, 2005) and gross energy (method ISO 9831; ISO, 1998). 
Calculations and statistical analysis 
Short chain fatty acids. The SCFA concentration in the digesta of different GIT segments was analysed using the PROC GLM of SAS (version 9.3, SAS Institute Inc., Cary, NC). Diet was used as main effect. Means were separated using the Tukey-Kramer post-hoc test when a significant diet effect was detected. 
 
Growth performance. Growth performance was analysed during the 0-35 d period to avoid the confounding influence of dissections (d 39) and LPS challenge (d 42). Average FI, BW gain and feed conversion ratio (FCR) were analysed using the PROC MIXED of SAS (version 9.3, SAS Institute Inc., Cary, NC) using the following model:  
𝑌𝑌𝑌𝑌𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 = µ + 𝐷𝐷𝐷𝐷𝑖𝑖𝑖𝑖 + 𝑊𝑊𝑊𝑊𝑖𝑖𝑖𝑖 + 𝐷𝐷𝐷𝐷𝑊𝑊𝑊𝑊𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 + 𝐵𝐵𝐵𝐵𝑖𝑖𝑖𝑖 +  𝜀𝜀𝜀𝜀𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  where 𝑌𝑌𝑌𝑌𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  is the performance response of the mth pen (m = 1 to 30) fed the ith diet (i = CTR, UP, TB, FCB, WAX, CAB) during the jth measurement week (j = 1 to 5) in the kth block (k = 1 to 5). Diet (Di), measurement week (Wj) and the interaction between diet and measurement week (DWij) where included as fixed effects while block (Bk) was included as a random factor. Means related to significant fixed effects were separated using the Tukey-Kramer post-hoc test. The effect of butyrate presence in the diet was tested using a contrast (Butyrate: CTR vs UP+TB+FCB+WAX+CAB). 
 
Immunoglobulins binding HuSA or KLH. Immunoglobulin titers were analysed with the PROC MIXED procedure of SAS (version 9.3, SAS Institute Inc., Cary, NC) using the following model:  
𝑌𝑌𝑌𝑌𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 = µ + 𝐷𝐷𝐷𝐷𝑖𝑖𝑖𝑖 + 𝑆𝑆𝑆𝑆𝑖𝑖𝑖𝑖 +  𝐷𝐷𝐷𝐷𝑆𝑆𝑆𝑆𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 + 𝐵𝐵𝐵𝐵𝑖𝑖𝑖𝑖 + 𝜀𝜀𝜀𝜀𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  where 𝑌𝑌𝑌𝑌𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖  is the Ig titer of mth bird (m = 1, 2) fed the ith diet (i = CTR, UP, TB, FCB, WAX, CAB) in the kth block (k= 1 to 5) and sampled on the jth day post initial i.p. HuSA administration (j = 0, 3, 7, 18). Diet (Di), sampling day (Sj) and the interaction between diet and sampling day (DSij) where included as fixed effects while block (Bk) was included as a random factor. Means related to significant fixed effects were separated using the Tukey-Kramer post-hoc test. The effect of butyrate presence in the diet was tested using a contrast (Butyrate: CTR vs UP+TB+FCB+WAX+CAB).   
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Performance, energy and nitrogen retention during the LPS challenge. Nitrogen retention (NR; g/kg diet consumed) was calculated at a pen level during the balance period (0-24 h post i.p. LPS injection) as follows:  
𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁 = (𝐼𝐼𝐼𝐼 × 𝑁𝑁𝑁𝑁𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓)  − (𝐷𝐷𝐷𝐷 ×  𝑁𝑁𝑁𝑁𝑓𝑓𝑓𝑓𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑖𝑖𝑖𝑖𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑)(𝐼𝐼𝐼𝐼 × 𝑁𝑁𝑁𝑁𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓) × 100 where I is the pen FI in g; Nfeed and Ndroppings are as-is basis nitrogen contents of the feed and of the droppings, respectively; D is the pen dropping mass in g.  Total nitrogen corrected apparent metabolizable energy (AMEn) intake (MJ) was calculated at a pen level during the balance period using the equation of Meloche and coworkers (2013). A nitrogen correction factor of 8.73 kcal/g was used (Titus, 1956) and negative nitrogen retention values were set to zero. Apparent MEn (MJ/kg) was calculated as follows:  
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝑑𝑑𝑑𝑑 = 𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝑑𝑑𝑑𝑑 𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑖𝑖𝑖𝑖𝑒𝑒𝑒𝑒 𝐼𝐼𝐼𝐼   Bodyweight gain, FI, NR and AMEn during the balance period were analysed using the PROC GLM procedure of SAS (version 9.3, SAS Institute Inc., Cary, NC). Diet was considered as a main effect. Mortality during the balance period was analysed using the Chi-square test of the PROC FREQ procedure of SAS.  
RESULTS 
Short chain fatty acids Table 3 shows the effect of the dietary treatments on SCFA concentrations in the digesta of different GIT segments of broilers at 39 d of age. Significant dietary effects were observed for butyrate concentrations in the contents of the crop (P<0.001), pooled proventriculus + gizzard (P<0.001) and pooled duodenum + jejunum (P<0.001). Post-hoc analysis showed that birds fed the WAX additive resulted in significantly higher butyrate concentration in the crop and pooled proventriculus + gizzard contents than birds fed other diets (P<0.05). The UP, TB, and FCB additives also significantly increased butyrate concentration in the crop and pooled proventriculus + gizzard contents in comparison to the CTR, albeit to a lesser extent than the WAX additive (P<0.05). In addition, post-hoc analysis revealed that the TB diet significantly increased butyrate concentration in pooled duodenum and jejunum contents compared to the control diet (P<0.05). Acetate and propionate concentrations in the digesta of the different GIT segments were not influenced (P>0.05) by dietary intervention.   
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Table 3. Mean acetate, propionate and butyrate concentration in the digesta of distinct gastrointestinal tract segments of 39 day old broilers fed a diet without or with various butyrate additives 
Fatty acid Dietary treatment groups1 SEM Treatment P-value Location2 CTR UP TB FCB WAX CAB 
Acetate (μmol/ g DM)  Crop 33.3 20.6 41.7 21.2 23.4 22.9 7.9 0.355 P + G 12.4 8.7 15.0 9.8 10.3 11.4 2.5 0.563 D + J 11.0 23.8 21.5 22.2 21.7 21.7 3.3 0.113 Ileum 43.4 42.9 48.7 40.6 36.8 42.3 4.2 0.533 Colon 175.4 227.0 107.8 82.8 87.1 135.6 47.6 0.225 Ceca 455.9 500.8 552.5 448.5 422.5 426.9 50.2 0.450 
Propionate (μmol/ g DM)  Crop 0.7 0.7 1.1 0.6 1.1 0.7 0.2 0.322 P + G 1.1 0.7 0.8 0.6 1.0 0.9 0.2 0.457 D + J 1.1 2.4 2.0 1.9 2.0 2.0 0.4 0.439 Ileum 2.7 2.6 2.7 2.5 2.2 2.6 0.3 0.733 Colon 7.6 10.9 6.5 4.7 4.9 7.3 2.6 0.531 Ceca 41.0 30.9 53.5 35.7 33.0 30.5 6.4 0.135 
Butyrate (μmol/ g DM)        Crop 0.1c 6.5b 6.1b 6.2b 13.1a 0.1c 0.9 <0.001 P + G 0.1c 2.6b 1.9b 2.2b 3.7a 0.1c 0.4 <0.001 D + J 0.1c 0.4b 1.6a 0.5bc 0.8ab 0.1c 0.2 <0.001 Ileum 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.120 Colon 25.9 20.1 9.7 2.9 2.8 11.0 6.9 0.145 Ceca 104.0 84.8 138.8 86.0 99.7 95.6 14.5 0.136 1Dietary treatments groups: CTR (no butyrate supplementation), UP (butyrate anion provided as unprotected salt), TB (butyrate anion provided as tributyrin), FCB (butyrate anion provided as fat-coated butyrate), WAX (butyrate anion provided as wax-coated butyrate), CAB (butyrate anion provided as cellulose-acetate-butyrate). Butyrate was provided at 1 g/kg as is basis. Values are means of 10 birds per treatment group. 2P + G: Proventriculus-gizzard; D + J: Duodenum-jejunum. 
 Growth performance There was no significant effect of dietary treatment on the growth performance of HuSA-challenged and non-challenged birds during the 1-35 d period, as indicated in Table 4. Dietary treatments tended (P=0.085) to influence FI of birds but did not (P>0.05) influence FCR.  
Table 4. Growth performance (d 1 to 35) of broiler chickens fed a diet without or with various butyrate additives  Parameter1 Dietary treatment groups2 SEM P-values3 CTR UP TB FCB WAX CAB D W D x W B4 ADG (g) 76 77 77 75 75 77 8.4 0.704 <0.001 0.915 0.787 FI (g) 108 109 110 107 105 109 9.5 0.085 <0.001 0.819 0.755 FCR  1.42 1.41 1.43 1.42 1.41 1.43 0 0.759 <0.001 0.271 0.365 1ADG: Average daily gain; FI: Feed intake; FCR: Feed conversion ratio. 2Dietary treatment groups: No butyrate supplementation (CTR) or 1 g/kg butyrate anion provided in the diet in the form of unprotected butyrate (UP), tributyrin (TB), fat coated butyrate (FCB), wax coated butyrate (WAX) or cellulose acetate butyrate (CAB). Means represent average values of 5 replicate pens per group 3D: Diet; W: Week; B: Butyrate. 4Statistical contrast: CTR vs UP+TB+FCB+WAX+CAB.   
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Immunoglobulins binding HuSA or KLH Dietary intervention did not influence titers of IgM (P=0.636) and IgY (P=0.849) binding HuSA. There was no significant interaction between number of days following the initial i.t. HuSA administration and dietary intervention for both IgM (P=0.867) and IgY (P=0.984) binding HuSA. Titers of IgM and IgY binding HuSA did increase significantly from 0 to 18 d following the initial i.t. HuSA administration (P<0.001; Figure 1). Birds subjected to i.t. HuSA administration tended (P=0.079) to have a lower ADG than their non-challenged counterparts during the 21-35 d period. 
Figure 1. Anti-human serum albumin (HuSA) IgM (panel a) and IgG (panel b) antibodies at d 0, 3, 7 and 18 post initial intratracheal administration of HuSA. HuSA administered at d 21 and 22 post-hatch at a dose of 0.5 mg/day to 10 birds per treatment group. 
 Titers of IgM and IgY binding KLH increased significantly from 0 to 18 d following the initial i.t. HuSA administration (P<0.001; Table 5). A significant diet effect was found for the titers of IgY binding KLH (P=0.002). Contrast analysis indicated that butyrate supplementation significantly increased titers of IgY binding KLH (P=0.002). Post-hoc analysis revealed that birds fed the TB diet had significantly higher titers of IgY binding KLH than birds fed the other diets (P<0.05). A linear relationship between IgY NAbs and BW was observed at 39 d of age (P=0.007, R2=0.151; Figure 2). For every additional unit of IgY titers, birds grew, on average, 3.5 g/d more over the 0-39 d period. Dietary intervention did not influence titers of IgM binding KLH (P=0.413). There was no significant interaction 
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Figure 2. Effect of anti-KLH IgY natural antibody titers on bodyweight of broilers at 39 days of age. Human serum albumin administered at d 21 and 22 post-hatch at the dose of 0.5 mg/day. Outliers (n=3) were identified as being more than two standard deviations away from the calculated mean and subsequently removed from the regression analysis  
𝐵𝐵𝐵𝐵𝑇𝑇𝑇𝑇𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝐵𝐵𝐵𝐵ℎ𝑇𝑇𝑇𝑇 = 2848 + 136 × 𝐾𝐾𝐾𝐾𝐾𝐾𝐾𝐾𝐾𝐾𝐾𝐾 𝐼𝐼𝐼𝐼𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵  R2=0.151 
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between number of days following the initial i.t. HuSA administration and dietary intervention for both IgM (P=0.637) and IgY (P=0.516) binding KLH.  
Table 5. Effect of dietary treatments on titers of Ig binding keyhole lympet hemocyanin (KLH) proteins at d 0, 3, 7 and 8 after initial intratracheal administration of HuSA1   IgM Dietary treatment groups2    P-values CTR UP TB FCB WAX CAB Mean  Diet Day Diet*Day B3 d 0 1.7 1.8 1.9 1.4 1.4 1.6 1.6b  0.413 0.001 0.637 0.195 d 3 2.2 2.7 2.8 2.3 2.4 2.6 2.5ab      d 7 2.3 2.3 2.7 2.6 2.1 2.3 2.4ab      d 18 2.9 3.3 3.3 3.1 3.8 3.3 3.3a      
Mean 2.3 2.5 2.6 2.3 2.4 2.5 -  
    SEM 0.14 0.14 0.14 0.14 0.14 0.14       
IgY Dietary treatment groups2   P-values CTR UP TB FCB WAX CAB Mean  Diet Day Diet*Day B3 d 0 1.0 1.0 1.0 1.0 1.4 1.3 1.1b  0.002 0.001 0.516 0.002 d 3 0.9 1.2 1.6 0.9 1.5 1.3 1.2b      d 7 1.1 1.3 1.3 1.2 1.2 1.4 1.3b      d 18 1.8 2.3 3.2 2.3 2.9 2.9 2.5a      
Mean 1.2B 1.5B 1.8A 1.3B 1.7B 1.7B -  
    SEM 0.15 0.15 0.15 0.14 0.15 0.15             1Human serum albumin administered at d 21 and 22 post-hatch at the dose of 0.5 mg/day to 10 birds per group. 2Dietary treatment groups: No butyrate supplementation (CTR) or 1 g/kg butyrate anion provided in the diet in the form of unprotected butyrate (UP), tributyrin (TB), fat coated butyrate (FCB), wax coated butyrate (WAX) or cellulose acetate butyrate (CAB). 3Butyrate; Statistical contrast: CTR vs UP+TB+FCB+WAX+CAB. a-cMeans within a column lacking a common superscript differ (P< 0.05). A-BMeans within a row lacking a common superscript differ (P< 0.05).  
Performance, energy and nitrogen retention during the LPS challenge Growth, FI, mortality, nitrogen retention and AMEn data during the 24 h following i.p. LPS injection are presented in Table 6. There were no significant effects of dietary treatment on any of the measured parameters.  
Table 6. Body weight gain (BWG), feed intake (FI), mortality, nitrogen retention (NR) and nitrogen-corrected apparent metabolizable energy (AMEn) of broiler chickens 0-24 h post injection of lipopolysaccharide (0.5 mg/kg BW) fed a diet without or with various butyrate additives   Dietary treatments groups1 SEM P-value  Parameter CTR UP TB FCB WAX CAB BWG (g/d) -85.0 -41.1 -69.8 -89.1 -63.6 -66.2 21.0 0.641 FI (g/d) 112.5 89.4 110.4 127.3 114.2 86.3 15.3 0.332 Mortality (%) 6.9 0.0 7.7 3.4 11.5 7.1 4.0 0.585 NR (% N intake) 30.6 27.4 34.5 33.7 41.2 24.6 7.9 0.677 AMEn (MJ/kg) -71.7 -33.6 -80.4 -78.8 -98.4 -42.9 4575 0.186 1Dietary treatment groups: No butyrate supplementation (CTR) or 1 g/kg butyrate anion provided in the diet in the form of unprotected butyrate (UP), tributyrin (TB), fat coated butyrate (FCB), wax coated butyrate (WAX) or cellulose acetate butyrate (CAB).     
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Birds showed strong sickness behaviour after i.p. LPS injection. Animals displayed within an hour lethargic and anorectic behaviour which lasted for approximatively 15 hours. Birds had difficulty breathing during the first 12 h following LPS injection as their respiratory tract seemed to contain fluids. A total of 6.0 % (n= 10) of the animals died during the 24 hours that followed the injection. Mortality was not affected by dietary intervention (P=0.585). 
DISCUSSION 
Butyrate concentration in the digesta of distinct GIT segments The current study aimed to assess the effect of butyrate presence in distinct GIT segments on immune responses of broiler chickens subjected to non-infectious immune challenges. Differences in luminal butyrate concentration across GIT segments were achieved using five different butyrate additives (UP, TB, FCB, WAX, CAB). Birds fed the WAX diet had a significantly higher butyrate concentration in the crop, and proventriculus + gizzard contents compared to the birds fed the other experimental diets. Such findings contrasts with preliminary in vitro work showing that WAX prevented butyrate release in the proventriculus and small intestine more effectively than FCB. Damages to the WAX matrix during feed production, e.g. by steam conditioning and pelleting, may explain the difference between this in vitro and in vivo observation.   The UP, TB, and FCB additives also significantly increased butyrate concentration in the crop and proventriculus + gizzard contents, albeit to a lesser extent than the WAX additive. Increased butyrate concentration in the proximal GIT of birds fed UP, TB or FCB additives have already been reported elsewhere (Moquet et al., 2018). The release profile of UP and FCB are consistent with the intrinsic properties of these products: UP is quickly absorbed in the proventriculus while FCB provides only a partial protection against gastric absorption (Moquet et al., 2016b). Tributyrin is, however, supposed to only be released in the proximal small intestine under the action of pancreatic lipase (Moquet et al., 2016b). Pancreatic lipase can, however, end up in the gizzard of chickens due to retrograde peristalsis (Sklan et al., 1978). Such gastro-duodenal reflux may explain why TB-fed birds had significantly more butyrate in the crop, proventriculus + gizzard contents than to their CTR-fed counterparts.  Previous reports indicated that exogenous butyrate can be delivered to the colon and ceca of broilers by feeding FCB (Smith et al., 2012; van den Borne et al., 2015; Moquet et al., 2018) or butyrylated polysaccharides such as CAB (M'Sadeq et al., 2015). Supplementing broiler diets with FCB or CAB failed, however, to significantly increase butyrate concentration beyond the jejunum in the present experiment. The investigation of the effects of butyrate on immune responses along all segments of the birds’ GIT tract was, therefore, incomplete. Discrepancies between our study and data in the literature in the effects of feeding FCB or CAB on butyrate concentration in the distal GIT may be attributable to diet formulation. Rapeseed meal (RSM) based diets were used in the study of Moquet and coworkers (2018) while soybean meal (SBM) based diets were used in the present work. Soybean meal contains 3.3 times more oligosaccharides than RSM (Knudsen and Li, 1991). Raffinose and stachyose make up 
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half of SBM oligosaccharides (Choct et al., 2010). Such SBM oligosaccharides have a very low pre-cecal digestibility and are extensively fermented in the colon and ceca of birds (Coon et al., 1990). Hence, cecal butyrate production is increased when RSM is replaced by SBM as main protein source in broiler diets (Qaisrani et al., 2014).   The final step of butyrate production by the cecal microbiota is achieved by the butyryl-CoA: acetate CoA enzyme (Onrust et al., 2015). The gene coding for butyryl-CoA: acetate CoA is more abundantly expressed by the cecal microbiota of broilers when diets are diluted with purified cellulose (Bortoluzzi et al., 2017). This increase was, however, only observed in diets without supplemented butyrate. Using cecal contents of 28 d old broilers in an in vitro fermentation model, Onrust (Department of Pathology, Bacteriology and Avian Diseases, Ghent, BE, personal communication) demonstrated that the butyrogenic effect of purified cellulose as fermentation substrate is surpassed by the one of CAB only after 6 hours of fermentation. Mean retention time of solid particles in the ceca of broilers varies greatly across studies, with values ranging from 13-50 min (Rougière and Carré, 2010) to 119 min (Denbow and Scanes, 2015) or longer (Warriss et al., 2004; Liu et al., 2017). Diet structure, fibre composition as well as age of the bird are thought to influence cecal functions (Svihus, 2014). Hence, it is hitherto difficult to conclude if CAB has a superior butyrogenic effect than purified cellulose in vivo. In the present experiment, purified cellulose was added to the CTR, UP, TB, FCB and WAX diets to correct for the cellulose present in the CAB diet. In addition to SBM oligosaccharides, purified cellulose may have modified the endogenous (microbial) butyrate production in the ceca, thereby, masking the effect of exogenous (dietary) butyrate supplementation. Onrust and coworkers (2015) listed a series of strategies that could stimulate microbial butyrate production in the hindgut of broilers. It may be sound to use such strategies rather than protected butyrate additives in future studies aimed at increasing butyrate concentration in the hindgut. 
Growth performance  Immunologic stress depresses growth performance of broilers by reducing FI, shifting nutrient partitioning away from skeletal muscle deposition and increasing basal metabolism rate (Klasing and Johnstone, 1991). Antibiotic growth promoters (AGP) are known to prevent immunologic stress in chicks (Roura et al., 1992). Hence, sub-optimal rearing conditions are required to observe the growth-promoting effect of AGP. This has led Niewold (2007) to refer preferably to AGP as growth-permitting rather than growth-promoting molecules. Butyrate has been proposed as an alternative to the use of AGP in broiler diets (Huyghebaert et al., 2011). In the present experiment, dietary intervention did not change the growth performance of unchallenged birds during the 1-35 d period. In contrast, feeding butyrate was reported to influence growth performance of broilers subjected to i.p. LPS injections (Zhang et al., 2011), Salmonella infection (Liu et al., 2017) or feed challenge (Moquet et al., 2018). Overall, these observations indicate that growth-modulating effects of both butyrate and AGP are more prominent under sub-optimal rearing conditions.    
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Specific and natural Ig titers In the present study, i.t. HuSA administration was used at 21 and 22 d post-hatch to elicit a SpAb response. We did not observe any significant effect of dietary butyrate supplementation on HuSA-SpAb response. In contrast, Sikandar and coworkers (2017) reported that sodium butyrate enhanced the SpAb response of broilers after immunization against Newcastle disease virus via the ocular route at 1 d old and against SRBC via the intravenous route at 14 d. Newcastle disease vaccines contain pathogen-associated molecular patterns (PAMP) that can trigger an innate immune response (Schirrmacher, 2017). In contrast, purified model antigens such as HuSA allow to specifically stimulate the adaptive immune system without triggering a robust innate immune response (Klasing, 2004). The effect of butyrate on SpAb response may, therefore, be more prominent with PAMP-containing antigens. Discrepancies may be attributable, in addition, to differences in age and administration route.   Natural antibodies are defined as the Ig produced in absence of prior (known) external antigen stimulation (Schwartz-Albiez et al., 2009). Parmentier and colleagues (2004) reported that the serum of chickens contains Ig that can bind antigens to which chickens were never voluntarily exposed, e.g. KLH. Such Ig are considered to be avian NAb in the present study. There are two subpopulation of NAb: overt NAb are readily active in the serum while cryptic NAb only become active after cell damage (Berghof et 
al., 2015). In this study, overt NAb titers against KLH were measured. In agreement with earlier reports, both IgM and IgY NAb titers were found to increase significantly with age from 21 d post-hatch onwards (Simon et al., 2014). This increase is likely to be related to the maturation of the immune system and not to the HuSA challenge (Simon 
et al., 2014). Interestingly, dietary butyrate supplementation was found to significantly increase IgY NAb titers in the present study.   Butyrate has been shown to exert immuno-modulatory effects on mammalian gut cells through distinct mechanisms. Firstly, presence of butyrate in the cytoplasm of colonocytes and intestinal macrophages modifies IKK proteins, thereby down regulating NF-κB pathway activation (Luhrs et al., 2001). Secondly, the presence of butyrate in the nucleus of intestinal macrophages is thought to inhibit histone deacetylase enzymes in a manner where it can reduce production of pro-inflammatory cytokines (Chang et al., 2014). Finally, butyrate can be used as an energy substrate by regulatory T cells (Treg) and alternatively activated (M2) macrophages, but not by other immune cells having a more limited capacity to perform fatty acid oxidation and oxidative phosphorylation (Pearce and Pearce, 2013; O'Neill et al., 2016). Collectively, immuno-modulatory properties of butyrate are known to promote IL-10 production (Corrêa-Oliveira et al., 2016; Kim et al., 2014). Interleukin 10 influences the renewal and migration of NAb-producing B cells to their secretory sites in mice (Baumgarth, 2011). Similar mechanisms could underlie the observed increase in IgY NAb in the present experiment.  Interestingly, the increase in IgY NAb was more pronounced when butyrate was delivered in the duodenum and jejunum in comparison to other segments. Tissue-specific differences in butyrate uptake and metabolism may explain this observation. Butyrate may have limited effects on immunity when delivered in the crop, 
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proventriculus and gizzard, because these locations are sparsely populated with immune cells (Smith et al., 2014). When present in these proximal GIT segments, butyrate cannot reach distally located immune cells due to simple, non-ionic diffusion in the proventriculus (Moquet et al., 2016b). Hence, butyrate has to be delivered beyond the proventriculus to reach the dense immune cells populations harboured by the small and large intestine. Once absorbed in the small intestine, butyrate escapes oxidation in the epithelium since avian enterocytes rely preferentially on glucose, glutamate and glutamine for energy production (Watford et al., 1979). Enteric butyrate is, therefore, widely available to immune cells.   There were no significant differences among diets concerning digesta butyrate concentration in the colon/ceca in the present experiment. It is therefore difficult to compare the effect of an increasing digesta butyrate concentration in the small intestine or in the colon/ceca on immune responses of birds. One may argue that colonic butyrate is less likely to reach immune cells than enteric butyrate due to the extensive butyrate oxidation occurring in avian colonocytes (Sunkara et al., 2011). On the other hand, Moquet and coworkers (2018) reported that butyrate presence in the hindgut can modify the microbiota in a way that stimulates propionate production. In mammals, propionate regulates the number and function of the colonic Treg (Smith et al., 2013). This suggests that immune system homeostatis may be modulated in the colon by butyrate-induced changes in microbiota composition.    A significant linear relationship was found between IgY NAb titers and BW at 39 d of age. Avian IgY is structurally and functionally homologous to mammalian IgG (Härtle 
et al., 2014). Physiological roles of IgY/IgG NAb are less clearly established than those of IgM NAb (Panda and Ding, 2015). Mammalian IgG NAb appear to collaborate with soluble pattern recognition receptors such as mannan-binding lectin or ficolin to facilitate the phagocytosis of bacteria under inflammatory conditions (Panda et al., 2013). Other roles of IgG NAb in inflammation, immune regulation and tissue homeostasis remain unclear (Panda and Ding, 2015). It is hitherto difficult to speculate on the exact mechanisms underlying the relationship between IgY NAb titers and BWG in the present experiment.  
Nutrient retention during the LPS Challenge  Zhang and coworkers (2011) reported that feeding butyrate alleviated the negative effects of i.p. LPS injection on BWG of 21 d old broilers. We could not replicate such results with 42 d old broilers despite using the identical LPS strain, injection route and dose. The intestinal immune system of broilers undergoes dynamic changes in the 1-42 d period (Schokker et al., 2009; Lammers et al., 2010; Simon et al., 2014). Age-related differences in intestinal immune development may explain why butyrate failed to alleviate the negative effects of i.p. LPS injection on growth performance of broilers in the present study.   The fact that LPS dose was injected in the body cavity after an adjustment for BW may also explain partly such discrepancy. In fast growing broilers, the weight of the intestines relative to total BW increases during the 1-4 d post-hatch, reaches a peak at 4 d, and then decreases continuously till 42 d (Sørensen et al., 2012). In other words, the size of the body cavity increases at a lower rate than the BW of the bird after 4 d 
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post hatch. According to our calculations, broilers subjected to the LPS challenge in the present experiment received a dose identical to those of Zhang and coworkers (2011) when expressed as mg LPS/kg BW. The dose used in our study was, however, 1.9 fold higher than the one of Zhang and coworkers (2011) when expressed as mg LPS/kg empty intestine weight. Ji and coworkers (2015) studied in 22 d old broilers the effect of different i.p. LPS injection doses on intestinal inflammation using mucosal IL-1β concentration as biomarker. A dose of 0.5 mg LPS/kg BW was found to partly reduce FI compared to an unchallenged control while a dose of 1 mg/kg BW was found to supress completely FI while triggering significantly more inflammation than lower LPS doses. Hence, inflammation induced by i.p. LPS injection may have been greater in the present study compared to the one of Zhang and coworkers (2011) due to age-related differences in GIT growth allometry. When considering i.p. LPS injection in future studies, it may be sound to adjust the LPS dose based on the predicted empty GIT weight instead of the measured BW.  In the present experiment, birds realised only half of their predicted ad libitum FI during the 24 h following the i.p. LPS injection (Aviagen, 2014). This observation is in line with reported anorexigenic effects of pro-inflammatory cytokines in poultry (Klasing and Johnstone, 1991). In chickens, inflammatory challenges result in increased skeletal muscle catabolism (Klasing and Austic, 1984a; Klasing et al., 1987), reduced skeletal muscle synthesis as well as increased protein accretion in primary and secondary lymphoid organs (Klasing and Austic, 1984b). Such changes in protein metabolism result in a net protein loss from skeletal muscles that could explain the body weight loss and low nitrogen retention reported in the present study. 
CONCLUSION In agreement with previous broiler studies, the present work demonstrates that different butyrate additives can be used to create a contrast in luminal butyrate concentrations across GIT segments until the end of the jejunum. It is, however, more difficult to achieve consistent contrasts in butyrate concentration beyond the small intestine across studies using such additives. This may be due to the confounding influence of diet composition on endogenous microbial butyrate production. Dietary butyrate supplementation increased IgY NAb titers of birds in the present experiment. The positive effect of butyrate on IgY NAb was more pronounced when the molecule was present in the duodenum and jejunum. This indicates that tissue-specific differences in butyrate uptake and metabolism modulate the immuno-modulatory effects of the molecule. We could not replicate the findings of other researchers concerning the positive effect of dietary butyrate on specific humoral responses of birds and on their growth performance during i.p. LPS challenge. Various factors may explain such discrepancies and additional research is required to better understand the effect of butyrate on inflammatory and specific immune responses of birds.    
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INTRODUCTION There is an apparent consensus among current-day scientists to describe butyrate as a health-promoting molecule for humans (Canani et al., 2011), poultry (Dethlefsen et 
al., 2007; Moquet et al., 2016), pigs and other monogastric farm animals (Guilloteau et 
al., 2010a; Kaiser and Stäheli, 2014). Butyrate is portrayed in both the scientific and non-scientific literature as a molecule that elicits unique and beneficial effects in the 
gut (Textbox 1). Butyrate was discovered in 1815 and characterized in 1817 by the chemist E.M. Chevreul (Chevreul, 1823). Until the late 1960s, the physiological effects of butyrate remained largely unknown and butyrate was described as a potentially toxic pollutant present in the smoke of cigarettes (Gold et al., 1946).   A renewal for the interest in butyrate research was sparked in the late 1970s when butyrate was identified as a potential chemo-therapeutic agent in humans (for review, see Prasad and Sinha, 1976). The physiological effects of butyrate have been more thoroughly investigated than those of other short chain fatty acids (SCFA) as a consequence of the prime discovery of its potent anti-tumorigenic properties in humans and associated animal models (Fung et al., 2012). The initial findings summarized by Prasad and Sinha (1976) initiated an era of unprecedented activity in the history of butyrate research that is, to date, ongoing (Figure 1). There were nearly three times more scientific articles published on butyrate in 2017 than in the first 150 years that followed its discovery. Numerous research teams studied the regulatory effect of butyrate on digestive functions, immune responses, cell proliferation and gut integrity using animal models and human cell cultures (for review, see Guilloteau et al., 2010a).  In the wake of these intense scientific developments, Mroz and colleagues (1997) started to evaluate the effect of dietary butyrate supplementation on the growth performance of swine in the late 
Textbox 1. BUTYRATE IN THE SCIENTIFIC AND 
NON-SCIENTIFIC LITERATURE 
Scientific journals 
When considering signals derived from bacterial 
fermentation, butyric acid has been shown to be the 
main driving force toward an optimal gut health. Onrust et al., 2015 in Frontiers in Veterinary Sciences  
Among these [short chain fatty acids], butyric acid 
possesses interesting characteristic features. (Ahsan 
et al., 2016) in World’s Poultry Science Journal  
Online animal nutrition magazines 
SCFA, butyrate in particular, have a strong capacity 
to enhance [...] critical components of the animal's 
innate immunity. Byrne, 2017 on Feed Navigator  
Multifarious effect of butyrate on intestinal health: 
[...] Butyrate is a short chain fatty acid naturally 
produced in the digestive tract by the fermentation 
of fibres. Ahsan, 2016 on the Poultry Site 
Feed additives companies communications 
Butyrate is somewhat unique among its biological 
functions when compared with other short chain 
fatty acids. Nutriad  
Butyrate is [a] very important energy source for the 
villi, and plays a vital role in balancing a healthy 
intestinal flora. Palital 
Newspaper articles 
[Goat butter] contains a short-chain fatty acid 
called butyrate which may also enhance intestinal 
barrier function - i.e. gut health. Chalmers, 2017 in the Daily Mail  
Ghee also has butyric acid, shown to support healthy 
digestion. Seidenberg, 2017 in the Washington Post  
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1990s. At that time, there were only a few studies investigating the effect of organic acids on the growth performance of poultry (Dibner and Buttin, 2002). Such studies were mostly focused on fumaric acid and the growth-promoting potential of butyrate was unexplored (Dibner and Buttin, 2002). As a matter of fact, butyrate was merely considered for its influence on voluntary feed intake of chickens (Pinchasov and Jensen, 1989). The results of Mroz and colleagues (1997) in swine prompted poultry nutritionists to investigate the effect of dietary butyrate supplementation on the growth performance of poultry. To the best of my knowledge, 2005 was the year when the first 
in vivo studies investigating the effect of butyrate on the health and growth performance of broiler chickens were published (Leeson et al., 2005; Van Immerseel et 
al., 2005a). Such pioneering works did not go unnoticed and, in the following decade, no less than 90 in vivo experiments investigated the effect of dietary butyrate supplementation on the growth performance of chickens (Polycarpo et al., 2017). This body of literature has established butyrate as a relatively unique and beneficial molecule in the eyes of poultry nutritionists (Onrust et al., 2015; Ahsan et al., 2016; Moquet et al., 2016). 
Nowadays, the positive image of butyrate has overstepped the bounds of the scientific community. Increasing butyrate presence in the intestines by eating specific fibres or butyrate-containing food items is widely perceived by food manufacturers and consumers as a good strategy to correct health issues that may arise from the consumption of heavily processed western diets (Textbox 1; Fung et al., 2012).   The perception of butyrate by scientists has swung from neutral to bad to good over time, like a pendulum (Figure 2). The very first reported research endeavours mentioning butyrate were non-judgmental as they only considered the chemical structure of the molecule. Initial research into the physiological effects of butyrate portrayed the molecule negatively as a toxic pollutant present in the smoke of cigarettes. This view changed gradually as several researchers proposed to use butyrate as a chemotherapeutic agent. In other words, butyrate became a toxic substance that could have some usefulness in human medicine. This change in paradigm opened an era of intense investigations on the physiological effects of butyrate. As a result of such 
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Figure 1. Number of scientific publications having a title containing ‘butyrate’ between 1823 and 2017. No data are shown between 1823 and 1920 because there were no results. Data generated using the search engine of Sciencedirect (https://www.sciencedirect.com/science/search)  
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investigations, the perception of butyrate evolved further and, nowadays, butyrate is seen as a molecule having unique and beneficial effects for intestinal health in both humans and non-ruminant farm animals (Textbox 1). 
Yet, butyrate has not always achieved all the multifarious, positive effects in a consistent manner in mammals and poultry (Moquet et al., 2016). As a result, reviews related to this molecule sometimes contain interrogative titles, e.g. ‘The butyrate story: 
old wine in new bottles?’ (Scheppach and Weiler, 2004) and ‘Butyrate: what is the future 
for this old substance?’ (Sossai, 2012).  The aim of this thesis was to ascertain the effect of dietary butyrate supplementation on the digestive function, microbiota composition and immune responses of broilers. In addition, the aim of this thesis was to verify whether such effects were conditioned by the gastrointestinal tract (GIT) segment wherein butyrate is present.  Proven and putative mechanisms underlying the effects of butyrate in the avian GIT were identified through a literature review (Chapter 2). This review highlighted a potential role of butyrate presence in the digesta of distinct GIT segments in triggering specific effects. An in vitro model was developed to compare the release profile of commercially available and experimental butyrate additives (Chapter 3). Based on the outcome of this in vitro screening, several additives were included in two in vivo trials (Chapters 4 and 7). Samples collected during these two trials allowed detailed investigation of the effect of butyrate on digestive processes (Chapter 4), energy metabolism and endocrine regulation of the gut (Chapter 5), microbiota composition (Chapter 6) and immune responses (Chapter 6 and 7) of broiler chickens. In this final Chapter, the results of the in vitro and in vivo studies are integrated and discussed. 
1815: Discovery 
Neutral 
1970s: Chemo-therapeutic agent 
Necessary Evil 
1960s: Toxic pollutant 
Evil 
2018: Unique and beneficial 
Stinky Miracle 
Figure 2. Depiction of the perception of butyrate by scientists from its discovery to the present 
General discussion 
151  
 From the literature review (Chapter 2), a popular view among scientists emerged. Several observations reported in the present Thesis, however, do not agree with this popular view that depicts butyrate as a molecule that exerts systematically beneficial effects on growth performance (e.g. observed reduction in amino acid digestibility in Chapter 4) and the health status of birds (e.g. observed dysbiosis that resulted in inflammation in Chapter 6). Hence, in this final Chapter I will revisit the popular view that portrays butyrate as a molecule having unique and beneficial properties in the gut of poultry. In the first part of the discussion, I have assessed the uniqueness of the multifarious effect of butyrate by comparing its physiological effects to those elicited by other SCFA and by describing the microbial fermentation pathways that contribute to the production of SCFA including butyrate. In the second part, I have discussed whether the effects elicited by butyrate are beneficial for the health and growth performance of broilers.   
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PART I:  
EXPLAINING THE MULTIFARIOUS EFFECTS OF BUTYRATE 
Main messages: 
• Acetate and propionate may replicate the physiological effects of butyrate with various degrees of efficacy 
• Conditions that contribute to butyrate production can be either positive or negative to the host, depending on the location and substrate considered 
• Host-microbiota crosstalk is more likely to be driven by the integration of various signals (e.g. short chain fatty acids, pathogen associated molecular patterns, biogenic amines, hydrogen sulphide) than being governed uniquely by microbial butyrate production 
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INTRODUCTION At the beginning of this millennium, Gibson (2000) stated “A vexing question has 
been how this small molecule exerts such a wide array of effects”. Concerted efforts of different research teams addressed over the subsequent years this question and have unravelled many mechanisms underlying the multifarious effects of butyrate on prokaryotic and eukaryotic cells (For review in poultry see Ahsan et al., 2016; Moquet 
et al., 2016 and in mammals Guilloteau et al., 2010a; Meijer et al., 2010; Astbury and Corfe, 2012). A logical follow-up question would be: “Why does this small molecule exerts 
such widespread effects?”  
 Intricate relationships exist between the host and the microbial meta-communities residing in distinct GIT segments. Such relationships can be characterized by the classical ecological concepts, e.g. parasitism, commensalism or mutualism (Ley et al., 2006). The diversity of relationships that may occur between the host and the microorganisms populating distinct segments of the GIT bears significant implications for poultry health and energy harvest (Gabriel et al., 2006). Positive and negative feedback loops exist between the host and the microbial meta-communities populating distinct GIT segments. The succession of feedback loops constitutes a crosstalk that favours the onset of a healthy steady state (Lozupone et al., 2012). At a mucosal level, host-microbiota crosstalk is mediated by pathogen-associated molecular patterns (PAMP) and by microbial metabolites (e.g. SCFA; Wells et al., 2011).   In nature, butyrate is produced in the GIT of vertebrates as a metabolite by the microbiota (Guilloteau et al., 2010a) One could argue that the multifarious effects exerted by the presence of butyrate in the GIT indicates that this molecule has been selected through evolutionary processes as a key mediator of host-microbiota crosstalk. This theory would require three pieces of empirical evidence:  (1)  Proposed mechanisms mediating host responses to butyrate presence have to be butyrate-specific or, at least, butyrate should be the most potent trigger when compared to other SCFA (2) Microbial butyrate production needs to reflect the presence and activities of specific microbial meta-communities that are of evolutionary interest for the host (i.e. influence reproductive fitness or survival) (3) Host’s responses to butyrate presence have to be coherent with the microbial meta-community that contributed to butyrate production (i.e. host’s responses to butyrate-feedback should be meaningful)  Due to a dearth of avian research covering such fundamental issues, this section will focus on work conducted on more thoroughly investigated mammal species such as pigs, mice and humans. As a consequence, the validity of argument extrapolation from mammals to avian species has also to be addressed.  
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ASSESSING THE SPECIFICITY OF BUTYRATE-INDUCED HOST RESPONSES 
Epigenetic effects Epigenetic effects of butyrate are mediated by its histone deacetylase (HDAC) inhibitory properties, as demonstrated in human cell cultures (Riggs et al., 1977; Sealy and Chalkley, 1978). Butyrate is the most potent HDAC inhibitor among SCFA, followed by propionate and then acetate as assessed with human cell cultures (Cousens et al., 1978; Sealy and Chalkley, 1978; Waldecker et al., 2008). Little research has been conducted to compare the respective merits of each SCFA in modulating gene expression. HDAC classes that are inhibited by acetate and propionate are, to the best of my knowledge, unknown. Butyrate starts to act as an HDAC inhibitor when present at the 0.01 mM concentration (Cousens et al., 1978). This concentration is in the range of those observed for intracellular butyrate across GIT segments of broilers (Chapter 5). 
Anti-inflammatory properties The anti-inflammatory effect of butyrate has been extensively studied over the past decades in a variety of animal species including humans (Segain et al., 2000), pigs (Grilli 
et al., 2016), mice (Jiminez et al., 2017) and chickens (Li et al., 2015; Bortoluzzi et al., 2017). Much less is known, however, about the anti-inflammatory properties of acetate and propionate. Butyrate’s anti-inflammatory properties are, among others, mediated 
by its inhibitory effect on the cytoplasmic IκB kinase enzyme that results in a reduced 
nuclear factor κB (NF-κB) pathway activity (Segain et al., 2000; Yin et al., 2001; Luhrs 
et al., 2002). Propionate has also been reported to exert similar effects (Zapolska-Downar and Naruszewicz, 2009). The potency of SCFA to inhibit NF-κB pathway of murine colon cells in vitro is as follows: butyrate > propionate > acetate (Tedelind et al., 2007). The half maximal effective concentration of butyrate to inhibit NF-κB activation is 0.06 mM (Tedelind et al., 2007). This concentration is in the range of those observed for intracellular butyrate across GIT segments of broilers (Chapter 5).  
Free fatty acid receptors activation Free fatty acid receptors (FFAR) 2 and 3, respectively, were referred to as G-protein coupled receptor (GPR) 43 and 41 up until 2003 (Kaji et al., 2014). Several attempts have been made to compare, on a molar basis, the capacity of SCFA to activate FFAR2 and FFAR3. It was concluded that for FFAR2 the order of activation is: acetate = propionate > butyrate while that of FFAR3 it is: propionate > butyrate > acetate (Brown 
et al., 2003; Le Poul et al., 2003). However, Kaji and coworkers (2014) also suggested that ligand specificity may vary across species for both FFAR2 and FFAR3. The G-protein coupled receptor GPR109a is known to be activated by butyrate (Singh et al., 2014) but, to the best of my knowledge, it is unknown whether GPR109a can also be activated by other SCFA. Only FFAR2 has been identified in the chicken genome and its expression seems to be reduced by the presence of butyrate in gastric and enteric digesta (Chapter 6).    
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G-cells secretory activities Gastrin is a peptide hormone produced by G-cells. In chickens, these cells are mostly located in the pyloric region and to a lower extent in the duodenum (Rawdon and Andrew, 1999). Gastrin release is triggered by dietary compounds such as calcium, amino acids or amines (Dockray et al., 2001) but not by SCFA despite the presence of FFAR3 in 90% of the G-cells of mice (Nohr et al., 2013). This confirms that expression of FFAR2 and FFAR3 does not necessarily indicate a cellular response to SCFA sensing (Liou, 2013). Nonetheless, dietary supplementation with butyrate (3 g/kg DM) has been reported to increase the expression of gastrin mRNA in the pyloric mucosa of weaned piglets (Mazzoni et al., 2008). It has been postulated that the autonomic nervous system can transmit a butyrate-induced nervous signal from the hindgut to the central nervous system, resulting in the release of trophic signals such as gastrin (Sakata, 1989; Reilly 
et al., 1995). This mechanism has been scarcely investigated. It is hitherto impossible to state if it is butyrate-specific or not. In the present thesis, there was no evidence at the transcriptional level that butyrate presence in the gastric region affected the secretory activity of G-cells (Chapter 5) 
I-cells secretory activities Cholecystokinin (CCK) is a peptide hormone produced by I-cells. In chickens, I-cells are located in the proximal half of the small intestine (Rawdon and Andrew, 1999). Up until the end of the second millennium, SCFA were thought to be unable to trigger CCK release (Liddle, 1997; McLaughlin et al., 1998). This view was challenged by reports indicating that supplementing diets with unprotected butyrate (3 g/kg, as fed basis) increased circulatory CCK levels in piglets (Kotunia et al., 2004) and calves (Guilloteau 
et al., 2010b). Pancreatic enzyme outflow can be considered as indicative of circulatory CCK level. Such outflow has been shown to be positively influenced by ileal infusion of butyrate and propionate (5 mM and 7.5 mM, respectively) in growing pigs (Sileikiene 
et al., 2005). Interestingly, the outflow was unchanged compared to a control when butyrate concentration was increased to 10 mM or even significantly reduced when priopionate was infused at 15 mM. Finally, pancreatic enzyme outflow was decreased by acetate (85 and 170 mM). Such effects could be attributed to the presence of FFAR3 in I-cells (Nohr et al., 2013). Collectively, these results indicate that butyrate is not the sole SCFA having effect on CCK release and that release location, dose and species should be taken into consideration when discussing this effect. We observed that, in broilers, the presence of butyrate in the digesta of the small intestine increased the expression of the CCK prohormone (Chapter 5) 
L-cells secretory activities 
Localization of L-cells. Peptide YY (PYY) and glucagon-like peptides (GLP) are peptide hormones produced by L-cells. In mammals, L-cells are localized in the distal ileum and in the colon (Liou, 2013; Kaji et al., 2014). The distribution of L-cells seems to be different in chickens. In birds, L-cells are equally present in the duodenum and ileum, as indicated by PYY positive cell counts (Rawdon and Andrew, 1999). Both FFAR2 and FFAR3 are expressed in L-cells (Liou, 2013). Recent evidence supports a role of FFAR2 sensing for GLP-1 release (Lin et al., 2012; Psichas et al., 2015) whilst acetate did not significantly increase PYY. Similarly, ileal SCFA infusion did not change 
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PYY levels in portal blood whereas colonic infusion resulted in a significant increase in PYY release (Fu-Cheng et al., 1995). Collectively, these results indicate that the small intestine reacts indistinctly to abnormal elevated concentrations of propionate or butyrate in rats. In contrast, physiological concentrations of these SCFAs in the colon can induce PYY release, with a markedly higher release observed for butyrate.   
GLP-1 release. Concerning GLP-1, a release was observed in mice after oral dosing with butyrate (400 mg/kg BW) but an identical dose of propionate did not elicit any endocrine change (Lin et al., 2012). Colonic administration of propionate (180 mmol/min with a total of 0.45 mmol) resulted in a significant release of GLP-1 in rats. In contrast with these results, acetate, propionate and butyrate infusion in an isolated rat colon at physiological (5 mM) and supraphysiological concentrations (20 and 100 mM), did not increase GLP-1 in the portal blood (Plaisancie et al., 1995). Factors such as dose, administration route and specie-specific ligand affinity may, therefore, have a confounding influence on the observed effects of SCFA presence in the hindgut on GLP-1 release. In the present thesis, we did not find any evidence at the transcriptional level that butyrate presence in the small intestine and colon affected the secretion of GLP-1 (Chapter 5)  FFAR3 sensing mediates PYY release (Liou, 2013). It is, therefore, likely that butyrate can trigger PYY and GLP-1 release. Ligand affinity of FFAR also indicates that this capacity is not butyrate-specific, with other SCFA being more potent triggers (e.g. propionate for PYY release through FFAR3) (Brown et al., 2003). The body of published evidences illustrates the difficulty to generalize the effect of butyrate sensing on GLP-1 and PYY release.  
PYY release. When considered individually, the SCFA concentration seldom reaches the 1-5 mM range in the in the digesta of the small intestine. When infused in this range in the ileum of rats, SCFA failed to induce an increase in PYY release. Higher concentrations of propionate and butyrate (20 mM) induce a transient release of PYY in portal blood (Dumoulin et al., 1998). Provision of butyrate (0.5 to 5 mM) to the isolated colon of rats and rabbits increases the release of PYY in the portal blood in a dose-dependent manner (Longo et al., 1991; Plaisancie et al., 1996). Propionate was reported to be less potent in eliciting a PYY release than butyrate whilst acetate did not significantly increase PYY. Similarly, ileal SCFA infusion did not change PYY levels in portal blood whereas colonic infusion resulted in a significant increase in PYY release (Fu-Cheng et al., 1995). Collectively, these results indicate that the small intestine reacts indistinctly to abnormal elevated concentrations of propionate or butyrate in rats. In contrast, physiological concentrations of these SCFA in the colon can induce PYY release, with a markedly higher release observed for butyrate.   
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Conclusion: Acetate and propionate may replicate the effect of butyrate with 
various degrees of efficacy 
Table 1. Potency of different short chain fatty acids to elicit effects observed when butyrate is present in the digestive tract of mammals Butyrate-induced effect Proposed mechanism1 Butyrate specificity SCFA potency ranking2 Changes in gene expression HDAC inhibition No B>P>A Reduced inflammation NF-κB inhibition No B>P>A G-cells activity  Gastrin secretion: Hindgut derived mechanisms mediated by FFAR-sensing and nervous system Unclear Unknown I-cells activity CCK secretion: Stomach-derived mechanism mediated by nervous or peptides intermediaries Unclear Unknown L-cells activity PYY secretion: FFAR3 sensing No P>B>A; possibly specie-dependent GLP-1 secretion: FFAR2 sensing No A=P>B; possibly specie-dependent 
1HDAC: Histone deacetylase, NF-κB: Nuclear factor κB, FFAR: Free fatty acid receptor, CCK: Cholecystokinin, 
PYY: Peptide YY, GLP-1: Glucagon like peptide 1. 
2B: Butyrate, P: Propionate, A: Acetate.  It can be concluded that none of the butyrate-induced effects are proven to be a unique feature of butyrate (Table 1). Changes in gene expression and anti-inflammatory effects, however, do seem to be more marked with butyrate than with propionate and acetate. Underlying mechanisms mediating the release of gastrin and CCK are unclear. It is, therefore, impossible to determine if such effects are butyrate-specific. On the other hand, release of GLP-1 and PYY hormones is mediated by FFAR2 and 3 triggering, respectively. Such receptors can be activated by other SCFA, with a SCFA potency ranking that could be specie-specific. This indicates that GLP-1 and PYY responses can be triggered by other SCFA than butyrate. As a consequence, most of the effects of butyrate on eukaryotic cells can be replicated with other SCFA as well, with various degrees of efficacy. 
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MICROBIAL PATHWAYS LEADING TO THE PRODUCTION OF BUTYRATE Fermentation is the metabolic processing of different substrates, e.g. fibres or proteins, by microbial enzymes. Fermentation results in the production of various metabolites, including butyrate. If butyrate has been selected by evolutionary processes as a key mediator of intestinal host-microbiota crosstalk, then butyrate production must reflect microbiota conditions that are of evolutionary interest to the host.  
Carbohydrate fermentation Carbohydrates of dietary and non-dietary origin can be fermented in the GIT (Figure 3). During carbohydrate fermentation, primary reactions consume oxidized pyridine nucleotides (i.e. soluble coenzymes: NAD+, NADP+) and produce substantial amounts of their reduced equivalents (i.e. NADH, NADPH). The progression of carbohydrate fermentation is, therefore, partly conditioned by the replenishment of oxidized pyridine nucleotides pools (Cummings and Branch, 1986), which is predominantly achieved by hydrogen (H2) formation (Macfarlane and Macfarlane, 2003). Due to thermodynamic constrains, H2 formation is facilitated by low hydrogen partial pressure (den Besten et al., 2013). Hence, H2 removal is critical for the maintenance of the redox state of the pyridine nucleotides pool and, consequently, for the progression of carbohydrate fermentation processes.  H2 removal can be achieved by hydrogenotrophic acetogenesis, methanogenesis or dissimilatory sulphate reduction (Gibson et al., 1993;; Sahakian et al., 2010; Louis et al., 2014; Figure 3). The relative importance of these pathways is influenced by various factors, including thermodynamic properties (Sahakian et al., 2010), pH (Gibson et al., 1990), passage rate (Sahakian et al., 2010) or the presence of chemical compounds other than H2 such as sulphur amino acids (Takahashi et al., 1997) or lactate (Dar et al., 2008). In birds, the relative importance of dissimilatory sulphate reduction and acetogenesis in cecal hydrogen removal seems to be increased when butyrate is present in the gastric region (Chapter 6).  When not restrained by H2 partial pressure, primary fibre fermentation results in the formation of large amounts of phosphoenol pyruvate, which is converted to pyruvate (Figure 3). A large proportion of pyruvate is converted to acetyl-CoA in a reaction that also generates H2 and CO2 (den Besten et al., 2013). Acetyl-CoA is a precursor used in butyrate synthesis, leading to the production of butyryl-CoA in a four 
step reaction that is remarkably similar to the β-oxidation of fatty acids observed in eukaryotes (Bennett and Rudolph, 1995). This pathway, referred to as acetyl-CoA pathway, is the most prevalent in the human hindgut (Vital et al., 2014). Final conversion of butyryl-CoA to butyrate can be achieved through three distinct pathways. In the classical pathway, butyryl-CoA is converted to CoASH, butyrate and ATP (den Besten et al., 2013). Alternatively, butyryl-CoA can be converted to butyryl-phosphate and then to butyrate in a pathway that seems restricted to a few bacterial species (Louis 
et al., 2014). Finally, the butyrogenic cross-feeding pathway involves the condensation of butyryl-CoA with exogenous acetate to form butyrate and acetyl-CoA. The butyrogenic cross-feeding pathway seems to predominate over other pathways in the conversion of butyryl-CoA to butyrate in the human hindgut (Duncan et al., 2002). 
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Summarizing, butyrate originates mostly from the fermentation of carbohydrates by commensal gut bacteria present in the colon and ceca of non-ruminant species (e.g. 
Faecalibacterium, Roseburia, Butyrivibrio; Anand et al., 2016). This production involves bacterial cross-feeding and requires, therefore, a diverse and stable microbiota (Onrust 
et al., 2015). In poultry, bacterial diversity is lower in the crop, gastric region and small intestine than in more distal GIT segments (Pedroso and Lee, 2014). As a consequence, digesta butyrate concentration is very low in the proximal GIT of broilers that are not supplemented with dietary butyrate (Chapters 4 and 7). In addition to butyrate, carbohydrate fermentation can also generate other SCFA such as acetate and propionate (Figure 3). 
Amino acid fermentation Next to carbohydrate fermentation, amino acid (AA) fermentation can also result in the production of butyrate. The production of butyrate from AA fermentation requires additional pathways that are coined after their respective precursors, namely glutarate, lysine and succinate/4-aminobutyrate (Herrmann et al., 2008). Each pathway consists in a specific set of enzymes that catalyse the transformation of their respective substrate to crotonyl-CoA. Crotonyl-CoA is then converted to butyryl-CoA (Figure 3). Glutarate is produced during the catabolism of several AA including lysine and tryptophan while succinate originates from the fermentation other AA such as arginine (Anand et al., 2016). When originating from AA fermentation, the production of butyrate is accompanied by the release of potentially harmful metabolites such as ammonia or biogenic amines (Anand et al., 2016). Hence, butyrate may occasionally originate from the fermentation of essential amino acids by butyrogenic gut pathogens (e.g. Fusobacterium; Anand et al., 2016). Butyrate production is, therefore, not an absolute indicator of gut health. Ratios between different microbial metabolites may provide more relevant information on the potential effect of microbiota activities on host health. A beneficial microbiota may, for instance, be indicated by a high butyrate production and, concomitantly, low ammonia and biogenic amines production.   
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COHERENCE OF HOST RESPONSES TO GUT CONDITIONS THAT CONTRIBUTE TO BUTYRATE 
PRODUCTION 
Butyrate signalling in the proximal GIT of broilers Two separate situations should be considered when discussing the relevance of butyrate production as an indicator of microbiota activities to the host. Butyrate is present at very low concentrations in the digesta of the crop, gastric region and small intestine of birds that are not supplemented with dietary butyrate (Chapters 4 and 7). Diverse and stable microbiota activities are required to produce butyrate (Onrust et al., 2015; Figure 3). Hence, butyrate production in proximal GIT segments such as the crop, gastric region or small intestine of birds may indicate a complex microbiota and, consequently, a competition between the host and local meta-communities of microbiota for the use of digestible carbohydrates and AA, as described in pigs (Gaskins, 2008). The presence of butyrate in such proximal GIT segments signals, therefore, a potential detrimental microbiota overgrowth. The host increases, in response to such signalling, intestinal retention time (Chapter 4), pepsin output (Chapter 4; Qaisrani et 
al., 2014)), host defence peptides gene expression (Chapter 6; Sunkara et al., 2011; Sunkara et al., 2014), mucus gene expression (Chapter 6) and, sometimes villus length (for review, see Chapter 2). The host reduces, at the same time feed intake (Chapters 4 and 7) and experiences inflammation (Chapter 6). Such physiological changes evoke an attempt to improve digestive efficiency (retention time, gut morphology and pepsin secretion) while trying to deal with microbial overgrowth using local and systemic mechanisms (local mechanisms: increased mucus and host defence peptides; systemic mechanisms: reduced feed intake, recruitment of leukocytes as a result of inflammatory chemotaxis). Overall, physiological changes induced by the presence of butyrate in the proximal GIT may be positive for growth performance of poultry (Chapter 2) but they originate, nonetheless, from the perception of a negative signal by the host. The dietary interventions reported in Chapter 4 resulted in changes in digesta butyrate concentration in the gastric region, duodenum and ileum that were sufficient to reduce the expression of levels of FFAR2 (Chapter 5). This may indicate that the signalling was so strong that expression of FFAR2 receptor in gut cells was reduced, as is seen for instance with insulin resistance in the context of type II diabetes (Krupp and Lane, 1981). The tolerance threshold to increases in digesta butyrate concentration may, therefore, be low in the crop, gastric region and small intestine of poultry. Like butyrate, propionate is scarcely present in the digesta of the proximal GIT of poultry (Chapters 4 and 7) and requires a diversified and stable microbiota to be produced (Figure 5). In rats, L-cells seems to react indistinctly to the presence of butyrate and propionate in the digesta of the small intestine (Dumoulin et al., 1998). This may indicate that, in the proximal GIT of poultry, propionate could induce similar responses as butyrate.  
Butyrate signalling in the distal GIT of broilers In birds, the ceca and colon are major fermentation sites (Józefiak et al., 2004) Hence, butyrate concentration is much higher in the colon and ceca than in more proximal GIT segments (Control groups in Chapters 4 and 7). Cecal and colonic butyrate production results mostly from the fermentation of undigested carbohydrates by commensal gut bacteria ( Onrust et al., 2015; Anand et al., 2016). Thus, butyrate can be considered to be a double messenger molecule. Not only is it indicative for microbial 
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activities that can be detrimental to the host when present in the crop, gastric region and small intestine of birds, but when present in the colon and ceca, butyrate can be a signalling molecule for a cooperative relationship between the host and the microbiota. Butyrate may, occasionally, also originate from the fermentation in the distal GIT of nutrients that are critical for growth of the host (e.g. essential AA or starch; Anand et 
al., 2016). Butyrate signalling in the distal GIT of poultry is, therefore, nonspecific. Such signalling results in increased intestinal retention time (Chapter 4), possibly due to changes in L-cell secretory activities (Onrust et al., 2015). Such response does not seem to induce any inflammation (Chapter 6). Hence, the distal GIT seems to tolerate higher butyrate levels than the proximal GIT. It is also likely that, in the distal GIT, detrimental shifts in microbiota activity are not only signalled by changes in SCFA levels, but also by concomitant increases in other metabolites such as biogenic amines or ammonia. 
Butyrate is not the only metabolite 
mediating host-microbiota crosstalk Our current knowledge indicates that, in mammals, acetate and propionate may replicate the effect of butyrate with various degrees of efficacy. In other words, butyrate does not seem to trigger unique responses in the gut of mammals. The conditions that contribute to butyrate production in the hindgut can be either positive or negative for the host, depending on the location and substrate considered. It is, therefore, unlikely that butyrate is a unique compound which has been selected through evolutionary processes to be a central molecule for host-microbiota crosstalk. Such crosstalk is more likely to be driven by the integration of various signals (e.g. SCFA, PAMP, biogenic amines, hydrogen sulphide, etc). It is known that birds differ from other monogastric farm animals such as pigs in many aspects of their physiology (Textbox 2). The absence of a clear host-microbiota crosstalk based solely on the existence butyrate in mammals does not incline me to think that such relationship exists in poultry.    
Textbox 2. SPECIFICITIES OF CHICKENS 
COMPARED TO PIGS 
Chickens are not mice with feathers  J. Kaufman 
Digestive physiology Existence of reverse peristalsis (reflux)  Presence of a crop and muscular stomach (gizzard)  Transport of lipids to the liver by portomicrons  Short transit time  
Microbiota  Paired ceca as primary fermentation organs   Very short colon  Lactic fermentation in the crop  
Immune responses Higher resistance to the toxic effects of LPS compared to mammals 
 
In ovo transfer of maternal IgG, IgM and IgA   B cells maturation occurs in the bursa of Fabricius  Existence of several cytokines still controversial   No neutrophils but presence of heterophils  Chickens lack encapsulated lymph nodes but have lymphoid nodules along the course of lymphatics  Very confined period of developmental oral  tolerance (5-10 d post-hatch) 
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PART II:  
ASSESSING THE BENEFITS OF BUTYRATE 
Main messages: 
• Presence of butyrate in the gastric region and small intestine can induce dysbiosis and inflammation 
• Immunomodulatory effects of butyrate are inconsistent and their relevance in improving the health performance of broilers is conditioned by the type of challenge encountered 
• Butyrate sensing induces hormonal changes that can increase the digestibility of amino acids, fat and energy while reducing feed intake 
• Butyrate may affect calcium and phosphorus metabolism in broilers 
• Intracellular butyrate concentration is tightly regulated by butyrate transport and oxidation, possibly to avoid cytotoxic effects 
• Endogenous production of butyrate is a major confounding factor in studying the effects of exogenous butyrate supplementation 
• The industry could consider supplementing broiler diets with fat coated butyrate in the starter phase and with butyrogenic fibres in the grower/finisher phases 
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INVESTIGATING HOST RESPONSES TO BUTYRATE PRESENCE IN DIFFERENT 
GIT SEGMENTS 
How to discriminate between endogenous and exogenous butyrate? The signalling effect of butyrate may vary depending on the GIT segment considered (Chapter 2). Feeding butyrate additives with markedly different release kinetics may allow the study of such location effects in poultry. Release profiles of five experimental butyrate formulations and of five commercially available butyrate additives were evaluated in a novel in vitro method in Chapter 3. Changes in digesta butyrate concentration along the GIT of broilers reported in Chapter 4 were consistent with the 
in vitro release patterns of the butyrate additives used. Changes in digesta butyrate concentration reported in Chapter 7, however, were in constrat with the in vitro release patterns of the additives butyrate used. Such differences may be attributable to differences in ingredient composition between the basal diets used in the first and second in vivo experiment and in particular the fibre composition and levels (Chapter 7). Such differences may have resulted in distinct endogenous butyrate production patterns across studies . The method used to determine butyrate release patterns in 
vivo did not allow discrimination among exogenous (dietary) and endogenous (microbial) butyrate. Such limitation may be overcome by labelling exogenous butyrate.  Due to the approach chosen, it is unclear if the responses described in Chapter 4 to 7 are triggered by exogenous or endogenous butyrate. Hence, results described in the present Thesis are the results of an overall “butyrate location effect” and not a precise “dieterary butyrate release location effect” as initially intended (Chapters 1 and 2). Although labelling butyrate with stable isotopes has been used by others (Smith et al., 2012; van den Borne et al., 2015) in order to characterize the release pattern of butyrate additives, two assumptions are made when the appearance of stable isotopes in the breath is used as a proxy of butyrate release time: (1) Butyrate is absorbed by the gut immediately upon release (2) Butyrate is oxidized immediately upon absorption Changes in digesta butyrate concentration reported in Chapters 4 and 7 indicate that a delay may exist between butyrate release and absorption. Results reported in Chapter 5 indicate that assumption 2 may be invalid. As such, the use of stable isotopes in the breath to study dietary butyrate release location in the avian GIT has inherent limitations.  
Butyrate concentration and butyrate fluxes Figure 4 illustrates the fluxes of butyrate occurring in the digesta, gut wall and liver of broilers. Digesta butyrate concentration is the net result of the production, release and absorption of butyrate in the lumen of the gut. Digesta butyrate concentration is, therefore, an incorrect estimate of endogenous (microbial) production (Montoya et al., 2017) and, by extension, of exogenous (dietary) butyrate release.   
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 It is likely that the pleiotropic effects of butyrate on digestive functions, microbiota composition and immune responses of broilers are more influenced by butyrate fluxes in the digesta (i.e. production, release and absorption) than by the absolute digesta butyrate concentration. Digesta butyrate concentration was, nonetheless, used in Chapters 4 to 7 as an explanatory variable to interpret the observed effects of butyrate in poultry. The validity of the latter can be questioned.  
REGULATION OF DIGESTIVE PROCESSES BY BUTYRATE 
Hormones involved in the regulatory effect of butyrate on digestive functions  Presence of butyrate in various GIT segments is thought to modulate the secretion of numerous gut hormones, e.g. gastrin, CCK, PYY and GLP (Chapter 2). The results in Chapter 4 indicate that the presence of butyrate in the colon and ileum of broilers increases intestinal digesta retention time. Qaisrani and coworkers (2014) reported that fat coated butyrate increased the proteolytic activity of the proventriculus. Here similar effects were observed when butyrate was present in the gastric region (Chapter 4). Such changes evoke shifts in the secretory activities of G and L cells, which could not be demonstrated at the transcriptional level in the present Thesis (Chapter 6). It is known in mammals that butyrate presence in the colon increases gastrin secretion (Sakata, 1989). Such indirect effect was not evaluated in the present Thesis and may explain the results reported by Qaisrani and coworkers (2014). Finally, the presence of butyrate in the duodenum increased the expression of the CCK prohormone (Chapter 5).   Cellular mechanisms that may explain the effect of butyrate on the secretion of regulatory peptides in the gut have been addressed above in this Chapter. These mechanisms involve the sensing of butyrate by FFAR by enteric nerves or by enteroendocrine cells. Butyrate was found to decrease the expression of FFAR2 all measured GIT segments except the colon (Chapter 6). As mentioned earlier, this may indicate that butyrate signalling was too strong due to high concentrations. Hence, further studies should inverstigate different butyrate inclusion rates to gain insight into possible dose-response effects of butyrate on regulatory peptides of the poultry gut. 
Figure 4. Schematic representation of butyrate fluxes occurring in broilers from the digesta to the liver 
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Effects on the digestibility of AA, fat and energy The apparent ileal digestibility of methionine and histidine tended to be improved when butyrate was present in the colon and ceca, possibly as a results of the putative activation of L-cells (Chapter 4). The influence of butyrate on CCK prohormone secretion indicates a change in I cell activity (Chapter 5). Increased CCK secretion may result in increased bile salt and pancreatic enzymes outputs (Denbow, 2015). This may explain why fat coated butyrate and tributyrin, two butyrate additives that extend the activity of butyrate beyond the gastric region, have been reported to increase the apparent metabolisable energy of broiler diets as well as fat digestibility (Smilukowska 
et al., 2007; Kaczmarek et al., 2016; Liu et al., 2017). Such effects can be considered as positive for the growth performance of broilers. Butyrate may, in addition, influence the digestibility and metabolism of calcium (Ca) and phosphorus (P), as discussed below.  
Effects on Ca and P metabolism Evidence describing the influence of intestinal microbiota activity, including butyrate production on Ca and P mammalian metabolism have been reviewed to more fully understand the origin of postmenopausal osteoporosis (Xu et al., 2017). The intestinal microbiota is thought to have a threefold effect on Ca/P metabolism in mammals. Firstly, SCFA have been shown to induce the expression of different Ca transporters, e.g. TRPV6 or CALB1 (Fukushima et al., 2009; Fukushima 
et al., 2012) in vitro and in vivo. This may explain why feeding various fermentable fibre sources influences Ca absorption in rats (Coudray et al., 2003; Kruger et al., 2003; Demigne et al., 2008) and humans (Teramoto et al., 2006; Whisner et al., 2013). Secondly, butyrate is known to influence the expression of tight junctions proteins (Peng et al., 2009). This may influence the paracellular absorption of Ca and P (Xu et al., 2017). Finally, intestinal butyrate inhibits the release of INF-γ and TNF-α by leukocytes after Staphylococcus 
aureus (Saemann et al., 2000) and lipopolysaccharide (LPS) stimulation (Nancey et al., 2002). Both INF-γ and TNF-α are known to modulate the activity of osteoblasts and osteoclasts, and consequently, bone mass and micro-architecture (Kobayashi et al., 2000; Lam et 
al., 2000; Duque et al., 2011). Microbiota activity can, therefore, affect Ca/P metabolism in mammals (Xu et al., 2017). 
Textbox 3. CALCIUM (Ca) AND 
PHOSPHORUS (P) ABSORPTION IN THE 
GUT OF BROILERS  
Model depicting Ca and P absorption in 
broiler chickens.  Transcellular Ca absorption: Uptake is mediated by TRPV6, intracellular transport by CALB1 and transport across the basolateral membrane by PMCA1. Transcellular P absorption: uptake is mediated by SLC34 A1, A2 and A3 family members. Paracellular absorption may occur depending on the integrity of the gut.  
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Phosphorus utilisation is thought to be important for the sustainability of poultry production because excessive P excretion leads to eutrophication (Valable et al., 2017). In addition, impairments of Ca/P metabolism increases the occurrence of skeletal abnormalities (Proszkowiec-Weglarz and Angel, 2013). In broilers, Ca and P absorption is the result of transcellular and paracellular mechanisms (Textbox 3). The expression of Ca and P transporters in the GIT of poultry is modulated by the dietary levels of digestible Ca and P (e.g. Centeno et al., 2004; Ashwell and Angel, 2010). Such mechanisms have been used to improve Ca/P efficiency of broilers through depletion/repletion strategies (Yan et al., 2005). The results of such strategies, are however, difficult to replicate (van Krimpen et al., 2017).  Levels of SCFA in the gut may explain partly such inconsistencies. As seen in chapter 6, levels of butyrate can affect the expression of TJ proteins in the gut of poultry. This, in turn, may affect the paracellular absorption of Ca and P. Butyrate modifies, in addition, the cytokine response of avian macrophages after LPS challenge and, in particular, INF-γ release (Zhou et al., 2014). This may influence the activity of osteoclasts and osteoblasts and, consequently, bone mass and microarchitecture. Finally, the presence of butyrate in the GIT of poultry seems to influence on the expression of Ca and P transporters in a location-dependent manner (Table 2, using the same approach as Table 3 in Chapter 5).   
Table 2. Effect of dietary treatments1 on the genetic expression of calcium and phosphorus transporters in 
different intestinal tract segments of broilers at 21-22 d of age 
  Average gene expression2 
Location TRPV6 CALB1 PMCA1 SLC34A1 SLC34A2 SLC34A3 
Duodenum       CTR 71.1 73.6 95.8 100.0 89.1 80.0 TB 37.4 100.0 100.0 69.8 100.0 77.9 
P-value 0.27 0.033 0.318 0.114 0.215 0.386 
Ileum       CTR 11.80 18.70 36.40 45.80 10.60 68.60 FCB 24.40 14.50 31.10 45.30 8.90 53.00 
P-value 0.072 0.135 0.026 0.318 0.186 0.159 
Colon       CTR 27.20 0.40 18.60 52.70 0.60 82.10 FCB 16.20 0.20 20.50 61.80 0.50 100.00 
P-value 0.181 0.500 0.343 0.095 0.282 0.112 1Dietary treatments groups: CTR (no dietary butyrate); TB (butyrate radical provided as tributyrin); FCB (butyrate radical provided as fat-coated butyrate). Butyrate was provided at 1 g/kg as in basis. Values are means of 8 birds per treatment. 2Arbitrary units. Quantitative mRNA measurement was performed by establishing a linear calibration using 10-fold serial dilutions of cDNA templates. Data were standardized using IPO8 as housekeeping gene. For each gene, the highest average gene expression across location and treatments was set to 100. 
  The link between Ca/P and microbiota has already been studied in broilers, but, as far as I know, it was always approached on the direction of the effect of Ca, P and phytase on microbiota activity (e.g. Ptak et al., 2015; Witzig et al., 2015; Borda-Molina 
et al., 2016). I suggest that the relationship is actually bidirectional. In other words, luminal butyrate, and, more generally, SCFA may influence Ca/P metabolism in broilers and such studies should be conducted to further improve the utilisation of these minerals by poultry.  
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IS IT A TOXIN?: BUTYRATE METABOLISM IN THE GIT OF POULTRY 
Unlike other SCFA, butyrate does not reach peripheral tissues One unexpected result came from the intracellular butyrate data in Chapter 5. Some treatments led to a nearly 10 fold increase in digesta butyrate concentration compared to the control, but intracellular butyrate concentration was not affected and remained low. Iso-valeric and valeric acid are present in much lower concentrations than butyrate in the digesta of poultry. Yet, butyrate was found in the same concentration range as these SCFA in the tissue of the different GIT segment. It was also very clear from observed changes in the transcription of genes involved in SCFA transportation and energy metabolism that butyrate had been absorbed as number were upregulated. In mammals, it is known that butyrate is metabolized in the GIT and liver in such a way that very little of it passes to the peripheral circulation (Astbury and Corfe, 2012). This is in contrast to other SCFA such as acetate and propionate, which may reach the peripheral circulation (Astbury and Corfe, 2012). As shown in Table 3, similar observations can be obtained in broilers (Moquet, unpublished).   
Table 3. Effects of dietary treatments on short chain fatty (SCFA) concentrations in the plasma of the wing 
vein (peripheral blood) of broilers1 at 39 d of age 
  Dietary treatments2 Diet P-value3 
SCFA in mM CTR UP TB FCB WAX CAB Acetate 2.12 2.00 1.89 1.57 2.10 2.05 0.588 Propionate 0.35 0.29 0.26 0.22 0.32 0.34 0.281 
Butyrate 0.01 0.00 0.01 0.01 0.01 0.01 0.717 Iso-butyrate 0.01 0.01 0.01 0.01 0.02 0.01 0.484 Valerate 0.01 0.01 0.01 0.01 0.01 0.01 0.568 Iso-valerate 0.04 0.03 0.03 0.03 0.04 0.03 0.568 
1Birds received at d 21 and 22 post-hatch intratracheal administrations of human serum albumin at the dose 
of 0.5 mg/day.  
2Dietary treatment groups: No butyrate supplementation (CTR) or 1 g butyrate radical per kg diet in the form 
of unprotected butyrate (UP), tributyrin (TB), fat coated butyrate (FCB), wax coated butyrate (WAX) or 
cellulose acetate butyrate (CAB). Values are the average of 10 birds per treatment. 
3Data were analysed using PROC GLM of SAS 9.4.  Two theories can explain these observations: (1) Butyrate is a very valuable energy source that is oxidized in priority over other energy sources (2) Butyrate is a toxin whose concentration is tightly regulated in the body to avoid detrimental effects The first theory may be meaningful in the context of colonocytes. In poultry, dietary lipid, protein and starch is mostly absorbed before the colon (Denbow, 2015). Hence, colonocytes rely to a large extent on SCFA to cover their energy requirements (Roediger, 1982). Cellular energy is derived from the oxidation of SCFA in the mitochondria (Bender, 2014). Mitochondria biogenesis involves the synthesis of hundreds of proteins and is, therefore, an energy-demanding process (Cherry and Piantadosi, 2015). Energy yield increases with the chain length of SCFA (Bender, 2014). Butyrate, being a longer (C4) SCFA than acetate (C2) and propionate (C3), may be oxidized in priority to offer a quicker ‘return on investment’ in the energy homeostasis of colonocytes.  
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This theory does not hold, however, for enterocytes located in the proximal part of the small intestine. These cells have access to other preferred energy sources such as glucose, glutamine or glutamate (Watford et al., 1979). The presence of butyrate in the digesta of the proximal part of the small intestine results in an upregulation of the genes 
involved in glycolysis, indicating that the β-oxidation of lipids, including butyrate, was reduced (Chapter 5). Hence, butyrate cannot be considered a valuable energy source for the enterocytes located in the proximal part of the small intestine. Yet, intracellular butyrate also remains low in such cells. 
Cytotoxic effects of butyrate  As stated in Chapter 5, the influence of intracellular butyrate regulation on the survival of healthy and cancerous colonocytes is well established. Butyrate may act as a survival factor in healthy colonocytes or as an apoptotic agent in cancerous ones (Luciano et al., 2002). This paradox is explained by differences in energy metabolism existing between differentiated and proliferative cells, e.g. subtypes of cancerous cells and activated immune cells. Because of a limited number of mitochondria, proliferative cells rely on aerobic glycolysis (Textbox 4, Vander Heiden et al., 2009). In addition, proliferative cells use lipids as structural components to build novel cell membranes. Hence, such cells show enhanced lipid biosynthesis (Mashima et al., 2009). Cytosolic 
lipid biosynthesis inhibits mitochondrial β-oxidation to avoid the occurrence of a futile cycle (Bender, 2014).  
Intracellular butyrate concentration is thought to modulate the inhibitory effect of butyrate on histone deacetylase (HDAC) enzyme activity (Astbury and Corfe, 2012). Butyrate seems to exert stronger inhibition of total HDAC activity than other SCFA (Waldecker et al., 2008). Butyrate and its pharmaceutical analogues inhibit specifically class I HDAC enzymes, i.e. HDAC 1-2-3-8 (Fass et al., 2011). Such enzymes play a major role in the regulation of cell survival and proliferation (Licciardi et al., 2011). The inhibitory effect of butyrate (mM range) on class I HDAC enzyme results in cell death in peripheral blood monocytes (Licciardi et al., 2011) and cancer cells (Waldecker et al., 2008).  
Textbox 4. THE WARBURG EFFECT. This mechanism influences cellular energy metabolism in proliferative and differentiated cells and, consequently, intracellular butyrate concentration.  
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Hence, it can be hypothesised that butyrate concentration is tightly regulated in peripheral blood and tissues to avoid cytotoxic effects.   The two theories presented above are not mutually exclusive. Butyrate could be a potent toxic compound for different organs due to its HDAC activity while remaining a valuable energy source for the cells populating the distal GIT of poultry. I think that, in poultry, intracellular butyrate concentration is tightly regulated to prevent adverse effects on host cell liveability. 
Intracellular butyrate concentration is controlled by oxidation in the gut and liver The extent to which butyrate is oxidized in the gut of poultry appears to vary depending on the GIT segment considered (Chapter 5). In addition, the expression of putative butyrate transporters is induced in the proximal GIT while being constitutive in the more distal GIT (Figure 5). Such differences may reflect an evolutionary adaptation. Colonocytes of wild birds are, for instance, more likely to encounter butyrate than duodenal enterocytes due to the fermentation patterns observed in the gut (Pedroso and Lee, 2014). The classical work of Imondi and Bird (1966) indicated, in addition, that cell turnover rate is much lower in the ileum than in the duodenum of chicks. As shown in Textbox 3, high cell proliferation rates hamper butyrate catabolism. Hence, differences in cell turnover rates may also explain partly the differences in butyrate metabolism observed across GIT segments. As indicated in Table 3, butyrate does not pass into the peripheral circulation. The work of Yin and coworkers (2016) indicates that butyrate is oxidized in the liver. As shown in Figure 5, a variable fraction of the absorbed butyrate may escape oxidation in the gut to reach the liver. This transport of butyrate to the liver have significant implications for the carcass quality of broilers.  
 Gastric region Duodenum Jejunum Ileum Colon Uptake Passive Active & induced ? Active & constitutive Active & constitutive Butyrate metabolism Clues of oxidations Not oxidized Clues of oxidation (Yin et al., 2016) Clues of oxidations Clues of oxidations Transport to the liver ++ (?) ++++ (?) ? ++ (?) + (?)  
 
Figure 5. Summary of the sensing, uptake and metabolism. Based on the data presented in Chapter 5 and in Yin et al., (2016)  
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BUTYRATE MAY IMPROVE CARCASS QUALITY BY INDUCING PEROXISOME PROLIFERATOR-
ACTIVATED RECEPTOR-Α EXPRESSION IN THE LIVER Butyrate is known to induce the expression of the peroxisome proliferator-activated receptor-α (PPAR-α) in the murine liver (Weng et al., 2015). Yin and coworkers (2016) supplemented broiler diets with TB, a butyrate glyceride that increases digesta butyrate concentration in the duodenum and jejunum, and reported significant changes in jejunal and hepatic transcriptomes that evoked an increase in PPAR-α activity. Such signalling pathway is known to influence energy homeostasis (Textbox 5). This may explain why butyrate has been reported to improve carcass leanness of broilers fed butyrate glycerides (Bedford et al., 2017a,b) but not an when fed as unprotected salt (Panda et al., 2009).   Underlying mechanisms mediating the positive effect of butyrate on PPAR-α signalling are unclear. It is known that, in mammals, PPAR-α is activated by long chain fatty acids (e.g. palmitic, oleic or linoleic acids; Banner et al., 1993) and by eicosanoids (e.g. prostaglandins; Bishop-Bailey and Wray, 2003). In Chapter 6 it is reported that the presence of butyrate in the duodenum increased the expression of COX2, a prostaglandin forming enzyme. A similar trend was observed in the ileum. In addition and as previously explained, butyrate may enhance fat digestibilty by modulating CCK expression. Such changes may have influenced hepatic PPAR-α activity.  Finally, butyrate is known to activate PPAR-α in the liver of mice as a results of its inhibitory effect on HDAC 3 activity (Li et al., 2012). Hence, the increased carcass leanness observed when birds are fed butyrate glycerides (Bedford et 
al., 2017a,b) may also reflect a direct effect of butyrate on hepatocytes. Physiological effects of PPAR-α signalling go beyond the regulation of energy homeostasis and affect also immune responses (Textbox 5). Hence, this mechanism may also explain partly the immuno-modulatory properties of butyrate in poultry. 
Textbox 5. PEROXISOME PROLIFERATOR-
ACTIVATED RECEPTOR (PPAR) ALPHA SIGNALLING 
IN THE LIVER 
PPAR-α is a nuclear receptor and upon activation, acts as a transcription factor regulating inflammatory responses and energy homeostasis. There are other PPAR family members, namely PPAR-γ and PPAR-β/δ which are characterized by their tissue expression, ligands and target genes (Grygiel-Górniak, 2014).  
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IMMUNO-MODULATORY PROPERTIES OF BUTYRATE 
Modes of action described in mammals  In mammals, butyrate is thought to influence immune responses in different ways (Figure 6). Firstly, the presence of butyrate in the mM range in the culture medium of Caco 2 cells upregulates PPAR-γ expression (Wächtershäuser et al., 2000). It is, however, unclear if the observations made by the latter authors on cancer cell lines can be extrapolated to healthy enterocytes given the metabolic differences between cancerous and healthy cells (Textbox 4).  
Secondly, butyrate down regulates the NF-κB pathway by inhibiting cytoplasmic IκB kinase enzymes activity (Luhrs et al., 2001). Thirdly, the sensing of butyrate and other SCFA by FFAR affects inflammatory responses in the gut (Maslowski et al., 2009). Finally, butyrate can be used as an energy substrate by regulatory T cells (Treg) and alternatively activated (M2) macrophages, but not by other immune cells having a more limited capacity to perform fatty acid oxidation and oxidative phosphorylation (O'Neill 
et al., 2016; Pearce and Pearce, 2013). It is generally accepted that the combined action of butyrate on different gut cells leads to a reduction of gut inflammation (Figure 6; For review, see Meijer et al., 2010; Kim et al., 2014; Corrêa-Oliveira et al., 2016). 
Suggested modes of action in poultry Butyrate has been shown to modulate the expression of pro-inflammatory cytokines IL-1β and IL-6 in chickens in both in vitro (Zhou et al., 2014) and in vivo (Li et al., 2015; Bortoluzzi et al., 2017) experiments. Dietary butyrate supplementation has also been shown to alleviate the negative effects of intraperitoneal injections of the potent NF-κB inducer E. coli LPS on growth of broilers (Zhang et al., 2011). Immunologic stress depresses growth performance of broilers by reducing feed intake, shifting nutrient 
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Figure 6. Immunomodulatory effects of butyrate in the mammalian GIT  
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partitioning away from skeletal muscle deposition and increasing basal metabolic rate (Klasing and Johnstone, 1991). Reduction of immunological stress and, more precisely inflammation, is thought to be one of the mechanisms mediating the positive effect of antibiotic growth promoters on the growth performance of poultry (Roura et al., 1992; Niewold, 2007). In addition, it is thought that a decrease in NF-κB activity shifts adaptive immunity from cell-mediated to humoral responses in birds (Koutsos et al., 2014). This was confirmed by Sikandar (2017) who reported that butyrate improved the specific antibody (SpAb) response of broilers. Hence, published evidence indicates that the immune-modulatory properties of butyrate in mammals can be extrapolated to poultry species. The data reported in Chapter 6 and 7 indicate that the immunomodulatory effects of butyrate are inconsistent in poultry. In contrast data in the literature, in these Chapters it is reported that butyrate may induce bacterial dysbiosis and, hence, increase the intestinal expression of IL-6 (Chapter 6, in agreement with Bortoluzzi et 
al., 2017 and in contrast with Li et al. 2015). In addition, no improvement in specific antibody (SpAb) response was observed when broiler diets were supplemented with butyrate (Chapter 7 in contrast with Sikandar et al., 2017). Finally, dietary butyrate did not alleviate the negative effect of i.p. LPS injection on the growth performance of broilers (Chapter 7, in contrast with Zhang et al., 2011). Possible reasons explaining the discrepancies have been discussed in Chapter 7 and may relate to differences in age and types of challenges used.  It must be stressed that resolving such discrepancies will be a real challenge given the scarcity of resources available to study avian immunology at the protein expression level (Kaiser, 2014), and the ongoing debate concerning the existence in poultry of several genes critical to the understanding of the immuno-modulatory effect of butyrate (Textbox 6). An illustrative example is the paper from Zhang and coworkers (2011), wherein the effect of dietary butyrate supplementation on serum cytokines was evaluated in broilers using commercially available ELISA kits. It appears that such kits are not existent for poultry (Kaiser, 2014; Kaiser and Stäheli, 2014). ELISA kits referenced in the aforementioned paper have been originally designed for use in human and were not referenced by the supplier for chickens (J.F. Bellec, Bio-Techne, Minneapolis, US, personal communication). In addition, one of the cytokines measured by Zhang and workers (2011) was TNF-α, a cytokine whose existence is still controversial in poultry (Kaiser and Stäheli, 2014; Textbox 6). 
Textbox 6. THE MISSING GENES OF CHICKENS About 274 genes are thought to be missing in chickens while still being present in most of the other vertebrate lineages (Lovell et al., 2014). Such missing genes are associated with gastrointestinal diseases (n=40), inflammatory responses (n=27), immune cell trafficking (n=23), G-protein coupled receptor signalling (n=9) and humoral immune responses (n=6) (Lovell et al., 2014). This may explain why several genes that are critical in understanding the effect of butyrate in mammals are missing in the chicken genome (e.g. TNF-α, FFAR3, GPR109a; Kaiser, 2014; Meslin et al., 2015).  Recent evidences indicates, however, that several genes that have been described as missing in birds by Lovell and colleagues (2014) may have simply escaped sequencing due to their high GC content and long GC-rich stretches (Hron et al., 2015). Updated versions of the avian genome may help to design primers and monoclonal Ab in the near future to study several aspects of avian immunity that could not be captured so far (e.g. FOXP3 and TNF-α) as well of missing butyrate-sensing receptors (e.g. FFAR3 and GPR109a). 
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Focus on butyrate and humoral immunity in broilers In humans, butyrate has been reported to prevent the polarization of CD4+ T cells into T helper (TH) 1 while promoting TH2 polarization (Saemann et al., 2000). This may be due to the changes in cytokine milieu induced by butyrate presence in the 
mammalian gut (↗IL-4, ↘INF-γ; Figure 6). Such findings are partly in agreement with those of Nancey and coworkers, who reported that butyrate prevented TH1 polarization without resulting in a clear TH2 profile (Nancey et al., 2002). The TH1/TH2 balance is, therefore, affected by butyrate in mammals. Such balance is known to influence the antibody (Ab) response (Smith et al., 2000).  In poultry, the existence of a TH1-TH2 paradigm has not been clearly demonstrated yet, but a mounting body of evidence corroborates its existence (For review, see Kaiser and Stäheli, 2014). This may explain why, in birds, a decrease in NF-κB activity shifts adaptive immunity from cell-mediated to humoral responses in birds (Koutsos et al., 2014). The presence of butyrate along the intestine of broilers has an influence on IgM expression, but not on IgG expression nor IgG:IgM ratios (Table 4, using the same approach as Table 3 in Chapter 5).  
Table 4. Effect of dietary treatments1 on the genetic expression of immunoglobulins (Ig) M and G and the IgG:IgM ratio in different intestinal tract segments of broilers at 21-22 d of age  Intestinal segment Average gene expression2 IgG:IgM ratio Diet IgM IgG 
Duodenum    CTR 100 8 0.08 TB 65 9 0.15 
P-value 0.059 0.396 0.477 
Ileum    CTR 42 57 1.36 FCB 81 100 1.24 
P-value 0.014 0.282 0.128 
Colon    CTR 60 44 0.73 FCB 76 38 0.50 
P-value 0.078 0.215 0.159 1Dietary treatments groups: CTR (no dietary butyrate); TB (butyrate radical provided as tributyrin); FCB (butyrate radical provided as fat-coated butyrate). Butyrate was provided at 1 g/kg diet as is basis. Values are means of 8 birds per treatment. 2Arbitrary units. Quantitative mRNA measurement was performed by establishing a linear calibration using 10-fold serial dilutions of cDNA templates. Data were standardized using IPO8 as housekeeping gene. For each gene, the highest average gene expression across location and treatments was set to 100.     
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IgM exists as a membrane-bound Ig (i.e. B cell receptor) or as a secretory Ig (i.e. Ab). Assuming that IgM mRNA represents mostly naïve B cells and only a few activated B cells undergoing class switching, the results presented in this Thesis may indicate that butyrate has a location-dependent modulatory effect on B cell trafficking to the gut. In mammals, such trafficking is directed by chemokines such as CXCL13 (also known as BLC, B lymphocyte chemoattractant). It is known that, in mammals, butyrate induces CXCL13 expression in the small intestine (Lucero et al., 2013). Compared to mammals, birds have a somewhat more complex B cell development pathway that involves different locations, i.e. the bone marrow, Bursa of Fabricius and spleen. A range of three homeostatic B cell chemoattractant has, therefore, evolved in chickens from the expansion of an ancestral CXCL13 gene (Kaiser and Stäheli, 2014). The effect of butyrate on the expression of CXC chemokines is undocumented in poultry. If existing, such effect may bear implications for the production of secretory IgA (sIgA), a central Ig in mucosal immunity (Härtle et al., 2014). Unfortunately, IgA mRNA was not measured in the present work.  Other evidence pointing to an effect of butyrate on the humoral immunity of chickens came from the positive effect of dietary butyrate supplementation on keyhole limpet hemocyanin (KLH) binding IgY (Chapter 7). Such titers were positively correlated with the bodyweight of broilers. Titers of overt Ab binding KLH were used as proxy to evaluate natural antibodies (NAb) in birds that were not previously immunized against KLH. Keyhole limpet hemocyanin is a large antigen of approximately 390 kDa which shares epitopes with viruses, bacteria and protists (e.g. Hepatitis C, 
Escherichia coli and Trypanosoma; Sundsmo et al., 2012; Geyer et al., 2004). Hence, it is unclear whether KLH Ab titers reflect truly NAb levels or cross-reactive SpAb. In mammals, natural Ab are produced by B1 cells, a subpopulation of B cells expressing a clearly defined set of cellular markers (Baumgarth, 2004). In contrast to mammals, cellular markers specific to B1 cells have yet to be identified in birds. Surface markers that are specific to B1a cells in mammals such as CD5+ are common to all avian B cells (Ratcliffe et al., 2014). The existence of true NAb-producing B cells is, therefore, questionable in poultry. This has led Berghof (2018) to speculate that IgM NAb represent, in poultry, humoral adaptive baseline immunity rather than a pool of specialized NAb-producing B cells. The change in overt IgY binding KLH reported in Chapter 7 may, therefore, reflect secretory NAb levels or, alternatively, cross reactive Ab produced by B cells after class switching.  Overall, the results in this thesis and those of Sikandar and coworkers (2017) indicate that butyrate has an effect on the humoral immunity of broilers. Such effect, however, requires additional research to refine our understanding of the responses elicited by butyrate (change in SpAb, NAb, sIgA) and their underlying mechanisms (TH1/TH2 balance, CXCL chemokines).  
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Immuno-modulation does not always rhyme with improved health  Two factors hamper my capacity to discuss the relevance of dietary butyrate supplementation strategies to improve the health and growth performance of broilers. First, there are numerous discrepancies between the literature and the results in this Thesis concerning the immunomodulatory effect of butyrate in broilers diets. Exact reasons for such discrepancies remain unknown, partly because of a lack of experimental evidence, but also because reagents available to study immunology in birds are scarce. Secondly, it is known that, in poultry, the concept of adding one particular ingredient to the diet to prevent the adverse effect of a specific challenge may, at the same time, increase susceptibility to a different challenge (Klasing, 2007). This means that, even if the effect of butyrate on immune competence would have been consistent, the overall benefit to the health and growth performance would have been context-dependent. It is, therefore difficult to speculate on the relevance of immunomodulatory interventions in poultry production (Textbox 7).  
 
Salmonella entrica enteritidis and Eimeria infections have a very large impact on poultry production when taking into consideration economic impact, societal concern, zoonotic potential and, last but not least, animal welfare (Davies et al., 2009). Butyrate has been shown to reduce the colonization of the broiler GIT by Salmonella enteritidis under experimental conditions (Van Immerseel et al., 2005b; Sunkara et al., 2011) due to direct effects elicited on Salmonella (Gantois et al., 2006) and on the host (Sunkara et 
al., 2011; Sunkara et al., 2014).  Dietary strategies that have proven useful against Eimeria infections in poultry increase oxidative stress (e.g. flaxseed, fish oil or Artemisia annua supplementation) or IFN-γ levels in the gut (e.g. plum supplementation Allen et al., 1997a; Allen et al., 1997b; Danforth et al., 1997; Lee et al., 2008). Such effects are diametrically opposed to those elicited by dietary butyrate supplementation (Figure 6). Hence, the relevance of dietary butyrate supplementation in improving the health of broilers is conditioned by the type of challenge encountered.     
Textbox 7. A WORD OF WARNING ON THE INTERPRETATION OF IMMUNOCOMPETENCE RESULTS 
IN POULTRY STUDIES 
Because the immune system is a complex network of many cell types and accessory proteins, assessing its 
state of competence is difficult. Many nutritionists are not trained in immunology and lack the necessary 
background to design informative studies on immunocompetence or to interpret their results. This has 
resulted in a confusing and ugly literature rife with poorly thought-through experiments and misinterpreted 
results. Simply measuring every immunological end point possible is sure to find differences due to diet, but 
interpreting these differences and establishing whether a change is beneficial or detrimental is often 
impossible. K.C. Klasing Speech to the UK branch of the World’s Poultry Science Association in 2007 
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EFFECTS OF DIETARY BUTYRATE SUPPLEMENTATION ON MICROBIOTA COMPOSITION 
AND ACTIVITY  
Direct and indirect modes of action Several modes of action may explain the effect of butyrate presence in the GIT on the microbiota composition of the gut (Chapter 2). Briefly, such modes of action can be divided into two categories, depending on whether butyrate acts on the microbiota or on the host.   Direct effects of butyrate on the microbiota include epigenetic effects, such as those reported by Gantois and coworkers (2006) concerning the expression of genes regulating the invasiveness of Salmonella. Quorum sensing is an emerging concept in microbiology. This concept describes a cell to cell communication process that allows bacteria to adjust their activity based on the environmental clues provided by extracellular molecules (Papenfort and Bassler, 2016). It is hitherto unclear whether SCFA, including butyrate, can mediate a ‘quorum sensing’ type of effect. It has been reported in the literature that, in the oral cavity, metabolic end products of bacterial fermentation such as SCFA do not affect the growth of the producing species but inhibit the growth of other microorganisms with various degrees of efficacy (Huang et al., 2011). It remains, however, unclear whether the supply or exogenous (dietary) butyrate stimulates the (endogenous) microbial production of butyrate in the GIT of poultry while inhibiting the growth of other bacteria. Bortoluzzi and coworkers (2017) reported that dietary feeding of fat-coated butyrate did not affect the butyrogenic capacity of the cecal microbiota of broilers, as measured by the abundancy of the butyryl-CoA:acetate CoA transferase mRNA abundancy. The use of stable isotopes, e.g. 13C-labelled butyrate, may help to address this question.   Undissociated butyrate may, like many other organic acids, exert direct bacteriostatic and bactericidal effects (Van Immerseel et al., 2004; Ahsan et al., 2016). Butyrate is a weak organic acid (pKa of 4.82) that exists mostly in a undissociated form under acidic conditions (Ahsan et al., 2016). Such conditions are encountered in the crop, proventriculus and gizzard of chickens (Denbow, 2015). Based on the initial observations of Cherrington and coworkers (1991), poultry researchers speculated that undissociated butyrate diffuses through bacterial membranes (Ahsan et al., 2016). Subsequent dissociation in the circumneutral bacterial cytoplasm is thought to induce an acid stress that can impair bacterial fitness in a specie-dependent manner (Sun et al., 2013). This putative mode of action, although commonly relayed in recent reviews (Ahsan et al., 2016; Moquet et al., 2016), has been questioned as it fails to explain differences in susceptibility of Salmonella to organic acids of different carbon chain length (Van Immerseel and Atterbury, 2013). Accumulation of acid anions has been proposed as an alternative mechanism explaining the bacteriostatic effects of organic acids (Russell and Diez-Gonzalez, 1998).   
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Butyrate exerts not only direct effects on bacteria, but also elicits effects on the host that may affect indirectly microbiota composition. As described in the literature and in the present Thesis, butyrate modulates the expression of various mucus and host defence peptides (HDP) genes across the GIT (Sunkara et al., 2011; Sunkara et al., 2014; Chapter 6). Butyrate seems, in addition, to have a marked influence on humoral immunity at the systemic (SpAb and NAb: Sikandar et al. 2017; Chapter 7) and gut level (intestinal IgM mRNA; Chapter 8). Such influence may also modify sIgA production in the gut, which is a major mechanism by which the host influences microbiota composition. Finally, butyrate modulates digestive processes and nutrient digestibility (Chapter 4). Such effects may, theoretically, influence microbiota composition by changing the substrate left for growth in the hindgut. My results indicate, however, that butyrate-induced changes in digestive functions had little to no relevance in explaining the changes in cecal microbiota reported in Chapter 6.   
Relevance for the health and growth performance of broilers  High-throughput sequencing of 16S rRNA does not allow a phylogenetic identification that goes beyond the genus level in most cases, as shown in Chapter 6 (Zoetendal and Smidt, 2018). In addition, strains dominating the cecal microbiota of chickens are poorly characterized (Pedroso and Lee, 2014) and there is still a certain controversy regarding the specificity of the roles exerted by the bacterial species populating the GIT (Textbox 8). Yet, literature indicates that supplementing broiler diets with butyrate influences cecal microbiota composition in a manner that is positive for the health and growth performance of broilers (e.g. reduced occurrence of potentially pathogenic bacteria, improved energy yield; Qaisrani, 2014; Bortoluzzi et al., 2017). In contrast, the results presented in this Thesis indicate that the presence of butyrate in the gastric region of broilers induces cecal microbiota dysbiosis and inflammation in the distal GIT (Chapter 6) as well as intestinal Lactobacilli overgrowth and impaired AA digestibility (Chapter 4). My results indicate, in addition, that the presence of butyrate in the proximal part of the small intestine may result in fungal dysbiosis (Chapter 6). The presence of butyrate in the gastric region and in the proximal part of the small intestine seemed, therefore, to reduce gut health of broilers under the experimental conditions employed. The presence of butyrate in the more distal GIT did not result, in contrast, in measurable effects on microbiota composition and inflammation indicators.    
Textbox 8. REDUNDANT FUNCTIONS OR 
KEYSTONE SPECIES?  Phylogenetic dendograms of microbial communities inhabiting the hindgut of avian species are characterized by palm tree-like architectures (Zhu et al., 2002). Such architectures indicate a paucity of diversity at the phyla, genus and family levels and contrastingly high levels of species and strain variations (Lagerström et al., 2006; Ley et al., 2006; Onrust et al., 2015). In addition, hierarchy theory indicates that the higher level of complexity imposes selective constraints over lower, less complex levels (Koestler, 1967). This top-down selection process favours the settlement of stable microbial communities characterized by large degree of overlaps in functionalities (Benson et al., 2010). As a consequence, cecal microbiota is characterized by a paucity in diversity at intermediate levels of the phylogenetic dendogram, high levels of strain variation and overlaps in functions across strains.  At the same time, an opposing theory states that microbiota harbours bacterial species and strains having very unique and central functions that are referred to keystone species. Such species are thought to be the source of major interindividual differences in disease susceptibility and could be targeted by dietary interventions (Ze et al., 2013). 
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RECOMMENDATIONS TO THE INDUSTRY Increasing butyrate concentration in the colon and ceca seemed to be a way to positively influence digestive processes and performance (Chapter 4) without degrading the inflammatory status of the gut and the microbiota composition of broilers (Chapter 6). Feeding fat-coated butyrate to broilers is thought to increase the availability of butyrate beyond the ileum (van den Borne et al., 2015). A practical recommendation for the industry may be, therefore, to include fat-coated butyrate in the starter diets of broilers (0-10 d of age) to ensure that this location is provided with butyrate until the cecal microbiota are fully developed. When switching to grower and finisher diets, fat-coated butyrate may be replaced by a butyrogenic fibre source, e.g. inulin. Such a strategy may allow maximization of the positive effects of luminal butyrate on growth performance of broilers, especially when basal diets are devoid of butyrogenic fibres. Onrust and coworkers (2015) have published a list of dietary interventions that may stimulate endogenous butyrate production.  
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CONCLUSION The release profile of experimental and commercially available butyrate feed additives was measured in an in vitro study. Butyrate derivatives having markedly different release profiles were used in two in vivo experiments to inverstigate the effect of butyrate presence in distinct GIT segments on digestive processes, microbiota composition and immune responses of broilers. These studies have led to the following conclusions: 
• Unprotected butyrate is active in the gastric region of broilers. Tributyrin is active in the small intestine. There is an important variability of release profiles among fat-coated butyrate additives that have similar macroscopic shapes, colours and particle sizes. Some fat coated butyrate additives can extend the effect of butyrate to the colon and ceca. 
• Butyrate when present in the gastric region of poultry induces inflammation and dysbiosis in the colon and ceca. 
• Butyrate when present in the small intestine increases IgY NAb titers in peripheral blood and induces inflammation in the colon and ceca. 
• Butyrate when present in the colon and ceca of broilers increases intestinal retention time in a manner that can improve the digestibility of nutrients. 
• Transport of butyrate across the epithelium is a passive process in the gastric region and an active process in the small intestine and colon. The extent to which butyrate is oxidized in the gut of poultry appears to vary depending on the GIT segment considered. Intracellular butyrate concentration is low in the GIT and butyrate does not pass into the peripheral circulation. Butyrate does not always elicit positive effects for the gut health of broilers. Such findings support a shift in paradigm, from butyrate being a beneficial molecule to butyrate having effects that may be positive or negative depending on the GIT location considered and the concentration present. Broilers appear to react strongly to increases in digesta butyrate concentration in GIT segments where butyrate production is normally limited (crop, proventriculus, small intestine). Tolerance for the presence of butyrate in the digesta in the gastric region and small intestine may be low. The detrimental effects reported in the present thesis may be related to a strong response of broilers to butyrate signaling in such GIT segments. In contrast, GIT segments where normally butyrate production is substantial (colon and ceca) appear to have a higher tolerance for the presence of butyrate in digesta. And so the pendulum depicted in Figure 2 appears to swing back.   
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SUMMARY (EN) The broiler production sector is prompted to find strategies that can ensure improved growth performance, health and welfare of birds while using new feed ingredients that decrease cereal use and soybean meal dependence as well as the use of antibiotics. Among feed additives, butyrate has received much attention and has been proposed as a potential solution to assist the poultry sector to address the aforementioned challenges. Dietary butyrate supplementation has, however, an inconsistent effect on growth performance of broilers. Several mechanisms underlying the observed effects of butyrate on growth of livestock have been hypothesised, but, at present, a limited number of studies have investigated the existence of such mechanisms in poultry. It remains, in addition, uncertain whether the effects elicited by butyrate are conditioned by the gastrointestinal tract (GIT) segment wherein the molecule is present.  The aim of this thesis was to evaluate the effect of dietary butyrate supplementation on digestive functions, microbiota composition and immune responses of broilers and to verify whether such effects were conditioned by the GIT segment wherein butyrate is present. This research objective was addressed by supplementing broiler diets with butyrate derivatives having markedly different release profiles in the GIT. This thesis describes the results of an in vitro experiment and two in vivo trials. Chapter 2 consists of a review of the literature concerning potential modes of action of butyrate in the avian GIT, highlighting a potential role of butyrate presence in the digesta of distinct GIT segments in triggering specific effects. In Chapter 3, an in vitro model was used to compare the release profiles of experimental and commercially available butyrate derivatives along a simulated poultry GIT. Based on the outcome of this in vitro screening, several derivatives were included in the trial described in Chapter 4, in order to investigate the effects of butyrate presence in the digesta of distinct GIT segments on digestive processes and amino acid digestibility. In Chapter 5, a gene expression approach was applied in an effort to associate observed changes in digestive processes to changes in the secretory activities of different enteroendocrine cell subsets. In addition, the relationship between mucosal butyrate concentration and the expression of genes related to butyrate metabolism were investigated. In Chapter 6, the intricate relationship between cecal microbiota composition, pre-cecal digestive processes, butyrate presence along the GIT and expression of immune effectors were explored. In Chapter 7, a study is described where the effect of butyrate presence in the digesta of distinct GIT segments investigated on immune responses after in vivo stimulations. Finally, Chapter 8 summarizes and discusses the results of the previous chapters. 
Butyrate signalling in the proximal GIT  Microbial butyrate production is naturally low in the proximal GIT segments of the avian GIT such as the gastric region and the small intestine. Butyrate signalling in the gastric region increased the proteolytic activity of the proventriculus, prolonged intestinal digesta retention time and modulated the expression of host defence peptides and mucus genes in the proventriculus and pylorus (Chapters 4 and 6). Such changes were associated with changes in cecal microbiota composition that evoked dysbiosis 
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and inflammation (Chapter 6). Butyrate signalling in the small intestine increased the expression of cholecystokinin prohormone (Chapter 5), modulated the expression of host defence peptides and mucus genes (Chapter 6) and increased the titers of natural IgY antibodies in the peripheral blood (Chapter 7). Such changes were associated with intestinal inflammation (Chapter 6) and signs of intestinal microbiota overgrowth (Chapter 4). The presence of butyrate in the gastric region and small intestine reduced the expression of the free fatty acid receptor 2 (Chapter 5). The changes observed appear to be alterations in physiology and metabolism to improve digestive efficiency (retention time, gut morphology and pepsin secretion) while trying to deal with microbial overgrowth using local and systemic mechanisms (local mechanisms: increased mucus and host defence peptides; systemic mechanisms: reduced feed intake, recruitment of leukocytes as a result of inflammatory chemotaxis). Butyrate in this part of the GIT of poultry appears to be a negative signal to the broiler. 
Butyrate signalling in the distal GIT In broilers, the ceca and colon are the major fermentation sites. Hence, butyrate concentration is much higher in the colon and ceca in comparison to more proximal GIT segments (no butyrate supplementation; Chapter 4 and 7). Butyrate signalling in the colon and ceca increased intestinal retention time and tended to improve apparent pre-cecal digestibility of methionine and feed efficiency of broilers (Chapter 4). Such changes may be due to changes in L-cell secretory activities, although this mechanism could not be demonstrated at the transcriptional level (Chapter 5). Butyrate signalling in the distal GIT did not seem to induce gut inflammation (Chapter 6). In Chapter 8, a view emerged wherein broilers seem to react strongly to increases in digesta butyrate concentration in the GIT segment where naturally, butyrate production is limited. The tolerance threshold of the gastric region and small intestine to the presence of butyrate in the digesta may, therefore, be low. The detrimental effects reported in the present thesis may be related to a vigorous response of broilers to butyrate signaling in such GIT segments. In contrast, the GIT segments where naturally butyrate production is substantial, such as the colon and ceca, may have a higher tolerance threshold. 
Butyrate metabolism in the avian GIT Butyrate did not accumulate in gut tissues (Chapter 5) and did not pass into the peripheral circulation (Chapter 8), irrespective of the GIT segment considered. This indicates that, in the poultry host, intracellular butyrate concentration is tightly regulated. This may be related to possible cytotoxic effects of butyrate as a microbial metabolite (Chapter 8). Yet, an active uptake of butyrate was shown by changes in the expression of potential SCFA transporters along the GIT of broilers (Chapter 5). Transcriptional changes observed in the gastric region, ileum and colon indicated that butyrate may be oxidized in such tissues (Chapter 5). This may show that, from an evolutionary perspective, the benefits in term of energy harvest of a rapid butyrate oxidation outweighs possible detrimental effects incurred by intracellular butyrate accumulation in host tissues. 
Recommendations The results of this thesis indicate, therefore, that butyrate does not always elicit positive effects on gut health of broilers. Such findings support a paradigm shift, from 
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butyrate being a beneficial molecule to butyrate having effects that may be positive or negative depending on the GIT location considered. Unprotected butyrate was mostly active in the crop and gastric region of birds (Chapter 4). Results of the in vitro and in 
vivo studies presented in this thesis indicated that tributyrin, the triglyceride analogue of butyrate, had a release profile targeting enteric segments (Chapters 3, 4, and 7). Wax coated butyrate, an experimental derivative, had a sustained release profile in vitro (Chapter 3) but did not result in a protection of butyrate in vivo (Chapter 7). Commercial fat-coated products showed heterogeneous release profiles in the in vitro model, some products being non-protective whereas others displayed a sustained release profile (Chapter 4). Differences between the two in vivo studies concerning the patterns of digesta butyrate concentration along the GIT of birds fed the same fat-coated butyrate derivative (Chapters 4 and 7) were observed. This difference may have been caused by the composition of the basal diet (e.g. fibre composition and level) which can affect endogenous butyrate production in a way that may confound the effects induced by exogenous butyrate supplementation. Hence, it is difficult to propose, on the basis of the data presented in this thesis, practical recommendations for poultry nutritionists. It is recommended, nonetheless, to use sustained release butyrate formulations such as fat-coated butyrate in starter diets and to rely on endogenous butyrate production in later production stages by supplementing grower and finisher diets with butyrogenic fibres such as fructooligosaccharides or inulin. Such a strategy may allow to maximize the positive effects of luminal butyrate on growth performance of broilers, especially when basal diets are devoid of butyrogenic fibres.   
Summaries 
197  
RESUME (FR) Le secteur avicole doit trouver des stratégies permettant d’améliorer les performances zootechniques, la santé et le bien être des volailles tout en réduisant l’utilisation d’antibiotiques et l’importation de matières premières de contrées éloignées. Parmi les additifs alimentaires, le butyrate a reçu beaucoup d’attention de la part des nutritionnistes aviaires et a été proposé comme une solution possible pouvant aider le secteur avicole à relever les défis précédemment cités. La supplémentation alimentaire en butyrate a, cependant, des effets inconsistants sur les performances zootechniques des poulets de chair. Différents mécanismes ont été proposés pour expliquer les effets bénéfiques du butyrate sur les performances zootechniques des animaux de rentes mais, à l’heure actuelle, peu d’études ont été conduites pour vérifier l’existence de ces mécanismes chez le poulet de chair. Il est également incertain que les effets produits par le butyrate sont conditionnés par la partie du tractus digestif (TD) dans laquelle la molécule est présente. 
  Le but de cette thèse est d’évaluer les effets d’une supplémentation alimentaire en butyrate sur les fonctions digestives, la composition du microbiote et les réponses immunitaires du poulet de chair et de vérifier si ces effets sont conditionnés par la partie du TD dans laquelle la molécule est présente. Cette thématique de recherche a été traitée en utilisant des dérivatifs de butyrate ayant des profils de libération nettement différents. Cette thèse décrit les résultats d’une étude in vitro et de deux essais in vivo. Le chapitre 2 est une revue de la littérature portant sur les modes d’action du butyrate dans le TD de la volaille. Ce travail a mis en lumière le fait que la présence du butyrate dans des parties distinctes du TD peut potentiellement provoquer des réponses spécifiques. Un modèle in vitro a été utilisé dans le chapitre 3 pour comparer les cinétiques de libération de dérivatifs commerciaux et expérimentaux à base de butyrate. Sur la base de ce travail in vitro, différents dérivatifs ont été sélectionnés et utilisés dans l’essai décrit dans le Chapitre 4. Cet essai avait pour but d’évaluer les effets de la présence de butyrate dans différentes parties du TD du poulet de chair sur la physiologie digestive et sur la digestibilité des acides aminés. Une approche transcriptomique a été utilisée dans le Chapitre 5 pour tenter d’associer les changements observés en terme de physiologie digestive à des changements de l’activité sécrétrice des cellules entéroendocrines. Ce travail a permis, de plus, d’évaluer la relation existant entre le concentration en butyrate de la muqueuse digestive d’une part et l’expression de gènes liés au métabolisme du butyrate d’autre part. Dans le chapitre 6, les relations complexes existant entre la composition du microbiote caecal, les processus digestifs pré-caecaux, la présence de butyrate dans le TD et l’expression de gênes liés à l’immunité ont été explorés. Finalement, les effets de la présence de butyrate dans différentes parties du TD sur les réponses immunitaires du poulet ont été évalués dans le chapitre 7.  
Signalisation du butyrate dans la partie proximale du TD La production microbienne de butyrate est basse à l’état naturel dans la partie proximale du TD de la volaille, comme par exemple dans la région gastrique ou l’intestin grêle. La signalisation cellulaire du butyrate dans la région gastrique du poulet de chair a augmenté l’activité protéolytique du proventricule, la rétention intestinale du digesta et a modulé l’expression des peptides antimicrobiens et des mucines dans le 
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proventricule et le pylore (Chapitres 4 et 6). Ces changements ont été associés à une inflammation intestinale et à des modifications de la composition du microbiote caecal évoquant une dysbiose (Chapitre 6). La signalisation cellulaire du butyrate dans l’intestin grêle a augmenté l’expression du précurseur de la cholécystokinine (Chapitre 5), a modulé l’expression des peptides antimicrobiens et des mucines (Chapitre 6) et a augmenté le titre des anticorps naturels IgY dans la circulation périphérique (Chapitre 7). Ces changements ont été associés à une inflammation de l’intestin grêle et à des signes suggérant une croissance excessive du microbiote intestinal. La présence du butyrate dans la région gastrique et dans l’intestin grêle ont réduit l’expression du récepteur sensible aux acides gras volatils FFAR2 (Chapitre 5). Ces changements physiologiques évoquent une réponse de l’hôte visant à améliorer l’efficacité digestive (temps de rétention du digesta, sécrétions enzymatiques) et à contenir une croissance excessive du microbiote (localement avec les peptides antimicrobiens et les mucines, de manière systémique en réduisant l’ingéré et en recrutant des leucocytes par l’inflammation). Dans l’ensemble, l’adaptation de l’hôte à la présence de butyrate dans la partie proximale du TD peut avoir des effets variables sur les performances zootechniques (Chapitre 2). Cette adaptation résulte de l’intégration d’un signal négatif par l’hôte.  
Signalisation du butyrate dans la partie distale du TD Chez les oiseaux, les caeca et le colon sont des sites majeurs de fermentation. La concentration du butyrate dans le digesta du colon et des caeca est, en conséquence, supérieure à celle observée dans les parties du TD qui sont situées en amont de ces organes (Chapitres 4 et 7). La signalisation cellulaire du butyrate dans les caeca et le colon a augmenté le temps de rétention du digesta dans l’intestin grêle et a eu tendance à améliorer la digestibilité apparente iléale de la méthionine. Ces changements sont peut-être dus à une modification de l’activité sécrétrice des cellules entéroendocrines L, bien que ce mécanisme n’a pas pu être démontré au niveau transcriptionnel (Chapitre 5). La signalisation cellulaire du butyrate dans la partie distale du TD n’a pas semblé induire d’inflammation intestinale (Chapitre 6). Il est apparu dans le chapitre 8 que les poulets de chair semblent réagir vigoureusement à l’augmentation de la concentration en butyrate dans le digesta de parties du TD où, à l’état naturel, la production naturelle en butyrate est basse. Le niveau de tolérance de la région gastrique et de l’intestin grêle est donc probablement basse. Les effets négatifs de la signalisation cellulaire du butyrate dans ces parties du TD pourraient être attribuables à une réponse excessive de l’hôte. Les parties distales du TD qui, par nature, ont une production de butyrate supérieure, pourraient avoir un niveau de tolérance supérieur. 
Métabolisme du butyrate dans le TD de la volaille Il n’y a eu aucune accumulation de butyrate dans les tissus du TD (Chapitre 5) et le butyrate ne passe pas dans la circulation sanguine périphérique (Chapitre 8), quelle que soit la partie du TD où la molécule est présente. Cela suggère que, chez la volaille, la concentration intracellulaire en butyrate est finement régulée, possiblement pour éviter des effets cytotoxiques. Le transport actif de cette molécule a été néanmoins suggéré par des changements de l’expression de canaux transportant potentiellement les acides gras volatils à travers l’épithélium (Chapitre 5). Des changements au niveau transcriptionnel laissent également à penser que le butyrate pourrait être oxydé dans 
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la région gastrique, l’iléon et le colon. Cela semble indiquer que, d’un point de vue évolutif, les bénéfices en terme de couverture énergétique d’une oxydation rapide du butyrate sont supérieurs aux effets potentiellement délétères d’une accumulation de cette molécule dans le cytoplasme des cellules de l’hôte.  
Recommandations Les résultats de cette thèse indiquent donc que le butyrate n’exerce pas systématiquement des effets bénéfiques pour la santé des poulets de chair. Ces observations plaident pour un changement de paradigme : le butyrate n’est pas systématiquement associé à la santé intestinale. Cette molécule peut avoir des effets négatifs ou positifs en fonction de la partie du TD considérée. Le butyrate non protégé est principalement actif dans le jabot et la région gastrique des oiseaux (Chapitre 4). Les résultats de nos études in vitro et in vivo indiquent que la tributyrine, un triglycéride du butyrate, a un profil de libération ciblant l’intestin grêle (Chapitres 3, 4 and 7). Une encapsulation du butyrate dans de la cire permet un profil de libération graduel in vitro (Chapitre 3) mais n’offre que peu de protection in vivo (Chapitre 7). Les butyrates encapsulés avec de la matière grasse végétale qui sont disponibles commercialement ont des profils de libération hétérogènes; certains n’offrant aucune protection tandis que d’autres permettent une libération graduelle (Chapitre 4). Nous avons observé des différences du profil de concentration du butyrate dans le digesta du TD des volailles entre nos deux essais in vivo en dépit de l’utilisation du même produit commercial (Chapitres 4 et 7). Cela suggère que la composition de l’aliment (e.g. composition et niveau des fibres alimentaires) peut avoir un effet sur la production endogène de butyrate par le microbiote, ce qui rend plus difficile de distinguer les effets de la supplémentation alimentaire en butyrate. Il est donc difficile, à partir de cette thèse, de tirer des conclusions générales et pratiques à destination des nutritionnistes avicoles. Il est néanmoins recommandé d’utiliser un dérivatif du butyrate ayant un profil de libération graduel dans les aliments de démarrage. Certains produits commerciaux utilisant une encapsulation à base de matière grasse végétale pourraient être utilisés à cet effet. Il est ensuite recommandé de s’appuyer sur la production endogène de butyrate par le microbiote en supplémentant les aliments croissance et finition avec des fibres butyrogéniques tel que l’inuline ou les fructooligosaccharides. Cette stratégie alimentaire peut permettre maximiser les effets positifs du butyrate sur les performances zootechniques du poulet de chair, en particulier dans lorsque l’aliment est pauvre en fibres butyrogéniques.   
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SAMENVATTING (NL) Kippenvleesproductie in de toekomst zal worden gekenmerkt door een efficiënte groei van gezonde kuikens in een diervriendelijke omgeving die minder milieubelastend zal zijn. Daartoe wordt gebruik gemaakt van voeradditieven om de afhankelijkheid van (ook voor de mens geschikte) granen en soja te verminderen, alsook het gebruik van antibiotica. Een voorbeeld van zo’n voeradditief is boterzuur (butyraat). Boterzuur heeft in de wetenschappelijke en technische literatuur veel aandacht gekregen als mogelijke oplossing voor bovengenoemde uitdagingen voor de sector. Boterzuurtoevoeging aan het voer laat echter tegengestelde effecten zien op groeiprestaties van vleeskuikens. Verschillende hypotheses zijn geformuleerd omtrent de werkingsmechanismen van boterzuur, maar slechts enkele studies bestudeerden daadwerkelijk dit soort mechanismen bij pluimvee. Het blijft daardoor onduidelijk in hoeverre algemene effecten toegeschreven aan boterzuur wellicht meer specifiek zijn toe te schrijven aan het maagdarmsegment waarin dit molecuul vrijkomt.    Het doel van dit proefschrift was de effecten van het toevoegen van boterzuur aan het voer voor vleeskuikens te bestuderen op verteringskinetiek, microbiota-compositie en immunologische responsen. En daarbij te bepalen of de gemeten effecten afhankelijk waren van het maagdarmsegment waar boterzuur aanwezig was. In de proeven werd dit gerealiseerd door boterzuurformuleringen te gebruiken met een verschillende kinetiek in het vrijkomen van boterzuur in het maagdarmkannal (MDK). Dit proefschrift beschrijft de resultaten van een in vitro en twee in vivo experimenten. Hoofdstuk 2 bestaat uit een literatuuroverzicht waarin de werkingsmechanismen van boterzuur in de darm(inhoud) worden belicht. In Hoofdstuk 3 wordt een in vitro experiment beschreven, waarbij de kinetiek van verschillende experimentele en commerciële boterzuurformuleringen in het MDK op laboratoriumschaal wordt gesimuleerd. Gebaseerd op de uitkomsten van deze in vitro studie is een experiment uitgevoerd met verschillende boterzuurformuleringen om de effecten op vertering van nutriënten en specifiek aminozuren te bestuderen (Hoofdstuk 4). In Hoofdstuk 5 is de secretoire activiteit van verschillende entero-endocriene cellen in de darm door middel van genexpressie bestudeerd om deze activiteit te relateren aan verteringsprocessen. Daarnaast is bestudeerd of de boterzuur concentratie in de darmmucosa gerelateerd was aan de expressie van genen die coderen voor boterzuurmetabolisme. De complexe relatie tussen microbiota in de ceca, verteringsprocessen, de beschikbaarheid van boterzuur in bepaalde maagdarmsegmenten en de expressie van immunologische cellen werd bestudeerd in Hoofdstuk 6. Het effect van de aanwezigheid van boterzuur in specifieke maagdarmsegmenten op de immuunrespons na immunisatie was onderwerp van studie in Hoofdstuk 7. In het laatste hoofdstuk (Hoofdstuk 8) worden de bevindingen uit de eerdere hoofdstukken bediscussieerd. 
Signaalfunctie van boterzuur in het begin van het MDK Van nature vindt er weinig boterzuurproductie door microben plaats in het begin van het MDK (magen en dunne darm) bij pluimvee. Uit deze studie bleek dat de boterzuuractiviteit in de magen de proteolytische activiteit van de kliermaag verhoogt, alsook een langere retentietijd van de digesta in de darm veroorzaakt. Daarnaast verandert de genexpressie van eiwitten die de gastheer beschermen en die van mucus in kliermaag en pylorus (Hoofdstukken 4 en 6). Deze veranderingen gingen gepaard 
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met veranderingen in microbiota-compositie, die dysbiose en ontsteking veroorzaken (Hoofdstuk 6). Boterzuuractiviteit in de dunne darm verhoogde de expressie van het cholecystokine pro-hormoon (Hoofdstuk 5), en veranderde de genexpressie van host defense peptides en die van mucus (Hoofdstuk 6), en het verhoogde de titers van natuurlijke IgY antilichamen in de bloedbaan (Hoofdstuk 7). Deze veranderingen gingen gepaard met darmontstekingen (Hoofdstuk 6) en tekenen van overmatige darmbacteriegroei (Hoofdstuk 4). De aanwezigheid van boterzuur in magen en dunne darm verlaagde de expressie van de vluchtige vetzuurreceptor FFAR2 (Hoofdstuk 5). Deze fysiologische veranderingen suggereren een poging van het metabolisme om de voerefficiëntie te verhogen (retentietijd, darmmorfologie en pepsine secretie), terwijl tegelijkertijd getracht wordt de overmatige groei van microben te beperken, gebruikmakend van lokale (meer mucus en host defense peptides) en systemische mechanismen (verlaagde voeropname en toename van leukocyten ten gevolge van een ontstekingsreactie). Samenvattend, fysiologische veranderingen ten gevolge van de aanwezigheid van boterzuur in het begin van het MDK hebben een wisselend effect op groei bij vleeskuikens (Hoofdstuk 2). Dit komt door het negatieve signaal dat wordt afgegeven door het kuiken zelf. 
Signaalfunctie van boterzuur aan het einde van het MDK Bij vogels zijn de blinde darmzakken en de dikke darm de belangrijkste plaatsen van fermentatie. Vandaar dat de boterzuurconcentratie in die delen van de darm veel hoger ligt dan in de meer proximale delen van het MDK. Dit bleek uit de studies waarin dieren geen boterzuurtoevoeging aan het voer kregen (Hoofdstukken 4 en 7). Boterzuur activiteit in de blinde darmzakken en dikke darm veroorzaakte een langere retentietijd van de digesta in de darm en een tendens was zichtbaar van een verbeterde schijnbare darmverteerbaarheid van methionine en een verbeterde voerefficiëntie (Hoofdstuk 4). Dit type veranderingen kan veroorzaakt zijn door een gewijzigd afgiftepatroon van L-cellen, hoewel dit niet op transcriptieniveau kon worden aangetoond (Hoofdstuk 5). Boterzuur activiteit in de voorste delen van het MDK induceerden geen ontstekingsreacties (Hoofdstuk 6). Uit de resultaten in Hoofdstuk 8 blijkt echter dat kuikens sterk reageerden op een verhoogde boterzuurconcentratie in die segmenten van het MDK waar van nature slechts weinig boterzuur wordt geproduceerd. Het tolerantieniveau in het voorste deel van het MDK lijkt dus laag. De nadelige effecten, zoals beschreven in deze thesis, kunnen gerelateerd zijn aan een krachtige respons van vleeskuikens op de activiteit van boterzuur in deze maagdarmsegmenten. Delen van het MDK waar een hogere boterzuurproductie plaatsvindt, zoals in blinde en dikke darm, hebben wellicht een hogere drempelwaarde. 
Boterzuurmetabolisme in het maagdarmkanaal bij pluimvee Boterzuur hoopte zich niet op in het maagdarmepitheel (Hoofdstuk 5) en evenmin in de perifere circulatie (Hoofdstuk 8), ongeacht het bestudeerde maagdarmsegment. Dit suggereert dat bij pluimvee de intracellulaire boterzuurconcentratie binnen nauwe grenzen varieert. Dit kan te maken hebben met mogelijk cytotoxische effecten van boterzuur als metaboliet (Hoofdstuk 8) en dat zou kunnen betekenen dat boterzuur actief wordt opgenomen ten gevolge van een verandering in expressie van bepaalde korte keten vrije vetzuren in het MDK bij pluimvee (Hoofdstuk 5). Vanuit evolutionair oogpunt kan dit een manier zijn om de energie uit een snelle oxidatie van boterzuur te 
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benutten om daarmee mogelijk nadelige effecten van een intracellulaire ophoping in darmweefsel te voorkomen. 
Aanbevelingen Uit de resultaten van dit onderzoek blijkt dat boterzuur de maagdarmgezondheid niet uitsluitend positief beïnvloedt. De resultaten ondersteunen een veranderend paradigma rondom de effecten van boterzuur, waarbij het molecuul niet slechts positief werkt maar een werking (positief of negatief) laat zien die afhankelijk is van het segment van de darm waar het molecuul aanwezig is. Vrij boterzuur was het meest actief in de krop en magen (Hoofdstuk 4). Daarentegen bleek uit de in vitro en in vivo studies dat tributerine, het triglyceride analoog van boterzuur, vooral vrijkwam in de dunne darmsegmenten (Hoofdstukken 3, 4 en 7). Boterzuur gecoat met wax, een experimentele formulering, kwam in vitro heel geleidelijk vrij in het MDK (Hoofdstuk 3), maar deze coating gaf in vivo geen enkele bescherming (Hoofdstuk 7). Commerciële vet-gecoate formuleringen lieten in vitro een grote variatie zien in het vrijkomen van boterzuur; sommige formuleringen beschermden totaal niet, waar andere formuleringen een geleidelijk vrijkomen van boterzuur lieten zien (Hoofdstuk 4). Tussen de twee in vivo experimenten zagen we verschillen in boterzuurconcentratie in hetzelfde darmsegment van de vet-gecoate formulering (Hoofdstukken 4 en 7). Dit zou kunnen betekenen dat het voer van de kuikens (bv de vezelfractie, die varieerde tussen beide experimenten) de endogene boterzuur productie kan hebben beïnvloed, waardoor de effecten van de exogene toediening vertroebeld werden. Vandaar dat het lastig is om op basis van de resultaten uit dit proefschrift een algemeen geldende praktische aanbeveling voor pluimveenutritionisten te doen. Desalniettemin zou ik, op basis van deze resultaten, aanbevelen om boterzuur geleidelijk te laten vrijkomen in het MDK (door bv vet-gecoat boterzuur te gebruiken) tijdens de startfase bij vleeskuikens en in latere fasen van de groei te vertrouwen op de endogene boterzuurafgifte ondersteund door een voer met boterzuurstimulerende vezels zoals fructo-oligosacchariden of inuline. Een dergelijke voerstrategie ondersteunt de groei en gezondheid van vleeskuikens, met name in de voeders die geen vezels bevatten.      
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